BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546-1555. [PMID: 26231459 DOI: 10.1016/s0140-6736(15)61412-x] [Cited by in Crossref: 1422] [Cited by in F6Publishing: 705] [Article Influence: 203.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhang YR, Wu DM, Liu XC, Zhou N, Cao CC, Liu WH, Wang CX, Wang H. Multimodal therapy and twenty years of valid management of a patient with chronic hepatitis B in a less developed Western Region in China---case report and review of the literature. BMC Infect Dis 2019;19:49. [PMID: 30642253 DOI: 10.1186/s12879-019-3673-4] [Reference Citation Analysis]
2 Hyun Kim B, Ray Kim W. Epidemiology of Hepatitis B Virus Infection in the United States. Clin Liver Dis (Hoboken) 2018;12:1-4. [PMID: 30988901 DOI: 10.1002/cld.732] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
3 Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Treeprasertsuk S, Tanwandee T, Charatcharoenwitthaya P, Thongsawat S, Leerapun A, Piratvisuth T, Boonsirichan R, Bunchorntavakul C, Pattanasirigool C, Pornthisarn B, Tuntipanichteerakul S, Sripariwuth E, Jeamsripong W, Sanpajit T, Poovorawan Y, Komolmit P. Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study. Asian Pac J Cancer Prev 2019;20:1257-64. [PMID: 31030503 DOI: 10.31557/APJCP.2019.20.4.1257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Badawi MM, Atif MS, Mustafa YY. Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan. Virol J. 2018;15:148. [PMID: 30253805 DOI: 10.1186/s12985-018-1060-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
5 Tang E, Torres S, Liu B, Baden R, Bhuket T, Wong RJ. High Prevalence of Cirrhosis at Initial Presentation Among Safety-Net Adults with Chronic Hepatitis B Virus Infection. J Clin Exp Hepatol 2018;8:235-40. [PMID: 30302039 DOI: 10.1016/j.jceh.2017.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Butt ZA, Wong S, Rossi C, Binka M, Wong J, Yu A, Darvishian M, Alvarez M, Chapinal N, Mckee G, Gilbert M, Tyndall MW, Krajden M, Janjua NZ. Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes. Open Forum Infect Dis 2020;7:ofaa347. [PMID: 32964065 DOI: 10.1093/ofid/ofaa347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lazarevic I, Banko A, Miljanovic D, Cupic M. Biological features of hepatitis B virus strains associated with fulminant hepatitis. Future Virology 2020;15:455-69. [DOI: 10.2217/fvl-2020-0011] [Reference Citation Analysis]
8 Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K. Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma. Sci Rep 2018;8:7958. [PMID: 29784950 DOI: 10.1038/s41598-018-26217-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
9 Jang Y, Kim JH, Lee K. Validation of the revised piper fatigue scale in Koreans with chronic hepatitis B. PLoS One 2017;12:e0177690. [PMID: 28542250 DOI: 10.1371/journal.pone.0177690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Wang H, Men P, Xiao Y, Gao P, Lv M, Yuan Q, Chen W, Bai S, Wu J. Hepatitis B infection in the general population of China: a systematic review and meta-analysis. BMC Infect Dis 2019;19:811. [PMID: 31533643 DOI: 10.1186/s12879-019-4428-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
11 Yu F, Zhang X, Tian S, Geng L, Xu W, Ma N, Wang M, Jia Y, Liu X, Ma J, Quan Y, Zhang C, Guo L, An W, Liu D. Comprehensive investigation of cytokine- and immune-related gene variants in HBV-associated hepatocellular carcinoma patients. Biosci Rep 2017;37:BSR20171263. [PMID: 29138264 DOI: 10.1042/BSR20171263] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chandrasekar E, Song S, Johnson M, Harris AM, Kaufman GI, Freedman D, Quinn MT, Kim KE. A Novel Strategy to Increase Identification of African-Born People With Chronic Hepatitis B Virus Infection in the Chicago Metropolitan Area, 2012-2014. Prev Chronic Dis 2016;13:E118. [PMID: 27584874 DOI: 10.5888/pcd13.160162] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
13 Xu Z, Zhao J, Liu J, Dong Y, Wang F, Yan J, Cao L, Wang P, Li A, Li J, Zhu S, Zhong Y, Zhang M, Wang FS. Assessment of liver fibrosis by transient elastography in young children with chronic hepatitis B virus infection. Hepatol Int 2021;15:602-10. [PMID: 34240319 DOI: 10.1007/s12072-021-10194-7] [Reference Citation Analysis]
14 Kim HS, Rotundo L, Yang JD, Kim D, Kothari N, Feurdean M, Ruhl C, Unalp-Arida A. Racial/ethnic disparities in the prevalence and awareness of Hepatitis B virus infection and immunity in the United States. J Viral Hepat. 2017;. [PMID: 28581638 DOI: 10.1111/jvh.12735] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
15 Xu B, Tang B, Wei J. Role of STAT1 in the resistance of HBV to IFN-α. Exp Ther Med 2021;21:550. [PMID: 33850522 DOI: 10.3892/etm.2021.9982] [Reference Citation Analysis]
16 Koneru A, Schillie S, Roberts H, Sirotkin B, Fenlon N, Murphy TV, Nelson NP. Estimating Annual Births to Hepatitis B Surface Antigen-Positive Women in the United States by Using Data on Maternal Country of Birth. Public Health Rep 2019;134:255-63. [PMID: 30943844 DOI: 10.1177/0033354919836958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Lu H, Wang Y, Wang X, Wu X, Zhou L, Lin L, Sheng R, Tian H, Li T, Xu H. Yisaipu® Provide AS Patients With an Economical Therapeutic Option While Original Biologicals are More Advantageous in the COVID-19 Epidemic Situation. Front Pharmacol 2021;12:692768. [PMID: 34552481 DOI: 10.3389/fphar.2021.692768] [Reference Citation Analysis]
18 Kornyeyev D, Ramakrishnan D, Voitenleitner C, Livingston CM, Xing W, Hung M, Kwon HJ, Fletcher SP, Beran RK. Spatiotemporal Analysis of Hepatitis B Virus X Protein in Primary Human Hepatocytes. J Virol 2019;93:e00248-19. [PMID: 31167911 DOI: 10.1128/JVI.00248-19] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
19 Niu C, Livingston CM, Li L, Beran RK, Daffis S, Ramakrishnan D, Burdette D, Peiser L, Salas E, Ramos H, Yu M, Cheng G, Strubin M, Delaney WE IV, Fletcher SP. The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection. PLoS One. 2017;12:e0169648. [PMID: 28095508 DOI: 10.1371/journal.pone.0169648] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 12.4] [Reference Citation Analysis]
20 Ayele A, Abera D, Hailu M, Birhanu M, Desta K. Prevalence and associated risk factors for Hepatitis B and C viruses among refugees in Gambella, Ethiopia. BMC Public Health 2020;20:721. [PMID: 32429964 DOI: 10.1186/s12889-020-08893-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Casillas R, Tabernero D, Gregori J, Belmonte I, Cortese MF, González C, Riveiro-Barciela M, López RM, Quer J, Esteban R, Buti M, Rodríguez-Frías F. Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population. World J Gastroenterol 2018; 24(6): 680-692 [PMID: 29456407 DOI: 10.3748/wjg.v24.i6.680] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
22 Agarwal L, Singh AK, Agarwal A, Singh RP. Incidental detection of hepatitis B and C viruses and their coinfection in a hospital-based general population in tertiary care hospital of Uttar Pradesh. J Family Med Prim Care 2018;7:157-61. [PMID: 29915751 DOI: 10.4103/jfmpc.jfmpc_196_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
23 Quinet J, Jamard C, Burtin M, Lemasson M, Guerret S, Sureau C, Vaillant A, Cova L. Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks. Hepatology 2018;67:2127-40. [PMID: 29251788 DOI: 10.1002/hep.29737] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
24 Chen MH, Wu CS, Chen MH, Tsai CY, Lee FY, Huang YH. High Risk of Viral Reactivation in Hepatitis B Patients with Systemic Lupus Erythematosus. Int J Mol Sci 2021;22:9116. [PMID: 34502025 DOI: 10.3390/ijms22179116] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Khaderi SA, Hollinger FB. Is the Risk of Death Enhanced in Immunosuppressed Hepatitis B Virus-infected Patients Who Develop Acute Liver Failure? Clin Gastroenterol Hepatol 2017;15:123-6. [PMID: 27693523 DOI: 10.1016/j.cgh.2016.09.141] [Reference Citation Analysis]
26 Enokida T, Moreira A, Bhardwaj N. Vaccines for immunoprevention of cancer. J Clin Invest 2021;131:146956. [PMID: 33938446 DOI: 10.1172/JCI146956] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wang Y, Zhou H, Zhang L, Zhong Q, Wang Q, Shen H, Zhang M, Huang Y, Wang A, Nelson K, Zhang Y, Yan D, Peng Z, Zhang Y, Xin X, Zhang H, Zhao J, Wang Y, Yang Y, He Y, Xu J, Liu X, Wang Y, Ma X. Prevalence of chronic hepatitis B and status of HBV care among rural women who planned to conceive in China. Sci Rep 2017;7:12090. [PMID: 28935971 DOI: 10.1038/s41598-017-12005-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
28 Woldegiorgis AE, Erku W, Medhin G, Berhe N, Legesse M. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia. PLoS One 2019;14:e0226890. [PMID: 31887192 DOI: 10.1371/journal.pone.0226890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Kruse RL, Barzi M, Legras X, Pankowicz FP, Furey N, Liao L, Xu J, Bissig-Choisat B, Slagle BL, Bissig KD. A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome. JHEP Rep 2021;3:100252. [PMID: 33733079 DOI: 10.1016/j.jhepr.2021.100252] [Reference Citation Analysis]
30 Mude W, Fisher C, Richmond J, Wallace J, Le Gautier R. A qualitative investigation of barriers, support-seeking and coping among South Sudanese people with chronic hepatitis B in Australia. Aust J Prim Health 2019. [PMID: 31213224 DOI: 10.1071/PY19015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Xiao SR, Xu GD, Wei WJ, Peng B, Deng YB. Antiviral effects of hepatitis B virus S gene-specific anti-gene locked nucleic acid in transgenic mice. World J Clin Cases 2018; 6(8): 183-191 [PMID: 30148146 DOI: 10.12998/wjcc.v6.i8.183] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Eller C, Heydmann L, Colpitts CC, Verrier ER, Schuster C, Baumert TF. The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D viruses. Cell Mol Life Sci. 2018;75:3895-3905. [PMID: 30097692 DOI: 10.1007/s00018-018-2892-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
33 Peng S, Chen H, Li X, Du Y, Gan Y. Maternal age and educational level modify the association between chronic hepatitis B infection and preterm labor. BMC Pregnancy Childbirth 2020;20:38. [PMID: 31937269 DOI: 10.1186/s12884-020-2729-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Chen YC, Jeng WJ, Hsu CW, Lin CY. Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study. BMC Gastroenterol 2020;20:146. [PMID: 32397963 DOI: 10.1186/s12876-020-01289-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Velkov S, Ott JJ, Protzer U, Michler T. The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data. Genes (Basel). 2018;9. [PMID: 30326600 DOI: 10.3390/genes9100495] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
36 Pan CQ, Chang TT, Bae SH, Brunetto M, Seto WK, Coffin CS, Tan SK, Mo S, Flaherty JF, Gaggar A, Nguyen MH, Çelen MK, Thompson A, Gane EJ. Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV. PLoS One 2021;16:e0251552. [PMID: 33984038 DOI: 10.1371/journal.pone.0251552] [Reference Citation Analysis]
37 Whitford K, Liu B, Micallef J, Yin JK, Macartney K, Van Damme P, Kaldor JM. Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis. Bull World Health Organ. 2018;96:484-497. [PMID: 29962551 DOI: 10.2471/blt.17.205153] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
38 Ndow G, Gore ML, Shimakawa Y, Suso P, Jatta A, Tamba S, Sow A, Touré-Kane C, Sadiq F, Sabally S, Njie R, Thursz MR, Lemoine M. Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes. PLoS One 2017;12:e0179025. [PMID: 28614401 DOI: 10.1371/journal.pone.0179025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
39 Bi X, Tong S. Impact of immune escape mutations and N-linked glycosylation on the secretion of hepatitis B virus virions and subviral particles: Role of the small envelope protein. Virology 2018;518:358-68. [PMID: 29604477 DOI: 10.1016/j.virol.2018.03.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
40 Al-Sadeq DW, Taleb SA, Zaied RE, Fahad SM, Smatti MK, Rizeq BR, Al Thani AA, Yassine HM, Nasrallah GK. Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update. Pathogens 2019;8:E63. [PMID: 31083509 DOI: 10.3390/pathogens8020063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
41 Yi YH, Kim YJ, Lee SY, Cho BM, Cho YH, Lee JG. Health behaviors of Korean adults with hepatitis B: Findings of the 2016 Korean National Health and Nutrition Examination Survey. World J Gastroenterol 2018; 24(28): 3163-3170 [PMID: 30065562 DOI: 10.3748/wjg.v24.i28.3163] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Chen L, Shi Y, Yang W, Zhang Y, Xie Q, Li Y, Li X, Li J, Zhang Z. Differences in Cpg Island Distribution Between Subgenotypes of the Hepatitis B Virus Genotype. Med Sci Monit 2018;24:6781-94. [PMID: 30253420 DOI: 10.12659/MSM.910049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Munshi SU, Tran TTT, Vo TNT, Tabassum S, Sultana N, Nguyen TH, Jahan M, Le CN, Baker S, Rahman M. Molecular characterization of hepatitis B virus in Bangladesh reveals a highly recombinant population. PLoS One 2017;12:e0188944. [PMID: 29216251 DOI: 10.1371/journal.pone.0188944] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
44 Wilson P, Parr JB, Jhaveri R, Meshnick SR. Call to Action: Prevention of Mother-to-Child Transmission of Hepatitis B in Africa. J Infect Dis 2018;217:1180-3. [PMID: 29351639 DOI: 10.1093/infdis/jiy028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
45 Wang YC, Yang SS, Su CW, Wang YJ, Lee KC, Huo TI, Lin HC, Huang YH. Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis. Sci Rep. 2016;6:29605. [PMID: 27405043 DOI: 10.1038/srep29605] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
46 Kostyushev D, Kostyusheva A, Brezgin S, Zarifyan D, Utkina A, Goptar I, Chulanov V. Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9. Sci Rep 2019;9:1847. [PMID: 30755668 DOI: 10.1038/s41598-019-38526-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
47 Megahed FAK, Zhou X, Sun P. The Interactions between HBV and the Innate Immunity of Hepatocytes. Viruses 2020;12:E285. [PMID: 32151000 DOI: 10.3390/v12030285] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
48 Stelma F, Willemse SB, Erken R, de Niet A, Sinnige MJ, van Dort K, Zaaijer HL, van Leeuwen EMM, Kootstra NA, Reesink HW. Dynamics of the Immune Response in Acute Hepatitis B Infection. Open Forum Infect Dis 2017;4:ofx231. [PMID: 29302605 DOI: 10.1093/ofid/ofx231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
49 Fiorino S, Bacchi-Reggiani ML, Leandri P, Loggi E, Andreone P. Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis. World J Hepatol 2017; 9(6): 333-342 [PMID: 28293383 DOI: 10.4254/wjh.v9.i6.333] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
50 Tavoschi L, Mason L, Petriti U, Bunge E, Veldhuijzen I, Duffell E. Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area. J Hosp Infect 2019;102:359-68. [PMID: 30885816 DOI: 10.1016/j.jhin.2019.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ridge LJ, Stimpfel AW, Klar RT, Dickson VV, Squires AP. Infection Prevention and Control in Liberia 5 Years After Ebola: A Case Study. Workplace Health Saf 2021;69:242-51. [PMID: 33845686 DOI: 10.1177/2165079921998076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Lô G, Sow-Sall A, Diop-Ndiaye H, Babacar N, Diouf NN, Daffé SM, Ndao B, Thiam M, Mbow M, Soumboundou MB, Lemoine M, Sylla-Niang M, Ndiaye O, Boye CS, Mboup S, Touré-Kane NC. Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level. Pan Afr Med J 2019;32:140. [PMID: 31303913 DOI: 10.11604/pamj.2019.32.140.14485] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
53 Zuure F, Bil J, Visser M, Snijder M, Boyd A, Blom P, Sonder G, Schinkel J, Prins M. Hepatitis B and C screening needs among different ethnic groups: A population-based study in Amsterdam, the Netherlands. JHEP Rep 2019;1:71-80. [PMID: 32039354 DOI: 10.1016/j.jhepr.2019.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Li X, Jiao Y, Xing Y, Gao P. Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis. Biomed Res Int. 2019;2019:5308308. [PMID: 31080822 DOI: 10.1155/2019/5308308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
55 Choga WT, Anderson M, Zumbika E, Moyo S, Mbangiwa T, Phinius BB, Melamu P, Kayembe MK, Kasvosve I, Sebunya TK, Blackard JT, Essex M, Musonda RM, Gaseitsiwe S. Molecular characterization of hepatitis B virus in blood donors in Botswana. Virus Genes 2019;55:33-42. [PMID: 30382563 DOI: 10.1007/s11262-018-1610-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
56 Bayliss J, Nissen M, Prakash D, Richmond P, Oh KB, Nolan T. Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine. Hum Vaccin Immunother 2021;17:176-90. [PMID: 32573398 DOI: 10.1080/21645515.2020.1764826] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Erdoğdu Hİ, Atalay E, Gürsoy G, Canbakan B, Aktürk S, Yazıcı C, Yücel O, Mersin S, Üçer S, Merhametsiz Ö, Öner C, Erat M. Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers. Clin Exp Nephrol 2019;23:530-6. [PMID: 30488288 DOI: 10.1007/s10157-018-1676-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
58 Adjei CA, Atibila F, Apiribu F, Ahordzor F, Attafuah PA, Ansah-Nyarko M, Asamoah R, Menkah W. Hepatitis B Infection among Parturient Women in Peri-Urban Ghana. Am J Trop Med Hyg 2018;99:1469-74. [PMID: 30298807 DOI: 10.4269/ajtmh.17-0752] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
59 Lei M, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China. World J Gastroenterol 2018; 24(48): 5525-5536 [PMID: 30622380 DOI: 10.3748/wjg.v24.i48.5525] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
60 Mirzaei Alavijeh M, Vaezi M, Jalilian F. Hepatitis B Vaccine Acceptability among Nurses: A Theory Based Conceptualization. Middle East J Dig Dis 2019;11:45-51. [PMID: 31049182 DOI: 10.15171/mejdd.2018.127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Choi J, Kim HJ, Lee J, Cho S, Ko MJ, Lim YS. Risk of Hepatocellular Carcinoma in Patients Treated with Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study. JAMA Oncol. 2019;5:30-36. [PMID: 30267080 DOI: 10.1001/jamaoncol.2018.4070] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 36.0] [Reference Citation Analysis]
62 Aljumah AA, Babatin M, Hashim A, Abaalkhail F, Bassil N, Safwat M, Sanai FM. Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions. Saudi J Gastroenterol 2019;25:73-80. [PMID: 30720000 DOI: 10.4103/sjg.SJG_421_18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
63 Cui F, Shen L, Li L, Wang H, Wang F, Bi S, Liu J, Zhang G, Wang F, Zheng H, Sun X, Miao N, Yin Z, Feng Z, Liang X, Wang Y. Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China. Emerg Infect Dis 2017;23:765-72. [PMID: 28418296 DOI: 10.3201/eid2305.161477] [Cited by in Crossref: 122] [Cited by in F6Publishing: 115] [Article Influence: 24.4] [Reference Citation Analysis]
64 Thai H, Lara J, Xu X, Kitrinos K, Gaggar A, Chan HLY, Xia GL, Ganova-Raeva L, Khudyakov Y. Complex genetic encoding of the hepatitis B virus on-drug persistence. Sci Rep 2020;10:15574. [PMID: 32968103 DOI: 10.1038/s41598-020-72467-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Cohen C, Evans AA, Huang P, London WT, Block JM, Chen G. Hepatitis B knowledge among key stakeholders in Haimen City, China: Implications for addressing chronic HBV infection. Hepatol Med Policy 2016;1:4. [PMID: 30288308 DOI: 10.1186/s41124-016-0004-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
66 Lam AM, Ren S, Espiritu C, Kelly M, Lau V, Zheng L, Hartman GD, Flores OA, Klumpp K. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants. Antimicrob Agents Chemother. 2017;61. [PMID: 28559265 DOI: 10.1128/aac.00680-17] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 7.8] [Reference Citation Analysis]
67 Zheng J, Guo MH, Peng HW, Cai XL, Wu YL, Peng XE. The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies. Epidemiol Infect 2020;148:e290. [PMID: 33222713 DOI: 10.1017/S0950268820002861] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Chen EQ, Feng S, Wang ML, Liang LB, Zhou LY, Du LY, Yan LB, Tao CM, Tang H. Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B. Sci Rep. 2017;7:173. [PMID: 28282964 DOI: 10.1038/s41598-017-00111-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]
69 Bigna JJ, Noubiap JJ, Nansseu JR, Aminde LN. Prevalence and etiologies of pulmonary hypertension in Africa: a systematic review and meta-analysis. BMC Pulm Med 2017;17:183. [PMID: 29221480 DOI: 10.1186/s12890-017-0549-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
70 Mason LM, Duffell E, Veldhuijzen IK, Petriti U, Bunge EM, Tavoschi L. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review. Euro Surveill 2019;24. [PMID: 31362808 DOI: 10.2807/1560-7917.ES.2019.24.30.1800614] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
71 Li D, He W, Liu X, Zheng S, Qi Y, Li H, Mao F, Liu J, Sun Y, Pan L, Du K, Ye K, Li W, Sui J. A potent human neutralizing antibody Fc-dependently reduces established HBV infections. Elife 2017;6:e26738. [PMID: 28949917 DOI: 10.7554/eLife.26738] [Cited by in Crossref: 45] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
72 El-Mokhtar MA, Hetta HF, Mekky MA, Abd El-Kareem DM, Ramadan M, Salah M, Mohamed NA, El-Masry EA, Adel S, Sayed IM. Characterization of Antigen Escape Mutations in Chronic HBV-Infected Patients in Upper Egypt. Infect Drug Resist 2021;14:2419-27. [PMID: 34234472 DOI: 10.2147/IDR.S315299] [Reference Citation Analysis]
73 Ramakrishnan D, Xing W, Beran RK, Chemuru S, Rohrs H, Niedziela-Majka A, Marchand B, Mehra U, Zábranský A, Doležal M, Hubálek M, Pichová I, Gross ML, Kwon HJ, Fletcher SP. Hepatitis B Virus X Protein Function Requires Zinc Binding. J Virol 2019;93:e00250-19. [PMID: 31167910 DOI: 10.1128/JVI.00250-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
74 Deng YD, Peng XB, Zhao RR, Ma CQ, Li JN, Yao LQ. The intestinal microbial community dissimilarity in hepatitis B virus-related liver cirrhosis patients with and without at alcohol consumption. Gut Pathog. 2019;11:58. [PMID: 31788031 DOI: 10.1186/s13099-019-0337-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
75 Zhang J, Liu X, Zhou W, Lu S, Wu C, Wu Z, Liu R, Li X, Wu J, Liu Y, Guo S, Jia S, Zhang X, Wang M. Identification of Key Genes Associated With the Process of Hepatitis B Inflammation and Cancer Transformation by Integrated Bioinformatics Analysis. Front Genet 2021;12:654517. [PMID: 34539726 DOI: 10.3389/fgene.2021.654517] [Reference Citation Analysis]
76 Huang R, Xi Z, Deng Y, He N. Fluorescence based Aptasensors for the determination of hepatitis B virus e antigen. Sci Rep 2016;6:31103. [PMID: 27499342 DOI: 10.1038/srep31103] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
77 Khan NU, Zalan A, Petruzziello A, Ud Din I, Haq F, Hayat Y. Determining the Actual Prevalence of Hepatitis B in Khyber Pakhtunkhwa-Pakistan: A Meta-Analysis. Open Virol J 2018;12:33-41. [PMID: 29576813 DOI: 10.2174/1874357901812010033] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
78 Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, Jia J, Tian Q, Aggarwal R, Muljono DH, Omata M, Ooka Y, Han KH, Lee HW, Jafri W, Butt AS, Chong CH, Lim SG, Pwu RF, Chen DS. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020;5:167-228. [PMID: 31852635 DOI: 10.1016/s2468-1253(19)30342-5] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 19.3] [Reference Citation Analysis]
79 Lungosi MB, Muzembo BA, Mbendi NC, Nkodila NA, Ngatu NR, Suzuki T, Wada K, Mbendi NS, Ikeda S. Assessing the prevalence of hepatitis B virus infection among health care workers in a referral hospital in Kisantu, Congo DR: a pilot study. Ind Health 2019;57:621-6. [PMID: 30674736 DOI: 10.2486/indhealth.2018-0166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
80 Wu Y, Liu J, Feng Y, Fu S, Ji F, Ge L, Yao N, Luo X, Zhao Y, Chen Y, Yang Y, Chen T. Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis. Hepatol Int 2020;14:180-9. [PMID: 32193814 DOI: 10.1007/s12072-020-10026-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
81 Hai T, Zou LQ. Clinical management and susceptibility of primary hepatic lymphoma: A cases-based retrospective study. World J Clin Cases 2021; 9(31): 9417-9430 [PMID: 34877277 DOI: 10.12998/wjcc.v9.i31.9417] [Reference Citation Analysis]
82 Li Y, Pan Q, Zhao H. Investigation of the values of CT perfusion imaging and ultrasound elastography in the diagnosis of liver fibrosis. Exp Ther Med 2018;16:896-900. [PMID: 30116343 DOI: 10.3892/etm.2018.6269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Wang B, Mufti G, Agarwal K. Reactivation of hepatitis B virus infection in patients with hematologic disorders. Haematologica. 2019;104:435-443. [PMID: 30733266 DOI: 10.3324/haematol.2018.210252] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
84 Lin YP, Lin SH, Wang CC, Lin CC, Chen DW, Chuang CH, Huang PY, Hung CH, Yang SY, Cho WR, Chen YS, Tsai MC. Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection. J Pers Med 2021;11:684. [PMID: 34442328 DOI: 10.3390/jpm11080684] [Reference Citation Analysis]
85 Eren C. An analysis on HBsAg, Anti-HCV, Anti-HIV½ and VDRL test results in blood donors according to gender, age range and years. PLoS One 2019;14:e0219709. [PMID: 31536507 DOI: 10.1371/journal.pone.0219709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Kasradze A, Shadaker S, Kuchuloria T, Gamkrelidze A, Nasrullah M, Gvinjilia L, Baliashvili D, Chitadze N, Kodani M, Tejada-Strop A, Drobeniuc J, Hagan L, Morgan J, Imnadze P, Averhoff F. The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey. Public Health 2020;185:341-7. [PMID: 32738575 DOI: 10.1016/j.puhe.2020.06.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Vučetić D, Jovičić M, Maslovarić I, Bogdanović S, Antić A, Stanojković Z, Filimonović G, Ilić V. Transfusion-transmissible infections among Serbian blood donors: declining trends over the period 2005-2017. Blood Transfus 2019;17:336-46. [PMID: 30865580 DOI: 10.2450/2019.0185-18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Park J, Cho H, Choi SJ, Lee GD, Sin SH, Ryu JH, Park HS, Lee H, Kim Y, Oh EJ. Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay. Ann Lab Med 2019;39:86-90. [PMID: 30215235 DOI: 10.3343/alm.2019.39.1.86] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Moore MS, Bocour A, Winters A. Surveillance-Based Estimate of the Prevalence of Chronic Hepatitis B Virus Infection, New York City, 2016. Public Health Rep 2019;134:695-702. [PMID: 31647883 DOI: 10.1177/0033354919882962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Kostyushev D, Brezgin S, Kostyusheva A, Zarifyan D, Goptar I, Chulanov V. Orthologous CRISPR/Cas9 systems for specific and efficient degradation of covalently closed circular DNA of hepatitis B virus. Cell Mol Life Sci. 2019;76:1779-1794. [PMID: 30673820 DOI: 10.1007/s00018-019-03021-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
91 Ahmad G, Khan MA, Abbas S, Athar A, Khan BS, Aslam MS. Automated Diagnosis of Hepatitis B Using Multilayer Mamdani Fuzzy Inference System.J Healthc Eng. 2019;2019:6361318. [PMID: 30867895 DOI: 10.1155/2019/6361318] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
92 Stasi C, Silvestri C, Berni R, Brunetto MR, Zignego AL, Orsini C, Milani S, Ricciardi L, De Luca A, Blanc P, Nencioni C, Aquilini D, Bartoloni A, Bresci G, Marchi S, Filipponi F, Colombatto P, Forte P, Galli A, Luchi S, Chigiotti S, Nerli A, Corti G, Sacco R, Carrai P, Ricchiuti A, Giusti M, Almi P, Cozzi A, Carloppi S, Laffi G, Voller F, Cipriani F. Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-world large-scale cohort study. World J Hepatol 2018; 10(5): 409-416 [PMID: 29844854 DOI: 10.4254/wjh.v10.i5.409] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
93 Lv M, Chen T, Yang Y, Tu T, Zhang N, Li W, Li W. Membranous nephropathy classification using microscopic hyperspectral imaging and tensor patch-based discriminative linear regression. Biomed Opt Express 2021;12:2968-78. [PMID: 34168909 DOI: 10.1364/BOE.421345] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Qiu Y, Wang DM, Lin ZN. Hepatitis B virus X protein and endoplasmic reticulum stress. Shijie Huaren Xiaohua Zazhi 2016; 24(7): 1040-1047 [DOI: 10.11569/wcjd.v24.i7.1040] [Reference Citation Analysis]
95 Charlton MR, Alam A, Shukla A, Dashtseren B, Lesmana CRA, Duger D, Payawal DA, Duy Cuong D, Jargalsaikhan G, Cua IHY, Sollano JD, Singh KR, Madan K, Win KM, Kyi KP, Tun KS, Salih M, Rastogi M, Saraf N, Thuy PTT, Hien PTD, Gani RA, Mohamed R, Tanwandee T, Piratvisuth T, Sukeepaisarnjaroen W, Naing W, Hashmi ZY. An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia. J Gastroenterol 2020;55:811-23. [PMID: 32666200 DOI: 10.1007/s00535-020-01698-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
96 Alberer M, Malinowski S, Sanftenberg L, Schelling J. Notifiable infectious diseases in refugees and asylum seekers: experience from a major reception center in Munich, Germany. Infection 2018;46:375-83. [PMID: 29616458 DOI: 10.1007/s15010-018-1134-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
97 Park S, Choi NK. Hepatitis virus infection and age-related cataract. Sci Rep 2017;7:13089. [PMID: 29026129 DOI: 10.1038/s41598-017-13283-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
98 Alghamdi M, Alghamdi AS, Aljedai A, Khathlan AA, Masri NA, Qutub A, Quaiz MA, Sanai F, Subahi G, Sulimani S. Revealing Hepatitis B Virus as a Silent Killer: A Call-to-Action for Saudi Arabia. Cureus 2021;13:e14811. [PMID: 34094765 DOI: 10.7759/cureus.14811] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Perazzo H, Pacheco AG, Luz PM, Castro R, Hyde C, Fittipaldi J, Rigolon C, Cardoso SW, Grinsztejn B, Veloso VG. Age-standardized mortality rates related to viral hepatitis in Brazil. BMC Infect Dis 2017;17:527. [PMID: 28760138 DOI: 10.1186/s12879-017-2619-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
100 Jaquet A, Tchounga B, Tanon A, Bagny A, Ekouevi DK, Traore HA, Sasco AJ, Maiga M, Dabis F. Etiology of hepatocellular carcinoma in West Africa, a case-control study. Int J Cancer 2018;143:869-77. [PMID: 29569722 DOI: 10.1002/ijc.31393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
101 Alnaggar M, Qaid AM, Chen J, Niu L, Xu K. Irreversible electroporation of malignant liver tumors: Effect on laboratory values. Oncol Lett. 2018;16:3881-3888. [PMID: 30128002 DOI: 10.3892/ol.2018.9058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
102 Pauly MD, Kamili S, Hayden TM. Impact of nucleic acid extraction platforms on hepatitis virus genome detection. J Virol Methods 2019;273:113715. [PMID: 31419455 DOI: 10.1016/j.jviromet.2019.113715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
103 Liu XQ, Ohsaki E, Ueda K. Establishment of a system for finding inhibitors of ε RNA binding with the HBV polymerase. Genes Cells 2020;25:523-37. [PMID: 32415897 DOI: 10.1111/gtc.12778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Anikhindi SA, Kumar A, Sharma P, Singla V, Bansal N, Arora A. Ideal Cure for Hepatitis B Infection: The Target is in Sight. J Clin Exp Hepatol 2018;8:188-94. [PMID: 29892183 DOI: 10.1016/j.jceh.2017.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
105 Tatar B, Acar A, Adar P, Kose S. Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients. Clin Exp Hepatol 2020;6:55-9. [PMID: 32166125 DOI: 10.5114/ceh.2020.93058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Zhang W, Wang X, Wang Y, Zhao X, Duan W, Wang Q, Wu X, Kong Y, Ma H, You H, Ou X, Jia J. Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up. Medicine (Baltimore) 2017;96:e8454. [PMID: 29095292 DOI: 10.1097/MD.0000000000008454] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
107 Kebede KM, Abateneh DD, Belay AS. Hepatitis B virus infection among pregnant women in Ethiopia: a systematic review and Meta-analysis of prevalence studies. BMC Infect Dis 2018;18:322. [PMID: 29996785 DOI: 10.1186/s12879-018-3234-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
108 Zhang P, Zhai S, Chang J, Guo JT. In Vitro Anti-hepatitis B Virus Activity of 2',3'-Dideoxyguanosine. Virol Sin 2018;33:538-44. [PMID: 30421112 DOI: 10.1007/s12250-018-0065-7] [Reference Citation Analysis]
109 Herrscher C, Roingeard P, Blanchard E. Hepatitis B Virus Entry into Cells. Cells 2020;9:E1486. [PMID: 32570893 DOI: 10.3390/cells9061486] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
110 Bollinger RC, Thio CL, Sulkowski MS, McKenzie-White J, Thomas DL, Flexner C. Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV. Lancet HIV 2020;7:e443-8. [PMID: 31870675 DOI: 10.1016/S2352-3018(19)30342-X] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
111 Craviotto V, Furfaro F, Loy L, Zilli A, Peyrin-Biroulet L, Fiorino G, Danese S, Allocca M. Viral infections in inflammatory bowel disease: Tips and tricks for correct management. World J Gastroenterol 2021; 27(27): 4276-4297 [PMID: 34366605 DOI: 10.3748/wjg.v27.i27.4276] [Reference Citation Analysis]
112 Muhammad H, Tehreem A, Hammami MB, Ting PS, Idilman R, Gurakar A. Hepatitis D virus and liver transplantation: Indications and outcomes. World J Hepatol 2021; 13(3): 291-299 [PMID: 33815673 DOI: 10.4254/wjh.v13.i3.291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
113 Zhang C, Li JW, Wu Z, Zhao H, Wang GQ. Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis. J Clin Transl Hepatol 2021;9:615-25. [PMID: 34722176 DOI: 10.14218/JCTH.2020.00136] [Reference Citation Analysis]
114 Hamdiui N, Stein ML, van der Veen YJJ, van den Muijsenbergh METC, van Steenbergen JE. Hepatitis B in Moroccan-Dutch: a qualitative study into determinants of screening participation. Eur J Public Health 2018;28:916-22. [PMID: 29346542 DOI: 10.1093/eurpub/cky003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
115 Xu C, Liu J, Liu L, Bi Y, Xu B, Chen J, Xu B, Chen T, Hu Y, Zhou YH. Comparison of hepatitis B viral loads and viral antigen levels in child-bearing age women with and without pregnancy. BMC Pregnancy Childbirth 2018;18:292. [PMID: 29980185 DOI: 10.1186/s12884-018-1932-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
116 McKee G, Butt ZA, Wong S, Salway T, Gilbert M, Wong J, Alvarez M, Chapinal N, Darvishian M, Tyndall MW, Krajden M, Janjua NZ. Syndemic Characterization of HCV, HBV, and HIV Co-infections in a Large Population Based Cohort Study. EClinicalMedicine 2018;4-5:99-108. [PMID: 31193601 DOI: 10.1016/j.eclinm.2018.10.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
117 Wang S, Xiong H, Luo C, Zhao H, Fan Y, Zhang T, Wang L, Wang Q, Xie W. Acute-on-Chronic Liver Failure in Pregnant Patients with Chronic Hepatitis B: A Retrospective Observational Case Series Study. Gastroenterol Res Pract 2020;2020:9831687. [PMID: 32849869 DOI: 10.1155/2020/9831687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Patel P, Schutzer SE, Pyrsopoulos N. Immunobiology of hepatocarcinogenesis: Ways to go or almost there? World J Gastrointest Pathophysiol 2016; 7(3): 242-255 [PMID: 27574562 DOI: 10.4291/wjgp.v7.i3.242] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
119 Sharif A, Abbas Z, Ahmed S, Ali Samjo S, Baqai K. Effect of Non-alcoholic Fatty Liver Disease on Transaminase Levels and Transient Elastography in Patients with Chronic Hepatitis B. Cureus 2019;11:e5995. [PMID: 31807383 DOI: 10.7759/cureus.5995] [Reference Citation Analysis]
120 Yim HJ, Kim JH, Park JY, Yoon EL, Park H, Kwon JH, Sinn DH, Lee SH, Lee JH, Lee HW. Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop. Clin Mol Hepatol. 2020;26:411-429. [PMID: 32854458 DOI: 10.3350/cmh.2020.0049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
121 Bos JC, Mistício MC, Nunguiane G, Mathôt RAA, van Hest RM, Prins JM. Paracetamol clinical dosing routine leads to paracetamol underexposure in an adult severely ill sub-Saharan African hospital population: a drug concentration measurement study. BMC Res Notes 2017;10:671. [PMID: 29202789 DOI: 10.1186/s13104-017-3016-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
122 Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V; HEPVIR working group of the European Society for translational antiviral research (ESAR). Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe. BMC Infect Dis 2018;18:251. [PMID: 29859062 DOI: 10.1186/s12879-018-3161-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
123 Zhang Q, Matsuura K, Kleiner DE, Zamboni F, Alter HJ, Farci P. Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology. J Transl Med. 2016;14:328. [PMID: 27894309 DOI: 10.1186/s12967-016-1085-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
124 Zhai M, Long J, Liu S, Liu C, Li L, Yang L, Li Y, Shu B. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017. Aging (Albany NY) 2021;13:279-300. [PMID: 33436531 DOI: 10.18632/aging.104127] [Reference Citation Analysis]
125 Dembele B, Affi-Aboli R, Kabran M, Sevede D, Goha V, Adiko AC, Kouamé R, Allah-Kouadio E, Inwoley A. Evaluation of Four Rapid Tests for Detection of Hepatitis B Surface Antigen in Ivory Coast. J Immunol Res 2020;2020:6315718. [PMID: 32676509 DOI: 10.1155/2020/6315718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
126 Gilbert Sandoval I, Wesseling S, Rietjens IMCM. Aflatoxin B1 in nixtamalized maize in Mexico; occurrence and accompanying risk assessment. Toxicol Rep 2019;6:1135-42. [PMID: 31993327 DOI: 10.1016/j.toxrep.2019.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
127 Grant J, Agbaji O, Kramvis A, Yousif M, Auwal M, Penugonda S, Ugoagwu P, Murphy R, Hawkins C. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians. Trop Med Int Health 2017;22:744-54. [PMID: 28376292 DOI: 10.1111/tmi.12873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
128 Goverwa-Sibanda TP, Mupanguri C, Timire C, Harries AD, Ngwenya S, Chikwati E, Mapfuma C, Mushambi F, Tweya H, Ndlovu M. Hepatitis B infection in people living with HIV who initiate antiretroviral therapy in Zimbabwe. Public Health Action 2020;10:97-103. [PMID: 33134123 DOI: 10.5588/pha.20.0008] [Reference Citation Analysis]
129 Yang S, Ma X, Cai C, Wang H, Xiao F, Yu C. Tenofovir Disoproxil Fumarate Is Superior to Entecavir in Reducing Hepatitis B Surface Antigen for Chronic Hepatitis B in China: 2-Year Comprehensive Comparative Result of a Matched Comparative Study. Front Med (Lausanne) 2021;8:637126. [PMID: 33791326 DOI: 10.3389/fmed.2021.637126] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Lee SY, Kim D, Lee SH, Sung JH. Microtechnology-based in vitro models: Mimicking liver function and pathophysiology. APL Bioeng 2021;5:041505. [PMID: 34703969 DOI: 10.1063/5.0061896] [Reference Citation Analysis]
131 Coste M, De Sèze M, Diallo A, Carrieri MP, Marcellin F, Boyer S; ANRS 12356 AmBASS Study Group. Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356). BMJ Open 2019;9:e030211. [PMID: 31320358 DOI: 10.1136/bmjopen-2019-030211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
132 Chen L, Huang X, Zhang W, Liu Y, Chen B, Xiang Y, Zhang R, Zhang M, Feng J, Liu S, Duan T, Chen X, Wang W, Pan T, Yan L, Jin T, Li G, Li Y, Xie T, Sui X. Correlation of PD-L1 and SOCS3 Co-expression with the Prognosis of Hepatocellular Carcinoma Patients. J Cancer. 2020;11:5440-5448. [PMID: 32742491 DOI: 10.7150/jca.46158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
133 Van Damme P, Dionne M, Leroux-Roels G, Van Der Meeren O, Di Paolo E, Salaun B, Surya Kiran P, Folschweiller N. Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults. J Viral Hepat. 2019;26:1066-1075. [PMID: 31087382 DOI: 10.1111/jvh.13125] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
134 Wykes MN, Lewin SR. Immune checkpoint blockade in infectious diseases. Nat Rev Immunol 2018;18:91-104. [PMID: 28990586 DOI: 10.1038/nri.2017.112] [Cited by in Crossref: 187] [Cited by in F6Publishing: 183] [Article Influence: 37.4] [Reference Citation Analysis]
135 Bilman FB, Tosun S, Yildiz IE, Alay H, Evrenos AN, Kutlu HH, Cakar ZS, Kesli R, Altuntas SB, Altuntas B. Prevalence of HBsAg seropositivity during pregnancy and evaluation of vaccination programs: A multicenter study in Turkey. North Clin Istanb 2021;8:359-64. [PMID: 34585070 DOI: 10.14744/nci.2020.26504] [Reference Citation Analysis]
136 de Beijer MTA, Jansen DTSL, Dou Y, van Esch WJE, Mok JY, Maas MJP, Brasser G, de Man RA, Woltman AM, Buschow SI. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength. J Virol 2020;94:e01663-19. [PMID: 31852786 DOI: 10.1128/JVI.01663-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
137 Gerlich WH. Do we need better hepatitis B vaccines? Indian J Med Res 2017;145:414-9. [PMID: 28862172 DOI: 10.4103/ijmr.IJMR_1852_16] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
138 Riveiro-Barciela M, Pericàs JM, Buti M. How to interpret viral markers in the management of chronic hepatitis B infection. Clin Microbiol Infect 2021:S1198-743X(21)00622-4. [PMID: 34768018 DOI: 10.1016/j.cmi.2021.10.020] [Reference Citation Analysis]
139 Harris AM, Isenhour C, Schillie S, Vellozzi C. Hepatitis B Virus Testing and Care among Pregnant Women Using Commercial Claims Data, United States, 2011-2014. Infect Dis Obstet Gynecol. 2018;2018:4107329. [PMID: 29805248 DOI: 10.1155/2018/4107329] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
140 Ding R, Lu W, Zhou X, Huang D, Wang Y, Li X, Yan L, Lin W, Song S, Zhang Z, Chen L. A Novel Non-invasive Model Based on GPR for the Prediction of Liver Fibrosis in Patients With Chronic Hepatitis B. Front Med (Lausanne) 2021;8:727706. [PMID: 34631748 DOI: 10.3389/fmed.2021.727706] [Reference Citation Analysis]
141 Soomar SM, Siddiqui AR, Azam SI, Shah M. Determinants of hepatitis B vaccination status in health care workers of two secondary care hospitals of Sindh, Pakistan: a cross-sectional study. Hum Vaccin Immunother 2021;:1-6. [PMID: 34757865 DOI: 10.1080/21645515.2021.1986332] [Reference Citation Analysis]
142 Guimarães LCDC, Brunini S, Guimarães RA, Galdino-Júnior H, Minamisava R, da Cunha VE, Santos JRS, Silveira-Lacerda EP, Souza CM, de Oliveira VLB, Albernaz GC, de Menezes TG, Rezza G. Epidemiology of hepatitis B virus infection in people living in poverty in the central-west region of Brazil. BMC Public Health 2019;19:443. [PMID: 31035990 DOI: 10.1186/s12889-019-6828-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Hong X, Kim ES, Guo H. Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B. Hepatology 2017;66:2066-77. [PMID: 28833361 DOI: 10.1002/hep.29479] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 16.8] [Reference Citation Analysis]
144 Bruni R, Villano U, Taffon S, Equestre M, Madonna E, Chionne P, Candido A, Dettori S, Pisani G, Rapicetta M, Bortolotti F, Ciccaglione AR. Retrospective analysis of acute HBV infections occurred in 1978-79 and 1994-95 in North-East Italy: increasing prevalence of BCP/pre-core mutants in sub-genotype D3. BMC Infect Dis 2020;20:78. [PMID: 31992230 DOI: 10.1186/s12879-019-4713-9] [Reference Citation Analysis]
145 Papatheodoridi M, Papatheodoridis G. Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B. Cells. 2020;9. [PMID: 32093411 DOI: 10.3390/cells9020493] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
146 Asao H. Interleukin-21 in Viral Infections. Int J Mol Sci 2021;22:9521. [PMID: 34502427 DOI: 10.3390/ijms22179521] [Reference Citation Analysis]
147 Brenner N, Mentzer AJ, Butt J, Braband KL, Michel A, Jeffery K, Klenerman P, Gärtner B, Schnitzler P, Hill A, Taylor G, Demontis MA, Guy E, Hadfield SJ, Almond R, Allen N, Pawlita M, Waterboer T. Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii. PLoS One 2019;14:e0210407. [PMID: 30615688 DOI: 10.1371/journal.pone.0210407] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
148 Mahale P, Aka P, Chen X, Pfeiffer RM, Liu P, Groover S, Mendy M, Njie R, Goedert JJ, Kirk GD, Glenn JS, O'Brien TR. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia. J Viral Hepat. 2019;26:738-749. [PMID: 30661282 DOI: 10.1111/jvh.13065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
149 Jeong JY, Sohn JH, Sohn W, Park CH, Kim TY, Jun DW, Kim Y, Jeong WK. Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. Gut Liver. 2017;11:852-859. [PMID: 28651307 DOI: 10.5009/gnl16521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Fagan O, Armstrong P, Merwe KVD, Crosnoi D, Steele C, Sopena-Falco J, Parihar V. Viral hepatitis: A brief introduction, review of management, advances and challenges. World J Meta-Anal 2021; 9(2): 139-152 [DOI: 10.13105/wjma.v9.i2.139] [Reference Citation Analysis]
151 Lô G, Ndiaye AJS, Sow A, Fall A, Sow A, Barry O, Diop NM, Ndiaye HD, Kâne NCT, Mboup S. Comparison of Amplix® hepatitis B virus and Roche COBAS AmpliPrep/COBAS Taqman hepatitis B virus assay in quantifying HBV DNA in plasma of chronic hepatitis B in Senegal. Pan Afr Med J 2021;38:294. [PMID: 34178213 DOI: 10.11604/pamj.2021.38.294.24819] [Reference Citation Analysis]
152 Lee HM, Ahn J, Kim WR, Lim JK, Nguyen M, Pan CQ, Kim D, Mannalithara A, Te H, Trinh H, Chu D, Tran T, Woog J, Lok AS. A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study. Dig Dis Sci 2019;64:358-66. [PMID: 30238203 DOI: 10.1007/s10620-018-5281-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
153 Beck IA, Payant R, Ngo-Giang-Huong N, Khamduang W, Laomanit L, Jourdain G, Frenkel LM. Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus. J Virol Methods 2016;233:51-5. [PMID: 27025356 DOI: 10.1016/j.jviromet.2016.03.014] [Reference Citation Analysis]
154 Dittharot K, Jittorntam P, Wilairat P, Sobhonslidsuk A. Urinary Metabolomic Profiling in Chronic Hepatitis B Viral Infection Using Gas Chromatography/Mass Spectrometry. Asian Pac J Cancer Prev 2018;19:741-8. [PMID: 29582629 DOI: 10.22034/APJCP.2018.19.3.741] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
155 Yoshioka N, Deguchi M, Hagiya H, Kagita M, Tsukamoto H, Takao M, Yoshida H, Yamamoto N, Akeda Y, Nabetani Y, Maeda I, Hidaka Y, Tomono K. Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations. PLoS One 2017;12:e0187661. [PMID: 29121107 DOI: 10.1371/journal.pone.0187661] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
156 Ogawa E, Furusyo N, Nguyen MH. Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy. Drug Des Devel Ther 2017;11:3197-204. [PMID: 29158666 DOI: 10.2147/DDDT.S126742] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
157 Luo H, Zhang XX, Cao LH, Tan N, Kang Q, Xi HL, Yu M, Xu XY. Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients. World J Gastroenterol 2019; 25(6): 719-728 [PMID: 30783375 DOI: 10.3748/wjg.v25.i6.719] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
158 Yin Y, He K, Wu B, Xu M, Du L, Liu W, Liao P, Liu Y, He M. A systematic genotype and subgenotype re-ranking of hepatitis B virus under a novel classification standard. Heliyon 2019;5:e02556. [PMID: 31687483 DOI: 10.1016/j.heliyon.2019.e02556] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
159 Lin Y, Zhao Z, Huang A, Lu M. Interplay between Cellular Autophagy and Hepatitis B Virus Replication: A Systematic Review. Cells 2020;9:E2101. [PMID: 32942717 DOI: 10.3390/cells9092101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
160 Bui TTT, Tran TT, Nghiem MN, Rahman P, Tran TTT, Dinh MNH, Le MH, Nguyen VVC, Thwaites G, Rahman M. Molecular characterization of hepatitis B virus in Vietnam. BMC Infect Dis 2017;17:601. [PMID: 28859616 DOI: 10.1186/s12879-017-2697-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
161 Lin J, Gu C, Shen Z, Liu Y, Wang W, Tao S, Cui X, Liu J, Xie Y. Hepatocyte nuclear factor 1α downregulates HBV gene expression and replication by activating the NF-κB signaling pathway. PLoS One 2017;12:e0174017. [PMID: 28319127 DOI: 10.1371/journal.pone.0174017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
162 Makvandi M, Soleimani Jelodar R, Samarbafzadeh A, Neisi N, Sharifi Z, Gholampour A, Masjedizadeh A, Shayesteh A. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran. Asian Pac J Cancer Prev 2018;19:2125-9. [PMID: 30139211 DOI: 10.22034/APJCP.2018.19.8.2125] [Reference Citation Analysis]
163 Cai FF, Song YN, Lu YY, Zhang Y, Hu YY, Su SB. Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinoma. Aging (Albany NY). 2020;12:14949-14965. [PMID: 32701483 DOI: 10.18632/aging.103554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
164 Lazarus JV, Stumo SR, Harris M, Hendrickx G, Hetherington KL, Maticic M, Jauffret-Roustide M, Tallada J, Simojoki K, Reic T, Safreed-Harmon K; Hep-CORE Study Group. Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017. J Int AIDS Soc 2018;21 Suppl 2:e25052. [PMID: 29633562 DOI: 10.1002/jia2.25052] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
165 Platt L, French CE, McGowan CR, Sabin K, Gower E, Trickey A, McDonald B, Ong J, Stone J, Easterbrook P, Vickerman P. Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis. J Viral Hepat. 2020;27:294-315. [PMID: 31603999 DOI: 10.1111/jvh.13217] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
166 Al-Amad SH. Prevalence of hepatitis B, C, and HIV among patients attending a teaching dental hospital. A 7-year retrospective study from the United Arab Emirates. Saudi Med J 2018;39:500-5. [PMID: 29738011 DOI: 10.15537/smj.2018.5.22116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Liu K, Qin M, Tao K, Liang Z, Cai F, Zhao L, Peng P, Liu S, Zou J, Huang J. Identification and external validation of the optimal FIB-4 and APRI thresholds for ruling in chronic hepatitis B related liver fibrosis in tertiary care settings. J Clin Lab Anal 2021;35:e23640. [PMID: 33146916 DOI: 10.1002/jcla.23640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
168 Jaquet A, Wandeler G, Nouaman M, Ekouevi DK, Tine J, Patassi A, Coffie PA, Tanon A, Seydi M, Attia A, Dabis F. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study. J Int AIDS Soc 2017;19:21424. [PMID: 28362065 DOI: 10.7448/IAS.20.1.21424] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
169 Cho WH, Lee HJ, Bang KB, Kim SB, Song IH. Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-naïve chronic hepatitis B: A case report and review of the literature. World J Gastroenterol 2018; 24(17): 1919-1924 [PMID: 29740207 DOI: 10.3748/wjg.v24.i17.1919] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
170 Ding Y, Lou J, Chen H, Li X, Wu M, Li C, Liu J, Liu C, Li Q, Zhang H, Niu J. Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infection. Br J Clin Pharmacol 2017;83:1056-71. [PMID: 27862178 DOI: 10.1111/bcp.13184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
171 Mao B, Wang Z, Pi S, Long Q, Chen K, Cui J, Huang A, Hu Y. Difluoromethylornithine, a Decarboxylase 1 Inhibitor, Suppresses Hepatitis B Virus Replication by Reducing HBc Protein Levels. Front Cell Infect Microbiol 2020;10:158. [PMID: 32373551 DOI: 10.3389/fcimb.2020.00158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
172 Michler T, Große S, Mockenhaupt S, Röder N, Stückler F, Knapp B, Ko C, Heikenwalder M, Protzer U, Grimm D. Blocking sense-strand activity improves potency, safety and specificity of anti-hepatitis B virus short hairpin RNA. EMBO Mol Med 2016;8:1082-98. [PMID: 27473329 DOI: 10.15252/emmm.201506172] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
173 Ilic I, Sipetic Grujicic S, Grujicic J, Radovanovic D, Zivanovic Macuzic I, Kocic S, Ilic M. Long-Term Trend of Liver Cancer Mortality in Serbia, 1991-2015: An Age-Period-Cohort and Joinpoint Regression Analysis. Healthcare (Basel) 2020;8:E283. [PMID: 32825549 DOI: 10.3390/healthcare8030283] [Reference Citation Analysis]
174 Appourchaux K, Dokmak S, Resche-Rigon M, Treton X, Lapalus M, Gattolliat CH, Porchet E, Martinot-Peignoux M, Boyer N, Vidaud M, Bedossa P, Marcellin P, Bièche I, Estrabaud E, Asselah T. MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C. Sci Rep 2016;6:34935. [PMID: 27731343 DOI: 10.1038/srep34935] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
175 He Q, Song X, Huang Y, Huang W, Ye B, Luo H, Luo H, Wu L, Wang Z, Chen W, Zhang L. Dexamethasone Stimulates Hepatitis B Virus (HBV) Replication Through Autophagy. Med Sci Monit 2018;24:4617-24. [PMID: 29972684 DOI: 10.12659/MSM.906250] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
176 Khadka S, Shrestha R, Pandit S, Pandit R, Bastola A. Late Response of Antiretroviral Therapy in an HIV-1-Infected Patient due to Hepatitis B and C Coinfections: The First Case Report in Nepal. Case Rep Med 2019;2019:2070973. [PMID: 30886633 DOI: 10.1155/2019/2070973] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
177 Ackermann N, Marosevic D, Hörmansdorfer S, Eberle U, Rieder G, Treis B, Berger A, Bischoff H, Bengs K, Konrad R, Hautmann W, Schönberger K, Belting A, Schlenk G, Margos G, Hoch M, Pürner F, Fingerle V, Liebl B, Sing A. Screening for infectious diseases among newly arrived asylum seekers, Bavaria, Germany, 2015. Euro Surveill 2018;23. [PMID: 29536830 DOI: 10.2807/1560-7917.ES.2018.23.10.17-00176] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
178 Lim CT, Goh GBB, Li H, Lim TK, Leow WQ, Wan WK, Azhar R, Chow WC, Kumar R. Presence of Hepatic Steatosis Does Not Increase the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Over Long Follow-Up. Microbiol Insights 2020;13:1178636120918878. [PMID: 32435130 DOI: 10.1177/1178636120918878] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
179 Yao CC, Hung CH, Hu TH, Lu SN, Wang JH, Lee CM, Chen CH. Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL. Sci Rep 2017;7:1839. [PMID: 28500322 DOI: 10.1038/s41598-017-02010-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
180 Cabezas C, Trujillo O, Balbuena J, Peceros FM, Terrazas M, Suárez M, Marin L, Apac J, Ramírez-Soto MC. Decrease in the prevalence of hepatitis B and D virus infections in an endemic area in Peru 23 years after the introduction of the first pilot vaccination program against hepatitis B. PLoS One 2020;15:e0236993. [PMID: 32760100 DOI: 10.1371/journal.pone.0236993] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 McNaughton AL, Lourenço J, Hattingh L, Adland E, Daniels S, Van Zyl A, Akiror CS, Wareing S, Jeffery K, Ansari MA, Klenerman P, Goulder PJR, Gupta S, Jooste P, Matthews PC. HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model. BMC Med 2019;17:43. [PMID: 30786896 DOI: 10.1186/s12916-019-1269-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
182 Schröeder SE, Pedrana A, Scott N, Wilson D, Kuschel C, Aufegger L, Atun R, Baptista-Leite R, Butsashvili M, El-Sayed M, Getahun A, Hamid S, Hammad R, 't Hoen E, Hutchinson SJ, Lazarus JV, Lesi O, Li W, Binti Mohamed R, Olafsson S, Peck R, Sohn AH, Sonderup M, Spearman CW, Swan T, Thursz M, Walker T, Hellard M, Howell J. Innovative strategies for the elimination of viral hepatitis at a national level: A country case series. Liver Int 2019;39:1818-36. [PMID: 31433902 DOI: 10.1111/liv.14222] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
183 Zhang C, Yang Z, Wang Z, Dou X, Sheng Q, Li Y, Han C, Ding Y. HBV DNA and HBsAg: Early Prediction of Response to Peginterferon α-2a in HBeAg-Negative Chronic Hepatitis B. Int J Med Sci 2020;17:383-9. [PMID: 32132873 DOI: 10.7150/ijms.39775] [Reference Citation Analysis]
184 Baecker A, Liu X, La Vecchia C, Zhang ZF. Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prev. 2018;27:205-212. [PMID: 29489473 DOI: 10.1097/cej.0000000000000428] [Cited by in Crossref: 64] [Cited by in F6Publishing: 41] [Article Influence: 21.3] [Reference Citation Analysis]
185 Sha M, Cao J, Zong ZP, Xu N, Zhang JJ, Tong Y, Xia Q. Identification of genes predicting unfavorable prognosis in hepatitis B virus-associated hepatocellular carcinoma. Ann Transl Med 2021;9:975. [PMID: 34277775 DOI: 10.21037/atm-21-2085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Kang XZ, Guo XR, Chen BB, Zhang TY, Yuan Q, Chen PJ, Zhang J, Xia NS. The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice. Hum Vaccin Immunother 2018;14:1779-81. [PMID: 29533134 DOI: 10.1080/21645515.2018.1449553] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
187 Falla AM, Hofstraat SHI, Duffell E, Hahné SJM, Tavoschi L, Veldhuijzen IK. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups. BMC Infect Dis 2018;18:79. [PMID: 29433454 DOI: 10.1186/s12879-018-2988-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
188 Chen Y, Li Y, Li N, Fan X, Li C, Zhang P, Han Q, Liu Z. A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels. Dis Markers 2018;2018:3924732. [PMID: 30405859 DOI: 10.1155/2018/3924732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
189 Jiang X, Zhang B, Zhao J, Xu Y, Han H, Su K, Tao J, Fan R, Zhao X, Li L, Li MD. Identification and characterization of SEC24D as a susceptibility gene for hepatitis B virus infection. Sci Rep 2019;9:13425. [PMID: 31530870 DOI: 10.1038/s41598-019-49777-8] [Reference Citation Analysis]
190 Kassa Y, Million Y, Biset S, Moges F. Hepatitis B and Hepatitis C Viral Infections and Associated Factors Among Prisoners in Northeast Ethiopia. J Blood Med 2021;12:561-70. [PMID: 34267568 DOI: 10.2147/JBM.S314556] [Reference Citation Analysis]
191 McNaughton AL, Lourenço J, Bester PA, Mokaya J, Lumley SF, Obolski U, Forde D, Maponga TG, Katumba KR, Goedhals D, Gupta S, Seeley J, Newton R, Ocama P, Matthews PC. Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis. PLoS Med 2020;17:e1003068. [PMID: 32315297 DOI: 10.1371/journal.pmed.1003068] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
192 Lee ACK, Vedio A, Liu EZH, Horsley J, Jesurasa A, Salway S. Determinants of uptake of hepatitis B testing and healthcare access by migrant Chinese in the England: a qualitative study. BMC Public Health 2017;17:747. [PMID: 28950835 DOI: 10.1186/s12889-017-4796-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
193 Ropero Álvarez AM, Pérez-Vilar S, Pacis-Tirso C, Contreras M, El Omeiri N, Ruiz-Matus C, Velandia-González M. Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas. BMC Public Health 2017;17:325. [PMID: 28415981 DOI: 10.1186/s12889-017-4227-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
194 Yao X, Huang S, Zhou H, Tang SH, Qin JP. Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt. World J Gastroenterol 2021; 27(30): 5088-5099 [PMID: 34497437 DOI: 10.3748/wjg.v27.i30.5088] [Reference Citation Analysis]
195 Giles-Vernick T, Hejoaka F, Sanou A, Shimakawa Y, Bamba I, Traoré A. Barriers to Linkage to Care for Hepatitis B Virus Infection: A Qualitative Analysis in Burkina Faso, West Africa. Am J Trop Med Hyg 2016;95:1368-75. [PMID: 27928086 DOI: 10.4269/ajtmh.16-0398] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
196 Cruz JNMD, Villar LM, Mello FCDA, Lampe E, Hyppolito EB, Lima JMC, Hyppolito SB, Pires Neto RDJ, Nicolete LDF, Coelho ICB. Hepatitis B virus genotypes prevalence in patients from hepatology services in Ceará, Brazil. Rev Soc Bras Med Trop 2021;54:e08072020. [PMID: 34495262 DOI: 10.1590/0037-8682-0807-2020] [Reference Citation Analysis]
197 Hafeez QU, Butt AS, Ahmed F. Management of Chronic Hepatitis B: Knowledge and Practices of Physicians in Pakistan. J Clin Exp Hepatol 2018;8:342-51. [PMID: 30563995 DOI: 10.1016/j.jceh.2017.12.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
198 Gao Y, Zhang TY, Yuan Q, Xia NS. Antibody-mediated immunotherapy against chronic hepatitis B virus infection. Hum Vaccin Immunother 2017;13:1768-73. [PMID: 28521640 DOI: 10.1080/21645515.2017.1319021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
199 Holmes JA, Yu ML, Chung RT. Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals. Expert Opin Drug Saf. 2017;16:651-672. [PMID: 28471314 DOI: 10.1080/14740338.2017.1325869] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
200 Escobar-Escamilla N, Fragoso-Fonseca DE, Arreguín-Porras DM, Esteban-Valencia Mdel C, Corona-Valdespino E, Falcón-Acosta JI, Vázquez-Campuzano R, Garcés-Ayala F, Ortiz-Alcantara JM, López-Martinez I, Diaz-Quiñonez JA, Ramírez-González JE. Complete Genome Sequence of Hepatitis B Virus Genotype E, the First Molecular Characterization from an Imported Case in Mexico. Genome Announc 2016;4:e00187-16. [PMID: 27034495 DOI: 10.1128/genomeA.00187-16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
201 Cheung KS, Seto WK, Wong DK, Mak LY, Lai CL, Yuen MF. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment. Oncotarget 2017;8:47507-17. [PMID: 28537900 DOI: 10.18632/oncotarget.17670] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
202 Mentha N, Clément S, Negro F, Alfaiate D. A review on hepatitis D: From virology to new therapies. J Adv Res 2019;17:3-15. [PMID: 31193285 DOI: 10.1016/j.jare.2019.03.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
203 Devine A, Harvey R, Min AM, Gilder MET, Paw MK, Kang J, Watts I, Hanboonkunupakarn B, Nosten F, McGready R. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis. BMC Infect Dis 2017;17:552. [PMID: 28793866 DOI: 10.1186/s12879-017-2660-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
204 Lam AM, Espiritu C, Vogel R, Ren S, Lau V, Kelly M, Kuduk SD, Hartman GD, Flores OA, Klumpp K. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus. Antimicrob Agents Chemother 2019;63:e01734-18. [PMID: 30373799 DOI: 10.1128/AAC.01734-18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
205 Amponsah-Dacosta E. Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030? World J Gastroenterol 2021; 27(36): 6025-6038 [PMID: 34629817 DOI: 10.3748/wjg.v27.i36.6025] [Reference Citation Analysis]
206 Coffin CS, Ramji A, Cooper CL, Miles D, Doucette KE, Wong P, Tam E, Wong DK, Wong A, Ukabam S, Bailey RJ, Tsoi K, Conway B, Barrett L, Michalak TI, Congly SE, Minuk G, Kaita K, Kelly E, Ko HH, Janssen HLA, Uhanova J, Lethebe BC, Haylock-Jacobs S, Ma MM, Osiowy C, Fung SK; Canadian HBV Network. Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network. CMAJ Open 2019;7:E610-7. [PMID: 31641059 DOI: 10.9778/cmajo.20190103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
207 Yoo J, Hann HW, Coben R, Conn M, DiMarino AJ. Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure. Diseases. 2018;6:E27. [PMID: 29677098 DOI: 10.3390/diseases6020027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
208 Liu Y, Maya S, Ploss A. Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions. Viruses 2021;13:777. [PMID: 33924793 DOI: 10.3390/v13050777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
209 Ekin N, Ucmak F, Atay AE. Evaluation of Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Reference Center Hospital in Turkey's Southeast Anatolia Among Patients Referred for Major or Minimally Invasive Surgery: Last Decade Experience in a Previously High Prevalence Area. Jundishapur J Microbiol 2021;14. [DOI: 10.5812/jjm.119654] [Reference Citation Analysis]
210 Altawalah H, Essa S, Ezzikouri S, Al-Nakib W. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study. Sci Rep 2019;9:6292. [PMID: 31000775 DOI: 10.1038/s41598-019-42810-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
211 Richmond JA, Sasadeusz J, Temple-Smith M. The Role of Primary Health Care in Hepatitis B Testing and Management: A Case Study. J Community Health 2018;43:38-47. [PMID: 28643212 DOI: 10.1007/s10900-017-0385-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
212 Seck A, Ndiaye F, Maylin S, Ndiaye B, Simon F, Funk AL, Fontanet A, Takahashi K, Akbar SMF, Mishiro S, Bercion R, Vray M, Shimakawa Y. Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West Africa. Am J Trop Med Hyg 2018;99:428-34. [PMID: 29869595 DOI: 10.4269/ajtmh.18-0116] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
213 Hamdiui N, Stein ML, Timen A, Timmermans D, Wong A, van den Muijsenbergh METC, van Steenbergen JE. Hepatitis B in Moroccan-Dutch: a quantitative study into determinants of screening participation. BMC Med 2018;16:47. [PMID: 29598817 DOI: 10.1186/s12916-018-1034-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
214 Ndeffo-Mbah ML, Vigliotti VS, Skrip LA, Dolan K, Galvani AP. Dynamic Models of Infectious Disease Transmission in Prisons and the General Population. Epidemiol Rev 2018;40:40-57. [PMID: 29566137 DOI: 10.1093/epirev/mxx014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
215 Shen X, Fu B, Liu Y, Guo C, Ye Y, Sun R, Li J, Tian Z, Wei H. NKp30+ NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B. Sci Rep 2016;6:38778. [PMID: 27941937 DOI: 10.1038/srep38778] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
216 Johnson KD, Lu X, Zhang D. Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study. BMC Public Health 2019;19:404. [PMID: 30987613 DOI: 10.1186/s12889-019-6693-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
217 Zhu Z, Huang S, Zhang Y, Sun C, Tang Y, Zhao Q, Zhou Q, Ju W, He X. Bioinformatics analysis on multiple Gene Expression Omnibus datasets of the hepatitis B virus infection and its response to the interferon-alpha therapy. BMC Infect Dis 2020;20:84. [PMID: 31996147 DOI: 10.1186/s12879-019-4720-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
218 Pettersson JH, Myking S, Elshaug H, Bygdås KIE, Stene-Johansen K. Molecular epidemiology of hepatitis B virus infection in Norway. BMC Infect Dis 2019;19:236. [PMID: 30845915 DOI: 10.1186/s12879-019-3868-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
219 Liao X, Yu T, Yang C, Huang K, Wang X, Han C, Huang R, Liu X, Yu L, Zhu G, Su H, Qin W, Deng J, Zeng X, Han B, Han Q, Liu Z, Zhou X, Liu J, Gong Y, Liu Z, Huang J, Lu L, Ye X, Peng T. Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma. J Cancer 2019;10:5689-704. [PMID: 31737106 DOI: 10.7150/jca.31287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
220 Liao M, Sun J, Zhang Q, Tang C, Zhou Y, Cao M, Chen T, Hu C, Yu J, Song Y, Li M, Liao W, Zhou Y. A Novel Post-Operative ALRI Model Accurately Predicts Clinical Outcomes of Resected Hepatocellular Carcinoma Patients. Front Oncol 2021;11:665497. [PMID: 34295811 DOI: 10.3389/fonc.2021.665497] [Reference Citation Analysis]
221 Chotun N, Preiser W, van Rensburg CJ, Fernandez P, Theron GB, Glebe D, Andersson MI. Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience. PLoS One 2017;12:e0181267. [PMID: 28732085 DOI: 10.1371/journal.pone.0181267] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
222 Sagami S, Kobayashi T, Hibi T. Prevention of Infectious Diseases due to Immunosuppression and Vaccinations in Asian Patients with Inflammatory Bowel Disease. Inflamm Intest Dis 2018;3:1-10. [PMID: 30505836 DOI: 10.1159/000489643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
223 Ansumana R, Dariano DF 3rd, Jacobsen KH, Leski TA, Lamin JM, Lahai J, Bangura U, Bockarie AS, Taitt CR, Yasuda C, Bockarie MJ, Stenger DA. Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012-2013. BMC Res Notes 2018;11:113. [PMID: 29422083 DOI: 10.1186/s13104-018-3218-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
224 Qi Y, Gao Z, Xu G, Peng B, Liu C, Yan H, Yao Q, Sun G, Liu Y, Tang D, Song Z, He W, Sun Y, Guo JT, Li W. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus. PLoS Pathog 2016;12:e1005893. [PMID: 27783675 DOI: 10.1371/journal.ppat.1005893] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 14.7] [Reference Citation Analysis]
225 Rahman MA, Ueda K, Honda T. A Traditional Chinese Medicine, Maoto, Suppresses Hepatitis B Virus Production. Front Cell Infect Microbiol 2020;10:581345. [PMID: 33553000 DOI: 10.3389/fcimb.2020.581345] [Reference Citation Analysis]
226 Kinder JM, Jiang TT, Way SS. Offspring's Tolerance of Mother Goes Viral. Immunity 2016;44:1085-7. [PMID: 27192574 DOI: 10.1016/j.immuni.2016.04.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
227 Tseng TC. Another oral antiviral treatment, but still far away from hepatitis B virus cure. Clin Mol Hepatol 2021;27:281-2. [PMID: 33687857 DOI: 10.3350/cmh.2021.0072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
228 Lee YB, Ha Y, Chon YE, Kim MN, Lee JH, Park H, Kim KI, Kim SH, Rim KS, Hwang SG. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B. Clin Mol Hepatol. 2019;25:52-64. [PMID: 30360031 DOI: 10.3350/cmh.2018.0040] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
229 Seto WK. Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies. World J Gastroenterol 2019; 25(3): 282-286 [PMID: 30686897 DOI: 10.3748/wjg.v25.i3.282] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
230 Jia X, Chen J, Megger DA, Zhang X, Kozlowski M, Zhang L, Fang Z, Li J, Chu Q, Wu M, Li Y, Sitek B, Yuan Z. Label-free Proteomic Analysis of Exosomes Derived from Inducible Hepatitis B Virus-Replicating HepAD38 Cell Line. Mol Cell Proteomics 2017;16:S144-60. [PMID: 28242843 DOI: 10.1074/mcp.M116.063503] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
231 Chabrol F, Noah Noah D, Tchoumi EP, Vidal L, Kuaban C, Carrieri MP, Boyer S; EVOLCam group. Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs. BMJ Open 2019;9:e025415. [PMID: 30898817 DOI: 10.1136/bmjopen-2018-025415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
232 Geffert K, Maponga TG, Henerico S, Preiser W, Mongella S, Stich A, Kalluvya S, Mueller A, Kasang C. Prevalence of chronic HBV infection in pregnant woman attending antenatal care in a tertiary hospital in Mwanza, Tanzania: a cross-sectional study. BMC Infect Dis 2020;20:395. [PMID: 32503443 DOI: 10.1186/s12879-020-05096-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
233 Wang H, Zhou J, Li Y, Wei L, Xu X, Zhang J, Yang K, Wei S, Zhang W. Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Ther Adv Neurol Disord 2021;14:17562864211056710. [PMID: 34950240 DOI: 10.1177/17562864211056710] [Reference Citation Analysis]
234 Li H, Liu J, Chen M, Li H, Long L. Therapeutic Evaluation of Radiotherapy with Contrast-Enhanced Ultrasound in Non-Resectable Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis. Med Sci Monit 2018;24:8183-9. [PMID: 30426970 DOI: 10.12659/MSM.911073] [Reference Citation Analysis]
235 Li Y, Si L, Zhai Y, Hu Y, Hu Z, Bei JX, Xie B, Ren Q, Cao P, Yang F, Song Q, Bao Z, Zhang H, Han Y, Wang Z, Chen X, Xia X, Yan H, Wang R, Zhang Y, Gao C, Meng J, Tu X, Liang X, Cui Y, Liu Y, Wu X, Li Z, Wang H, Hu B, He M, Gao Z, Xu X, Ji H, Yu C, Sun Y, Xing B, Yang X, Tan A, Wu C, Jia W, Li S, Zeng YX, Shen H, He F, Mo Z, Zhou G. Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese. Nat Commun. 2016;7:11664. [PMID: 27244555 DOI: 10.1038/ncomms11664] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
236 Tufon KA, Anong DN, Meriki HD, Georges TD, Maurice M, Kouanou YS, Bolimo AF, Tony NJ, Kwenti TE, Wung NH, Nkuo-Akenji T. Characterization and assessment of HBV chronically infected patients: Identification of those eligible for treatment in the South West region of Cameroon. PLoS One 2018;13:e0203312. [PMID: 30183765 DOI: 10.1371/journal.pone.0203312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
237 Mirian M, Khanahmad H, Darzi L, Salehi M, Sadeghi-Aliabadi H. Oligonucleotide aptamers: potential novel molecules against viral hepatitis. Res Pharm Sci 2017;12:88-98. [PMID: 28515761 DOI: 10.4103/1735-5362.202447] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
238 Alqahtani SM, A Alsagaby S, Mir SA, Alaidarous M, Bin Dukhyil A, Alshehri B, Banawas S, Alturaiki W, Alharbi NK, Azad TA, Al Abdulmonem W. Seroprevalence of Viral Hepatitis B and C among Blood Donors in the Northern Region of Riyadh Province, Saudi Arabia. Healthcare (Basel) 2021;9:934. [PMID: 34442071 DOI: 10.3390/healthcare9080934] [Reference Citation Analysis]
239 Andriamandimby SF, Olive MM, Shimakawa Y, Rakotomanana F, Razanajatovo IM, Andrianinarivomanana TM, Ravalohery JP, Andriamamonjy S, Rogier C, Héraud JM. Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO's elimination strategy. BMC Public Health 2017;17:636. [PMID: 28778194 DOI: 10.1186/s12889-017-4630-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
240 Xu C, Lu Y, Zheng X, Feng X, Yang X, Timm J, Wu J, Wang B, Lu M, Yang D, Liu J. TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure. Front Immunol 2017;8:1609. [PMID: 29218046 DOI: 10.3389/fimmu.2017.01609] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
241 Atteya A, Ahmad A, Daghstani D, Mushtaq K, Yassin MA. Evaluation of Hepatitis B Reactivation Among Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors. Cancer Control 2020;27:1073274820976594. [PMID: 33297765 DOI: 10.1177/1073274820976594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
242 Cathcart AL, Chan HL, Bhardwaj N, Liu Y, Marcellin P, Pan CQ, Shalimar, Buti M, Cox S, Parhy B, Zhou E, Martin R, Chang S, Lin L, Flaherty JF, Kitrinos KM, Gaggar A, Izumi N, Lim YS. No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection. Antimicrob Agents Chemother 2018;62:e01064-18. [PMID: 30038044 DOI: 10.1128/AAC.01064-18] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
243 Masrour-Roudsari J, Hasanjani-Roushan M, Yahyapour Y, Barari-Savadkoohi R, Bijani A, Sadeghi F, Mohammadnia-Afroozi M. HBS Ag seroclearance and seroconversion time in Patients with chronic hepatitis B Infection. Caspian J Intern Med 2020;11:205-10. [PMID: 32509250 DOI: 10.22088/cjim.11.2.205] [Reference Citation Analysis]
244 Wang ZY, Li YQ, Guo ZW, Zhou XH, Lu MD, Xue TC, Gao B. ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication. Acta Pharmacol Sin 2020;41:278-85. [PMID: 31554961 DOI: 10.1038/s41401-019-0302-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
245 Marino A, Cosentino F, Ceccarelli M, Moscatt V, Pampaloni A, Scuderi D, D'Andrea F, Rullo EV, Nunnari G, Benanti F, Celesia BM, Cacopardo B. Entecavir resistance in a patient with treatment-naïve HBV: A case report. Mol Clin Oncol 2021;14:113. [PMID: 33903819 DOI: 10.3892/mco.2021.2275] [Reference Citation Analysis]
246 Wu QJ, Lv WL, Li JM, Zhang TT, Zhou WH, Zhang Q, Wang JC, Wang QN, Zhang RX, Zhao X, Chen ST, Liu S, Li GH, Cao ZM, Xu L, Chen J. Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial. Trials 2020;21:482. [PMID: 32503608 DOI: 10.1186/s13063-020-04395-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
247 Ngaira JA, Kimotho J, Mirigi I, Osman S, Ng'ang'a Z, Lwembe R, Ochwoto M. Prevalence, awareness and risk factors associated with Hepatitis B infection among pregnant women attending the antenatal clinic at Mbagathi District Hospital in Nairobi, Kenya. Pan Afr Med J 2016;24:315. [PMID: 28154670 DOI: 10.11604/pamj.2016.24.315.9255] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
248 Adjei CA, Stutterheim SE, Naab F, Ruiter RAC. Chronic Hepatitis B stigma in Ghana: a qualitative study with patients and providers. BMJ Open 2019;9:e025503. [PMID: 31248915 DOI: 10.1136/bmjopen-2018-025503] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
249 Li W, Shen X, Fu B, Guo C, Liu Y, Ye Y, Sun R, Li J, Tian Z, Wei H. KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis B. Front Immunol 2017;8:1285. [PMID: 29075265 DOI: 10.3389/fimmu.2017.01285] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
250 Beran A, Mhanna M, Haghbin H, Sample JW, Burlen J. A Case of Hepatitis B Virus Reactivation Triggered by Acute Epstein-Barr Virus Infection. Cureus 2021;13:e18676. [PMID: 34786256 DOI: 10.7759/cureus.18676] [Reference Citation Analysis]
251 Yan B, Lv J, Feng Y, Liu J, Ji F, Xu A, Zhang L. Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005-2013) in eastern China. Sci Rep 2017;7:6669. [PMID: 28751727 DOI: 10.1038/s41598-017-07085-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
252 Xu S, Zhang W, Wang Q, Cui J, Yan W, Xie H, Ni A. Hepatitis B virus serological screen in a general hospital in Beijing from 2008 to 2018, and challenges to our vaccination policy. Vaccine X 2020;4:100057. [PMID: 32123866 DOI: 10.1016/j.jvacx.2020.100057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
253 Williams JR, Manfredi P, Melegaro A. The potential impact of the demographic transition in the Senegal-Gambia region of sub-Saharan Africa on the burden of infectious disease and its potential synergies with control programmes: the case of hepatitis B. BMC Med 2018;16:118. [PMID: 30041645 DOI: 10.1186/s12916-018-1100-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
254 Xu X, Xiang K, Su M, Li Y, Ji W, Li Y, Zhuang H, Li T. HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining. Viruses 2017;9:E199. [PMID: 28749433 DOI: 10.3390/v9080199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
255 Dietze KK, Schimmer S, Kretzmer F, Wang J, Lin Y, Huang X, Wu W, Wang B, Lu M, Dittmer U. Characterization of the Treg Response in the Hepatitis B Virus Hydrodynamic Injection Mouse Model. PLoS One. 2016;11:e0151717. [PMID: 26986976 DOI: 10.1371/journal.pone.0151717] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
256 Orlien SMS, Ismael NY, Ahmed TA, Berhe N, Lauritzen T, Roald B, Goldin RD, Stene-Johansen K, Dyrhol-Riise AM, Gundersen SG, Morgan MY, Johannessen A. Unexplained chronic liver disease in Ethiopia: a cross-sectional study. BMC Gastroenterol 2018;18:27. [PMID: 29439653 DOI: 10.1186/s12876-018-0755-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
257 Radzi Ah M, S Tan S, Mohamed R, Jaya F, K S, C Aun A, A Kutty G, S Wong H, Abdullah R, R Seman M, Al Mahtab M, Morad Z, Lim TO. Hepatitis Screening and Treatment Campaign in Malaysia-Validation of Low-cost Point of Care Screening Tests and Nucleic Acid Tests for Hepatitis B and C. Euroasian J Hepatogastroenterol 2018;8:101-7. [PMID: 30828549 DOI: 10.5005/jp-journals-10018-1273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
258 Chou JW, Lai HC, Chang CH, Cheng KS, Feng CL, Chen TW. Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan. Gastroenterol Res Pract. 2019;2019:4175923. [PMID: 31312216 DOI: 10.1155/2019/4175923] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
259 Knutsen HK, Alexander J, Barregård L, Bignami M, Brüschweiler B, Ceccatelli S, Cottrill B, Dinovi M, Edler L, Grasl-Kraupp B, Hogstrand C, Hoogenboom LR, Nebbia CS, Oswald IP, Rose M, Roudot AC, Schwerdtle T, Vleminckx C, Vollmer G, Wallace H, Fürst P, Baert K, Cortiñas Abrahantes J, Dujardin B, Ferrini K, Petersen A; EFSA Panel on Contaminants in the Food Chain (CONTAM). Effect on public health of a possible increase of the maximum level for 'aflatoxin total' from 4 to 10 μg/kg in peanuts and processed products thereof, intended for direct human consumption or use as an ingredient in foodstuffs. EFSA J 2018;16:e05175. [PMID: 32625810 DOI: 10.2903/j.efsa.2018.5175] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
260 Choudhuri G, Ojha R, Negi TS, Gupta V, Saxena S, Choudhuri A, Pal S, Choudhuri J, Sangam A. A school-based intervention of screening a movie to increase hepatitis B vaccination levels among students in Uttar Pradesh, India: impact on knowledge, awareness, attitudes and vaccination levels. Hepatol Med Policy 2017;2:10. [PMID: 30288323 DOI: 10.1186/s41124-017-0027-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
261 Zhang Q, Yu X, Zheng Q, He Y, Guo W. A Molecular Subtype Model for Liver HBV-Related Hepatocellular Carcinoma Patients Based on Immune-Related Genes. Front Oncol 2020;10:560229. [PMID: 33072587 DOI: 10.3389/fonc.2020.560229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
262 Wortmann N, Höner Zu Siederdissen C, Cornberg M. [Chronic hepatitis B and D (delta) : Current and future treatments]. Internist (Berl) 2018;59:519-27. [PMID: 29761292 DOI: 10.1007/s00108-018-0432-3] [Reference Citation Analysis]
263 Weng MT, Tung CC, Chang YT, Leong YL, Wang YT, Wong JM, Wei SC. Trends of Medication Usage and Associated Outcomes for Taiwanese Patients with Inflammatory Bowel Disease from 2001 to 2015. J Clin Med 2018;7:E394. [PMID: 30373275 DOI: 10.3390/jcm7110394] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
264 Wei L, Ploss A. Mechanism of Hepatitis B Virus cccDNA Formation. Viruses 2021;13:1463. [PMID: 34452329 DOI: 10.3390/v13081463] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
265 Wang B, Li W, Fang H, Zhou H. Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysis. Mol Med Rep. 2019;19:320-326. [PMID: 30387826 DOI: 10.3892/mmr.2018.9619] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
266 Hiva S, Negar K, Mohammad-Reza P, Gholam-Reza G, Mohsen A, Ali-Asghar NG, Mohammed-Jafar S. High level of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: a cross-sectional study. BMC Public Health 2020;20:920. [PMID: 32532228 DOI: 10.1186/s12889-020-09032-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
267 Chon YE, Kim DJ, Kim SG, Kim IH, Bae SH, Hwang SG, Heo J, Jang JW, Lee BS, Kim HJ, Jun DW, Kim KM, Chung WJ, Choi MS, Jang JY, Yim HJ, Tak WY, Yoon KT, Park JY, Han KH, Suk KT, Lee HW, Jang BK, Ahn SH. An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study. Medicine (Baltimore) 2016;95:e3026. [PMID: 27057828 DOI: 10.1097/MD.0000000000003026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
268 O'Connor SM, Mixson-Hayden T, Ganova-Raeva L, Djibo DA, Brown M, Xia GL, Kamili S, Jacobs M, Dong M, Thomas AG, Bulterys M, Hale B. Integrated HIV surveillance finds recent adult hepatitis B virus (HBV) transmission and intermediate HBV prevalence among military in uncharacterized Caribbean country. PLoS One 2019;14:e0222835. [PMID: 31574098 DOI: 10.1371/journal.pone.0222835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
269 Ziogas DC, Kostantinou F, Cholongitas E, Anastasopoulou A, Diamantopoulos P, Haanen J, Gogas H. Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy. J Immunother Cancer 2020;8:e000943. [PMID: 33067316 DOI: 10.1136/jitc-2020-000943] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
270 Gómez-Moreno A, Garaigorta U. Hepatitis B Virus and DNA Damage Response: Interactions and Consequences for the Infection. Viruses 2017;9:E304. [PMID: 29048354 DOI: 10.3390/v9100304] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
271 Hui Z, Nayagam S, Chan P, Fuzhen W, Thursz M, Zundong Y, Ning M, Xiaojin S, Cui F, Guomin Z, Hallett TB. Progress towards elimination of mother-to-child transmission of hepatitis B virus infection in China: a modelling analysis. Bull World Health Organ 2021;99:10-8. [PMID: 33658732 DOI: 10.2471/BLT.19.248146] [Reference Citation Analysis]
272 Schweitzer A, Akmatov MK, Krause G. Hepatitis B vaccination timing: results from demographic health surveys in 47 countries. Bull World Health Organ 2017;95:199-209G. [PMID: 28250533 DOI: 10.2471/BLT.16.178822] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
273 Reardon JM, O'Connor SM, Njau JD, Lam EK, Staton CA, Cookson ST. Cost-effectiveness of birth-dose hepatitis B vaccination among refugee populations in the African region: a series of case studies. Confl Health 2019;13:5. [PMID: 30858875 DOI: 10.1186/s13031-019-0188-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
274 Wang L, Cao M, Wei QL, Zhao ZH, Xiang Q, Wang HJ, Zhang HT, Lai GQ. A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice. PLoS One 2017;12:e0175992. [PMID: 28426720 DOI: 10.1371/journal.pone.0175992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
275 Li YY, Chen WW, Wei L, Xie YX, Wang LF, Fu JL, Wang FS. A survey of knowledge about hepatitis B among new military recruits in China. Mil Med Res 2017;4:2. [PMID: 28116112 DOI: 10.1186/s40779-016-0110-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
276 Dionne-Odom J, Westfall AO, Nzuobontane D, Vinikoor MJ, Halle-Ekane G, Welty T, Tita ATN. Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose. Pediatr Infect Dis J 2018;37:103-7. [PMID: 28787383 DOI: 10.1097/INF.0000000000001728] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
277 Shiina M, Yamada N, Sugiyama R, Murayama A, Aly HH, Muramatsu M, Wakita T, Imawari M, Kato T. Hepatitis B Virus Genotype-Dependent Vulnerability of Infected Cells to Immune Reaction in the Early Phase of Infection. Front Microbiol 2019;10:2427. [PMID: 31681253 DOI: 10.3389/fmicb.2019.02427] [Reference Citation Analysis]
278 Klok S, van Dulm E, Boyd A, Generaal E, Eskander S, Joore IK, van Cleef B, Siedenburg E, Bruisten S, van Duijnhoven Y, Tramper-Stranders G, Prins M. Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) infections among undocumented migrants and uninsured legal residents in the Netherlands: A cross-sectional study, 2018-2019. PLoS One 2021;16:e0258932. [PMID: 34714867 DOI: 10.1371/journal.pone.0258932] [Reference Citation Analysis]
279 Kwon JC, Chang HY, Kwon OY, Park JH, Oh IS, Kim HJ, Lee JH, Roh HJ, Lee HW. Seroepidemiology of Hepatitis Viruses and Hepatitis B Genotypes of Female Marriage Immigrants in Korea. Yonsei Med J 2018;59:1072-8. [PMID: 30328322 DOI: 10.3349/ymj.2018.59.9.1072] [Reference Citation Analysis]
280 Stockdale AJ, Chaponda M, Beloukas A, Phillips RO, Matthews PC, Papadimitropoulos A, King S, Bonnett L, Geretti AM. Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2017;5:e992-e1003. [PMID: 28911765 DOI: 10.1016/S2214-109X(17)30298-X] [Cited by in Crossref: 58] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
281 Tai DI, Jeng WJ, Lin CY. A global perspective on hepatitis B-related single nucleotide polymorphisms and evolution during human migration. Hepatol Commun. 2017;1:1005-1013. [PMID: 29404438 DOI: 10.1002/hep4.1113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
282 Ding R, Long J, Yuan M, Zheng X, Shen Y, Jin Y, Yang H, Li H, Chen S, Duan G. CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV. Int J Mol Sci 2021;22:4842. [PMID: 34063629 DOI: 10.3390/ijms22094842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
283 Adjei CA, Naab F, Donkor ES. Beyond the diagnosis: a qualitative exploration of the experiences of persons with hepatitis B in the Accra Metropolis, Ghana. BMJ Open 2017;7:e017665. [PMID: 29102991 DOI: 10.1136/bmjopen-2017-017665] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
284 Huang X, Glessner JT, Huang J, Zhou D, March ME, Wang H, Xia Q, Hakonarson H, Li J. Discovery of Novel Host Molecular Factors Underlying HBV/HCV Infection. Front Cell Dev Biol 2021;9:690882. [PMID: 34458256 DOI: 10.3389/fcell.2021.690882] [Reference Citation Analysis]
285 Koc Ö, Van Damme P, Busschots D, Bielen R, Forier A, Nevens F, Robaeys G. Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017. Euro Surveill 2019;24. [PMID: 31362809 DOI: 10.2807/1560-7917.ES.2019.24.30.1900064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
286 Do A, Reau NS. Chronic Viral Hepatitis: Current Management and Future Directions. Hepatol Commun 2020;4:329-41. [PMID: 32140652 DOI: 10.1002/hep4.1480] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
287 Jean Baptiste AE, Chevalier MS, Polo E, Noel E, Hulland EN, Archer WR. Trends in hepatitis B and hepatitis C seroprevalence among blood donors - Haiti, 2005-2014. ISBT Sci Ser 2018;13:150-7. [PMID: 30613210 DOI: 10.1111/voxs.12427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
288 Inoue J, Ninomiya M, Umetsu T, Nakamura T, Kogure T, Kakazu E, Iwata T, Takai S, Sano A, Fukuda M, Watashi K, Isogawa M, Tanaka Y, Shimosegawa T, McNiven MA, Masamune A. Small Interfering RNA Screening for the Small GTPase Rab Proteins Identifies Rab5B as a Major Regulator of Hepatitis B Virus Production. J Virol 2019;93:e00621-19. [PMID: 31118260 DOI: 10.1128/JVI.00621-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
289 Gencay M, Hübner K, Gohl P, Seffner A, Weizenegger M, Neofytos D, Batrla R, Woeste A, Kim HS, Westergaard G, Reinsch C, Brill E, Thu Thuy PT, Hoang BH, Sonderup M, Spearman CW, Pabinger S, Gautier J, Brancaccio G, Fasano M, Santantonio T, Gaeta GB, Nauck M, Kaminski WE. Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population. PLoS One 2017;12:e0172101. [PMID: 28472040 DOI: 10.1371/journal.pone.0172101] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
290 Li G, Lin J, Jiang C, Feng Q, Wen L. Trends in chronic hepatitis B treatment-related research from 1973 to 2018: a bibliometric and visual analysis. J Int Med Res 2020;48:300060519893234. [PMID: 31878813 DOI: 10.1177/0300060519893234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
291 Fu B, Wang D, Shen X, Guo C, Liu Y, Ye Y, Sun R, Li J, Tian Z, Wei H. Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24+CD38hi B Cells. Front Immunol 2020;11:591269. [PMID: 33424840 DOI: 10.3389/fimmu.2020.591269] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
292 Cheng HR, Yang HC, Lin SR, Yang TY, Lin YY, Su TH, Tseng TC, Liu CJ, Kao JH. Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients. Hepatol Int 2021;15:582-92. [PMID: 33886088 DOI: 10.1007/s12072-021-10186-7] [Reference Citation Analysis]
293 Zhang S, Li N, Sheng Y, Chen W, Ma Q, Yu X, Lian J, Zeng J, Yang Y, Yan J. Hepatitis B virus induces sorafenib resistance in liver cancer via upregulation of cIAP2 expression. Infect Agent Cancer 2021;16:20. [PMID: 33757557 DOI: 10.1186/s13027-021-00359-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Kataoka H, Mochizuki T, Akihisa T, Kawasoe K, Kawachi K, Makabe S, Sawada A, Manabe S, Sato M, Amemiya N, Mitobe M, Akanuma T, Ito Y, Inoue T, Suzuki T, Matsui K, Moriyama T, Horita S, Ohara M, Honda K, Nitta K. Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report. Medicine (Baltimore) 2019;98:e14014. [PMID: 30633192 DOI: 10.1097/MD.0000000000014014] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
295 Chen YL, Lin JZ, Mo YQ, Ma JD, Li QH, Wang XY, Yang ZH, Yan T, Zheng DH, Dai L. Deleterious role of hepatitis B virus infection in therapeutic response among patients with rheumatoid arthritis in a clinical practice setting: a case-control study. Arthritis Res Ther 2018;20:81. [PMID: 29720221 DOI: 10.1186/s13075-018-1548-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
296 Awili HO, Gitao GC, Muchemi GM. Seroprevalence and Risk Factors for Hepatitis B Virus Infection in Adolescent Blood Donors within Selected Counties of Western Kenya. Biomed Res Int 2020;2020:8578172. [PMID: 32685533 DOI: 10.1155/2020/8578172] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
297 Lee IC, Chau GY, Yeh YC, Chao Y, Huo TI, Su CW, Lin HC, Hou MC, Huang YH. Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure. PLoS One 2017;12:e0188552. [PMID: 29176777 DOI: 10.1371/journal.pone.0188552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
298 Zhang WH, Huang J, Feng M, Tong YQ, Guan XH, Jiang HW, Wei S. Elevated Arsenic Exposure Is Associated with an Increased Risk of Chronic Hepatitis B Virus Infection: NHANES (2003-2014) in U.S. Adults. Curr Med Sci 2018;38:610-7. [PMID: 30128869 DOI: 10.1007/s11596-018-1921-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
299 Li LJ, Wu XY, Tan SW, Xie ZJ, Pan XM, Pan SW, Bai WR, Li HJ, Liu HL, Jiang J, Wu B. Lnc-TCL6 is a potential biomarker for early diagnosis and grade in liver-cirrhosis patients. Gastroenterol Rep (Oxf). 2019;7:434-443. [PMID: 31857905 DOI: 10.1093/gastro/goz050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
300 Lu M, Zhou Y, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Boscarino JA, Daida YG, Schmidt MA, Li J, Rupp LB, Trudeau S, Gordon SC; Chronic Hepatitis Cohort Study Investigators. Trends in Diagnosed Chronic Hepatitis B in a US Health System Population, 2006-2015. Open Forum Infect Dis 2019;6:ofz286. [PMID: 31341929 DOI: 10.1093/ofid/ofz286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
301 Khan MA, Zargar SA, Upadhyay J, Lone TA, Aggarwal R, Bashir G, Ali M, Rabyang S, Namgyal T, Wani ZA. Epidemiology of hepatitis B and C viral infections in Ladakh region. Indian J Gastroenterol 2018;37:504-10. [PMID: 30543047 DOI: 10.1007/s12664-018-0888-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
302 Lau KCK, Burak KW, Coffin CS. Impact of Hepatitis B Virus Genetic Variation, Integration, and Lymphotropism in Antiviral Treatment and Oncogenesis. Microorganisms 2020;8:E1470. [PMID: 32987867 DOI: 10.3390/microorganisms8101470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
303 Kimanya ME, Routledge MN, Mpolya E, Ezekiel CN, Shirima CP, Gong YY. Estimating the risk of aflatoxin-induced liver cancer in Tanzania based on biomarker data. PLoS One 2021;16:e0247281. [PMID: 33705417 DOI: 10.1371/journal.pone.0247281] [Reference Citation Analysis]
304 Fisicaro P, Rossi M, Vecchi A, Acerbi G, Barili V, Laccabue D, Montali I, Zecca A, Penna A, Missale G, Ferrari C, Boni C. The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy. Int J Mol Sci 2019;20:E5080. [PMID: 31614928 DOI: 10.3390/ijms20205080] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
305 Cangelosi Q, Means SA, Ho H. A multi-scale spatial model of hepatitis-B viral dynamics. PLoS One 2017;12:e0188209. [PMID: 29216213 DOI: 10.1371/journal.pone.0188209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
306 Cheng X, Xia Y, Serti E, Block PD, Chung M, Chayama K, Rehermann B, Liang TJ. Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages. Hepatology. 2017;66:1779-1793. [PMID: 28665004 DOI: 10.1002/hep.29348] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 16.4] [Reference Citation Analysis]
307 Shimelis T, Tassachew Y, Tadewos A, Hordofa MW, Amsalu A, Tadesse BT, Tadesse E. Coinfections with hepatitis B and C virus and syphilis among HIV-infected clients in Southern Ethiopia: a cross-sectional study. HIV AIDS (Auckl) 2017;9:203-10. [PMID: 29238229 DOI: 10.2147/HIV.S150795] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
308 Samsunder N, Ngcapu S, Lewis L, Baxter C, Cawood C, Khanyile D, Kharsany ABM. Seroprevalence of hepatitis B virus: Findings from a population-based household survey in KwaZulu-Natal, South Africa. Int J Infect Dis 2019;85:150-7. [PMID: 31202910 DOI: 10.1016/j.ijid.2019.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
309 Lazarus JV, Sperle I, Spina A, Rockstroh JK. Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe. Croat Med J 2016;57:442-56. [PMID: 27815935 DOI: 10.3325/cmj.2016.57.442] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
310 Li N, Shi Y, Zhang P, Sang J, Li F, Deng H, Lv Y, Han Q, Liu Z. Association of the tandem polymorphisms (rs148314165, rs200820567) in TNFAIP3 with chronic hepatitis B virus infection in Chinese Han population. Virol J 2017;14:148. [PMID: 28784141 DOI: 10.1186/s12985-017-0814-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
311 Bafa TA, Egata AD. Seroepidemiological patterns and predictors of hepatitis B, C and HIV viruses among pregnant women attending antenatal care clinic of Atat Hospital, Southern Ethiopia. SAGE Open Med 2020;8:2050312119900870. [PMID: 32002184 DOI: 10.1177/2050312119900870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
312 Baauw A, Kist-van Holthe J, Slattery B, Heymans M, Chinapaw M, van Goudoever H. Health needs of refugee children identified on arrival in reception countries: a systematic review and meta-analysis. BMJ Paediatr Open 2019;3:e000516. [PMID: 31646192 DOI: 10.1136/bmjpo-2019-000516] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
313 Deng H, Fan X, Wang X, Zeng L, Zhang K, Zhang X, Li N, Han Q, Lv Y, Liu Z. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection. Sci Rep 2020;10:20276. [PMID: 33219288 DOI: 10.1038/s41598-020-77332-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
314 Otchere G, Dwomoh E, Kumah E, Ankomah SE, Fusheini A, Agyei-Baffour P, Afriyie EK, Agyei SK. Knowledge, attitude and practice towards hepatitis B infection among high school students in Asante Mampong, Ghana. Int J Risk Saf Med 2021. [PMID: 34719436 DOI: 10.3233/JRS-200077] [Reference Citation Analysis]
315 Makokha GN, Abe-Chayama H, Chowdhury S, Hayes CN, Tsuge M, Yoshima T, Ishida Y, Zhang Y, Uchida T, Tateno C, Akiyama R, Chayama K. Regulation of the Hepatitis B virus replication and gene expression by the multi-functional protein TARDBP. Sci Rep 2019;9:8462. [PMID: 31186504 DOI: 10.1038/s41598-019-44934-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
316 Dakurah OB, Tamandjou CRT, Zunza M, Preiser W, Maponga TG. Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review. BMC Cancer 2021;21:715. [PMID: 34144696 DOI: 10.1186/s12885-021-08426-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
317 Naing C, Poovorawan Y, Tong KS. Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis. BMC Infect Dis 2018;18:564. [PMID: 30428847 DOI: 10.1186/s12879-018-3506-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
318 Mo Y, Liu Y, Lu A, Zhang H, Tang L. Role of circRNAs in viral infection and their significance for diagnosis and treatment (Review). Int J Mol Med 2021;47:88. [PMID: 33786618 DOI: 10.3892/ijmm.2021.4921] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
319 Saha D, Pal A, Sarkar N, Das D, Blackard JT, Guha SK, Saha B, Chakravarty R. Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India. PLoS One. 2017;12:e0179035. [PMID: 28591184 DOI: 10.1371/journal.pone.0179035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
320 Allison RD, Patel MK, Tohme RA. Hepatitis B vaccine birth dose coverage correlates worldwide with rates of institutional deliveries and skilled attendance at birth. Vaccine 2017;35:4094-8. [PMID: 28668571 DOI: 10.1016/j.vaccine.2017.06.051] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
321 Behre U, Van Der Meeren O, Crasta P, Hanssens L, Mesaros N. Lasting immune memory against hepatitis B in 12-13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy. Hum Vaccin Immunother 2016;12:2916-20. [PMID: 27653771 DOI: 10.1080/21645515.2016.1202388] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
322 Suttichaimongkol T, Rattananukrom C, Wongsaensook A, Sawanyawisuth K, Sukeepaisarnjaroen W. Surveillance for hepatitis B virus seroprevalence nearly 30 years after the implementation of a national vaccination program. Germs 2021;11:403-7. [PMID: 34722362 DOI: 10.18683/germs.2021.1277] [Reference Citation Analysis]
323 Han Q, Deng H, Fan X, Wang X, Zhang X, Zhang K, Li N, Lv Y, Liu Z. Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1367-73. [PMID: 34805015 DOI: 10.2147/JHC.S337936] [Reference Citation Analysis]
324 Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin SR, Luo C, Makofane K, Martin NK, Mayer K, Millett G, Ntusi N, Pace L, Pike C, Piot P, Pozniak A, Quinn TC, Rockstroh J, Ratevosian J, Ryan O, Sippel S, Spire B, Soucat A, Starrs A, Strathdee SA, Thomson N, Vella S, Schechter M, Vickerman P, Weir B, Beyrer C. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet 2018;392:312-58. [PMID: 30032975 DOI: 10.1016/S0140-6736(18)31070-5] [Cited by in Crossref: 120] [Cited by in F6Publishing: 61] [Article Influence: 30.0] [Reference Citation Analysis]
325 Abu-Freha N, Abu Tailakh M, Fich A, Abu Bader N, Shemer-Avni Y, Alsana F, Gasper N, Abu-Kaf H, Etzion O. Adherence to Anti-Viral Treatment for Chronic Hepatitis B. J Clin Med 2020;9:E1922. [PMID: 32575498 DOI: 10.3390/jcm9061922] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
326 Ochu CL, Beynon CM. Hepatitis B vaccination coverage, knowledge and sociodemographic determinants of uptake in high risk public safety workers in Kaduna State, Nigeria: a cross sectional survey. BMJ Open 2017;7:e015845. [PMID: 28576900 DOI: 10.1136/bmjopen-2017-015845] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
327 Campbell B, Lopez A, Liu B, Bhuket T, Wong RJ. A Pilot Program Integrating Hepatitis B Virus (HBV) Screening into an Outpatient Endoscopy Unit Improves HBV Screening Among an Ethnically Diverse Safety-Net Hospital. Dig Dis Sci 2018;63:242-7. [PMID: 29209920 DOI: 10.1007/s10620-017-4870-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
328 Boubker S, Zerrouki N, Sidqi Z, Moussi M, El Mekkaoui A, Khannoussi W, Kharrasse G, Ismaili Z. Prevalence of hepatitis B and C in blood transfusion center, Oujda Morocco (2013-2015). Pan Afr Med J 2019;33:163. [PMID: 31565125 DOI: 10.11604/pamj.2019.33.163.18688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
329 Gétaz L, Casillas A, Siegrist CA, Chappuis F, Togni G, Tran NT, Baggio S, Negro F, Gaspoz JM, Wolff H. Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland's largest pre-trial prison. J Glob Health 2018;8:020407. [PMID: 30140433 DOI: 10.7189/jogh-08-020407] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
330 Zhang Y, Huang C, Nie Y, Liu Q, Xiao N, Liu L, Zhu X. Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis. Front Med (Lausanne) 2021;8:698502. [PMID: 34336902 DOI: 10.3389/fmed.2021.698502] [Reference Citation Analysis]
331 Deng F, Xu G, Cheng Z, Huang Y, Ma C, Luo C, Yu C, Wang J, Xu X, Liu S, Zhu Y. Hepatitis B Surface Antigen Suppresses the Activation of Nuclear Factor Kappa B Pathway via Interaction With the TAK1-TAB2 Complex. Front Immunol 2021;12:618196. [PMID: 33717111 DOI: 10.3389/fimmu.2021.618196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
332 Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650-2666. [PMID: 31401364 DOI: 10.1016/j.cgh.2019.07.060] [Cited by in Crossref: 102] [Cited by in F6Publishing: 110] [Article Influence: 34.0] [Reference Citation Analysis]
333 Ou G, Liu X, Xu H, Ji X, Liu X, Wang J. Variation and expression of HLA-DPB1 gene in HBV infection. Immunogenetics 2021;73:253-61. [PMID: 33710355 DOI: 10.1007/s00251-021-01213-w] [Reference Citation Analysis]
334 Wang HH, Sun SL, Jau RC, Tantoh DM, Hsu SY, Nfor ON, Chen PH, Liu WH, Ko JL, Liaw YP. Risk of HBV infection among male and female first-time blood donors born before and after the July 1986 HBV vaccination program in Taiwan. BMC Public Health 2021;21:1831. [PMID: 34627173 DOI: 10.1186/s12889-021-11846-x] [Reference Citation Analysis]
335 Xu T, Sun M, Wang H. Relationship between HLA-DQ Gene Polymorphism and Hepatitis B Virus Infection. Biomed Res Int 2017;2017:9679843. [PMID: 28512640 DOI: 10.1155/2017/9679843] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
336 Valery PC, Laversanne M, Clark PJ, Petrick JL, McGlynn KA, Bray F. Projections of primary liver cancer to 2030 in 30 countries worldwide. Hepatology. 2018;67:600-611. [PMID: 28859220 DOI: 10.1002/hep.29498] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 15.0] [Reference Citation Analysis]
337 Eun Y, Kim IY, Jeong H, Kim H, Lee J, Choi MS, Koh E, Cha HS. Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study. J Korean Med Sci 2018;33:e168. [PMID: 29853822 DOI: 10.3346/jkms.2018.33.e168] [Reference Citation Analysis]
338 Peng S, Wan Z, Lin X, Li X, Du Y. Maternal hepatitis B surface antigen carrier status increased the incidence of gestational diabetes mellitus. BMC Infect Dis 2019;19:147. [PMID: 30760217 DOI: 10.1186/s12879-019-3749-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
339 Fourati S, Pawlotsky JM. Recent advances in understanding and diagnosing hepatitis B virus infection. F1000Res. 2016;5:pii: F1000. [PMID: 27635243 DOI: 10.12688/f1000research.8983.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
340 You H, Kong Y, Hou J, Wei L, Zhang Y, Niu J, Han T, Ou X, Dou X, Shang J, Tang H, Xie Q, Ding H, Ren H, Xu X, Xie W, Liu X, Xu Y, Li Y, Li J, Chow SC, Zhuang H, Jia J. Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B. Sci Rep 2016;6:37498. [PMID: 27892487 DOI: 10.1038/srep37498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
341 Candotti D, Laperche S. Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures? Front Med (Lausanne) 2018;5:29. [PMID: 29515997 DOI: 10.3389/fmed.2018.00029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
342 Yang C, Han C, Wang X, Liao X, Liu X, Qin W, Yu L, Zhu G, Su H, Lu S, Chen Z, Yu T, Liu Z, Huang K, Liu Z, Liang Y, Huang J, Peng T. Clinical Implication and the Hereditary Factors of NM23 in Hepatocellular Carcinoma Based on Bioinformatics Analysis and Genome-Wide Association Study. J Oncol 2018;2018:6594169. [PMID: 30662464 DOI: 10.1155/2018/6594169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
343 Chen Q, Liu J, He Y, Yang L, Luo H, Wang Y, Zhang X, Li N. Prevalence of HBsAg among reproductive age couples in Chongqing: A population-based, cross-sectional study. PLoS One 2021;16:e0260028. [PMID: 34780552 DOI: 10.1371/journal.pone.0260028] [Reference Citation Analysis]
344 Eko Mba JM, Bisseye C, Mombo LE, Ntsame Ndong JM, Mbina Ekayeng SC, Bengone C, M'batchi B, Nagalo BM. Assessment of rapid diagnostic tests and fourth-generation Enzyme-Linked Immunosorbent Assays in the screening of Human Immunodeficiency and Hepatitis B virus infections among first-time blood donors in Libreville (Gabon). J Clin Lab Anal 2019;33:e22824. [PMID: 30485543 DOI: 10.1002/jcla.22824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
345 Abdullahi A, Fopoussi OM, Torimiro J, Atkins M, Kouanfack C, Geretti AM. Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting. Open Forum Infect Dis 2018;5:ofy251. [PMID: 30377627 DOI: 10.1093/ofid/ofy251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
346 Raihan R, Akbar SMF, Al Mahtab M, Takahashi K, Masumoto J, Tabassum S, Tee KK, Binti Mohamed R. Genomic analysis of Hepatitis B virus and its association with disease manifestations in Bangladesh. PLoS One 2019;14:e0218744. [PMID: 31251754 DOI: 10.1371/journal.pone.0218744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
347 Hatazawa Y, Yano Y, Okada R, Tanahashi T, Hayashi H, Hirano H, Minami A, Kawano Y, Tanaka M, Fukumoto T, Murakami Y, Yoshida M, Hayashi Y. Quasispecies variant of pre-S/S gene in HBV-related hepatocellular carcinoma with HBs antigen positive and occult infection. Infect Agent Cancer 2018;13:7. [PMID: 29434654 DOI: 10.1186/s13027-018-0179-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
348 Inoue J, Nakamura T, Masamune A. Roles of Hepatitis B Virus Mutations in the Viral Reactivation after Immunosuppression Therapies. Viruses 2019;11:E457. [PMID: 31109119 DOI: 10.3390/v11050457] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
349 Hu HH, Jeng WJ, Pan MH, Luo WS, Chang CL, Huang YT, Su CY, Chiang CT, Jen CL, Chien YC, Lu SN, Wang LY, Huang LR, Lee MH, Liu J, Nguyen MH, Chen CJ, Yang HI. Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B. Aliment Pharmacol Ther 2022. [PMID: 35032052 DOI: 10.1111/apt.16752] [Reference Citation Analysis]
350 Shirazi R, Ram D, Rakovsky A, Bucris E, Gozlan Y, Lustig Y, Shaked-Mishan P, Picard O, Shemer-Avni Y, Ben-Zvi H, Halutz O, Lurie Y, Veizman E, Carlebach M, Braun M, Naftaly MC, Shlomai A, Safadi R, Mendelson E, Sklan EH, Ben-Ari Z, Mor O. Characterization of hepatitis B and delta coinfection in Israel. BMC Infect Dis 2018;18:97. [PMID: 29486716 DOI: 10.1186/s12879-018-3008-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
351 Zhang JF, Xiong HL, Cao JL, Wang SJ, Guo XR, Lin BY, Zhang Y, Zhao JH, Wang YB, Zhang TY, Yuan Q, Zhang J, Xia NS. A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway. Theranostics. 2018;8:549-562. [PMID: 29290826 DOI: 10.7150/thno.20047] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
352 Kostaki EG, Karamitros T, Stefanou G, Mamais I, Angelis K, Hatzakis A, Kramvis A, Paraskevis D. Unravelling the history of hepatitis B virus genotypes A and D infection using a full-genome phylogenetic and phylogeographic approach. Elife 2018;7:e36709. [PMID: 30082021 DOI: 10.7554/eLife.36709] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
353 Li X, Kang N, Qi X, Huang Y. Artificial intelligence in the diagnosis of cirrhosis and portal hypertension. J Med Ultrason (2001) 2021. [PMID: 34787742 DOI: 10.1007/s10396-021-01153-8] [Reference Citation Analysis]
354 Bassoum O, Sougou NM, Ba MF, Anne M, Bocoum M, Dieye A, Sokhna C, Tal-Dia A. Vaccination against tuberculosis, polio and hepatitis B at birth in Podor health district, Northern Senegal: cross-sectional study of vaccination coverage and its associated factors. BMC Public Health 2022;22:110. [PMID: 35033057 DOI: 10.1186/s12889-022-12535-z] [Reference Citation Analysis]
355 de Oliveira SB, Sabidó M, Pascom ARP, Gisiviez JM, Benzaken AS, Mesquita F. State of viral hepatitis knowledge and testing uptake in Brazil: Findings from the National Survey of Knowledge, Attitudes and Practices (PCAP-2013). Hepatol Med Policy 2016;1:3. [PMID: 30288306 DOI: 10.1186/s41124-016-0003-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
356 Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030. J Clin Oncol. 2016;34:1787-1794. [PMID: 27044939 DOI: 10.1200/jco.2015.64.7412] [Cited by in Crossref: 185] [Cited by in F6Publishing: 108] [Article Influence: 30.8] [Reference Citation Analysis]
357 Katamba C, Chungu T, Lusale C. HIV, syphilis and hepatitis B coinfections in Mkushi, Zambia: a cross-sectional study. F1000Res 2019;8:562. [PMID: 32802310 DOI: 10.12688/f1000research.17983.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
358 Ko C, Bester R, Zhou X, Xu Z, Blossey C, Sacherl J, Vondran FWR, Gao L, Protzer U. A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection. Antimicrob Agents Chemother 2019;64:e01440-19. [PMID: 31658963 DOI: 10.1128/AAC.01440-19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]
359 Chen XF, Fan YN, Si CW, Yu YY, Shang J, Yu ZJ, Mao Q, Xie Q, Zhao W, Li J, Gao ZL, Wu SM, Tang H, Cheng J, Chen XY, Zhang WH, Wang H, Xu ZN, Wang L, Dai J, Xu JH. Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks. World J Clin Cases 2021; 9(18): 4690-4699 [PMID: 34222435 DOI: 10.12998/wjcc.v9.i18.4690] [Reference Citation Analysis]
360 Koopsen J, van Steenbergen JE, Richardus JH, Prins M, Op de Coul ELM, Croes EA, Heil J, Zuure FR, Veldhuijzen IK. Chronic hepatitis B and C infections in the Netherlands: estimated prevalence in risk groups and the general population. Epidemiol Infect 2019;147:e147. [PMID: 30869044 DOI: 10.1017/S0950268819000359] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
361 Wang W, Xiong L, Wang P, Wang F, Ma Q. Major vault protein plays important roles in viral infection. IUBMB Life 2020;72:624-31. [PMID: 31769934 DOI: 10.1002/iub.2200] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
362 Oleru OO, Premaratne ID, Rohde CH. The impact of hepatitis B and C diagnoses on surgical outcomes following mastectomy and breast reconstruction. J Plast Reconstr Aesthet Surg 2021;74:1101-60. [PMID: 33214118 DOI: 10.1016/j.bjps.2020.10.076] [Reference Citation Analysis]
363 Rashti R, Sharafi H, Alavian SM, Moradi Y, Mohamadi Bolbanabad A, Moradi G. Systematic Review and Meta-Analysis of Global Prevalence of HBsAg and HIV and HCV Antibodies among People Who Inject Drugs and Female Sex Workers. Pathogens 2020;9:E432. [PMID: 32486342 DOI: 10.3390/pathogens9060432] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
364 Ford JS, Marianelli LG, Frassone N, Debes JD. Hepatitis B screening in an argentine ED: Increasing vaccination in a resource-limited setting. Am J Emerg Med 2020;38:296-9. [PMID: 31353159 DOI: 10.1016/j.ajem.2019.158354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
365 Lisker-Melman M, Khalili M, Belle SH, Terrault NA, Lin HS, Smith CI, Chung RT, Tsai N, Bzowej NH, Tran TT, Schwarzenberg SJ; Hepatitis B Research Network (HBRN). Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B. Ann Hepatol 2020;19:388-95. [PMID: 32507734 DOI: 10.1016/j.aohep.2020.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
366 Lee AR, Cho JY, Kim JC, Dezhbord M, Choo SY, Ahn CH, Kim NY, Shin JJ, Park S, Park ES, Won J, Kim DS, Lee JH, Kim KH. Distinctive HBV Replication Capacity and Susceptibility to Tenofovir Induced by a Polymerase Point Mutation in Hepatoma Cell Lines and Primary Human Hepatocytes. Int J Mol Sci 2021;22:1606. [PMID: 33562603 DOI: 10.3390/ijms22041606] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
367 Park SK, Choi CH, Chun J, Lee H, Kim ES, Park JJ, Park CH, Lee BI, Jung Y, Park DI, Kim DY, Park H, Jeen YT;  IBD Research Group of the Korean Association for the Study of Intestinal Diseases. Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases. Intest Res. 2020;18:18-33. [PMID: 32013312 DOI: 10.5217/ir.2019.09155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
368 Guo H, Zhu B, Li S, Li J, Shen Z, Zheng Y, Zhao W, Tan D, Wu J, Zhang X, Jiang Q, Qi X, Mao R, Yu X, Su Z, Zhang J. Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B. Biomed Res Int 2019;2019:1621627. [PMID: 30937309 DOI: 10.1155/2019/1621627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
369 Schmit N, Nayagam S, Thursz MR, Hallett TB. The global burden of chronic hepatitis B virus infection: comparison of country-level prevalence estimates from four research groups. Int J Epidemiol. 2021;50:560-569. [PMID: 33367672 DOI: 10.1093/ije/dyaa253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
370 Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS; Hepatitis B Research Network (HBRN)., Harvard Consortium. Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B. Diabetes Care 2018;41:1251-9. [PMID: 29599296 DOI: 10.2337/dc18-0040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
371 Abesig J, Chen Y, Wang H, Sompo FM, Wu IXY. Prevalence of viral hepatitis B in Ghana between 2015 and 2019: A systematic review and meta-analysis. PLoS One 2020;15:e0234348. [PMID: 32530945 DOI: 10.1371/journal.pone.0234348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
372 Hashimoto K, Miura K, Takaoka Y, Nomoto H, Watanabe S, Tsukui M, Morimoto N, Isoda N, Nagashima S, Takahashi M, Okamoto H, Yamamoto H. A 79-year-old Woman with Acute Hepatitis B Caused by the Infection of Subgenotype D1 Hepatitis B Virus in Japan: A Case Study. Intern Med 2018;57:3099-104. [PMID: 29877273 DOI: 10.2169/internalmedicine.0977-18] [Reference Citation Analysis]
373 Han L, Zhou J, Zhou K, Zhu X, Zhao L, Fang B, Yin Q, Wei X, Zhou H, Li L, Xu B, Zhang J, Song Y, Gao Q. Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus. J Immunother Cancer 2020;8:e000927. [PMID: 32792360 DOI: 10.1136/jitc-2020-000927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
374 Hsieh AR, Fann CSJ, Lin HC, Tai J, Hsieh SY, Tai DI. Hepatitis B virus persistent infection-related single nucleotide polymorphisms in HLA regions are associated with viral load in hepatoma families. World J Gastroenterol 2021; 27(37): 6262-6276 [PMID: 34712031 DOI: 10.3748/wjg.v27.i37.6262] [Reference Citation Analysis]
375 Haering C, McMahon B, Harris A, Weis N, Lundberg Ederth J, Axelsson M, Olafsson S, Osiowy C, Tomas K, Bollerup S, Liitsola K, Archibald C, Blystad H, Bruce M, Nolen L. Hepatitis B virus elimination status and strategies in circumpolar countries, 2020. Int J Circumpolar Health 2021;80:1986975. [PMID: 34668463 DOI: 10.1080/22423982.2021.1986975] [Reference Citation Analysis]
376 Yuan Q, Wang F, Zheng H, Zhang G, Miao N, Sun X, Woodring J, Chan PL, Cui F. Hepatitis B vaccination coverage among health care workers in China. PLoS One 2019;14:e0216598. [PMID: 31063488 DOI: 10.1371/journal.pone.0216598] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
377 Guo Y, Gao P, Wang H, Wu J, Bai Q, Huang L, Li S, Lv M, Shi X. Risk factors of hepatitis B virus infection between vaccinated and unvaccinated groups among spouses in 2006 and 2014: a cross-sectional study in Beijing. Hum Vaccin Immunother 2020;16:148-57. [PMID: 31287778 DOI: 10.1080/21645515.2019.1640428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
378 Bockmann JH, Kohsar M, Murray JM, Hamed V, Dandri M, Lüth S, Lohse AW, Schulze-Zur-Wiesch J. High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities. Microorganisms 2021;9:968. [PMID: 33946154 DOI: 10.3390/microorganisms9050968] [Reference Citation Analysis]
379 Arora A, Singh SP, Kumar A, Saraswat VA, Aggarwal R, Bangar M, Bhaumik P, Devarbhavi H, Dhiman RK, Dixit VK, Goel A, Goswami B, Kapoor D, Madan K, Narayan J, Nijhawan S, Pandey G, Rai RR, Sahu MK, Saraf N, Shalimar, Shenoy T, Thomas V, Wadhawan M; INASL Hepatitis B Taskforce. INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements. J Clin Exp Hepatol 2018;8:58-80. [PMID: 29743798 DOI: 10.1016/j.jceh.2017.12.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
380 Yan Z, Wu D, Hu H, Zeng J, Yu X, Xu Z, Zhou Z, Zhou X, Yang G, Young JAT, Gao L. Direct Inhibition of Hepatitis B e Antigen by Core Protein Allosteric Modulator. Hepatology 2019;70:11-24. [PMID: 30664279 DOI: 10.1002/hep.30514] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
381 Salas-Coronas J, Cabezas-Fernández MT, Lozano-Serrano AB, Soriano-Pérez MJ, Vázquez-Villegas J, Cuenca-Gómez JÁ. Newly Arrived African Migrants to Spain: Epidemiology and Burden of Disease. Am J Trop Med Hyg 2018;98:319-25. [PMID: 29165212 DOI: 10.4269/ajtmh.17-0604] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
382 Akello J, Ortega-Beltran A, Katati B, Atehnkeng J, Augusto J, Mwila CM, Mahuku G, Chikoye D, Bandyopadhyay R. Prevalence of Aflatoxin- and Fumonisin-Producing Fungi Associated with Cereal Crops Grown in Zimbabwe and Their Associated Risks in a Climate Change Scenario. Foods 2021;10:287. [PMID: 33572636 DOI: 10.3390/foods10020287] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
383 Ahn HJ, Song MJ, Jang JW, Bae SH, Choi JY, Yoon SK. Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea. PLoS One 2017;12:e0170362. [PMID: 28114428 DOI: 10.1371/journal.pone.0170362] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
384 Ali MA, Means SA, Ho H, Heffernan J. Global sensitivity analysis of a single-cell HBV model for viral dynamics in the liver. Infect Dis Model 2021;6:1220-35. [PMID: 34786526 DOI: 10.1016/j.idm.2021.10.003] [Reference Citation Analysis]
385 Mbangiwa T, Kasvosve I, Anderson M, Thami PK, Choga WT, Needleman A, Phinius BB, Moyo S, Leteane M, Leidner J, Blackard JT, Mayondi G, Kammerer B, Musonda RM, Essex M, Lockman S, Gaseitsiwe S. Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana. Genes (Basel) 2018;9:E259. [PMID: 29772814 DOI: 10.3390/genes9050259] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
386 Abutaleb A, Khatun M, Clement J, Baidya A, Singh P, Datta S, Ahammed SM, George K, Mukherjee P, Santra A, Neogi S, Parikh S, Pillai V, Kottilil S, Chowdhury A. A Model of Care Optimized for Marginalized Remote Population Unravels Migration Pattern in India. Hepatology 2021;73:1261-74. [PMID: 32659859 DOI: 10.1002/hep.31461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
387 Ou G, Xu H, Yu H, Liu X, Yang L, Ji X, Wang J, Liu Z. The roles of HLA-DQB1 gene polymorphisms in hepatitis B virus infection. J Transl Med 2018;16:362. [PMID: 30563535 DOI: 10.1186/s12967-018-1716-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
388 Koffas A, Kumar M, Gill US, Jindal A, Kennedy PTF, Sarin SK. Chronic hepatitis B: the demise of the 'inactive carrier' phase. Hepatol Int 2021;15:290-300. [PMID: 33638770 DOI: 10.1007/s12072-021-10137-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
389 Dionne-Odom J, Njei B, Tita ATN. Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities. Clin Ther 2018;40:1255-67. [PMID: 29983265 DOI: 10.1016/j.clinthera.2018.05.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
390 Hofstraat SHI, Falla AM, Duffell EF, Hahné SJM, Amato-Gauci AJ, Veldhuijzen IK, Tavoschi L. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiol Infect 2017;145:2873-85. [PMID: 28891457 DOI: 10.1017/S0950268817001947] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
391 Lu XJ, Yang XJ, Sun JY, Zhang X, Yuan ZX, Li XH. FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients. Biomark Res 2020;8:48. [PMID: 33005419 DOI: 10.1186/s40364-020-00215-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
392 Taddei TH, Lo Re V 3rd, Justice AC. HIV, Aging, and Viral Coinfections: Taking the Long View. Curr HIV/AIDS Rep 2016;13:269-78. [PMID: 27614654 DOI: 10.1007/s11904-016-0327-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
393 Beykaso G, Mulu A, Giday M, Berhe N, Selamu M, Mihret A, Teklehaymanot T. Burden and Transmission Risks of Viral Hepatitis in Southern Ethiopia: Evidence Needed for Prevention and Control Measures. Risk Manag Healthc Policy 2021;14:4843-52. [PMID: 34880693 DOI: 10.2147/RMHP.S336776] [Reference Citation Analysis]
394 Hajiabdolbaghi M, Abdiliae Z, Bayani J, Qaempanah M, Ghiasvand F. Characteristics of Hepatitis B and D Co-infection: A Descriptive Study. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.101630] [Reference Citation Analysis]
395 Chen P, Zhang F, Shen Y, Cai Y, Jin C, Li Y, Tu M, Zhang W, Wang Y, Zhang SF, Wang J, Li L. Health-Related Quality of Life and Its Influencing Factors in Patients with Hepatitis B: A Cross-Sectional Assessment in Southeastern China. Can J Gastroenterol Hepatol 2021;2021:9937591. [PMID: 34307240 DOI: 10.1155/2021/9937591] [Reference Citation Analysis]
396 Yu HB, Jiang H, Cheng ST, Hu ZW, Ren JH, Chen J. AGK2, A SIRT2 Inhibitor, Inhibits Hepatitis B Virus Replication In Vitro And In Vivo. Int J Med Sci. 2018;15:1356-1364. [PMID: 30275764 DOI: 10.7150/ijms.26125] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
397 Ambachew H, Zheng M, Pappoe F, Shen J, Xu Y. Genotyping and sero-virological characterization of hepatitis B virus (HBV) in blood donors, Southern Ethiopia. PLoS One 2018;13:e0193177. [PMID: 29462187 DOI: 10.1371/journal.pone.0193177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
398 Da Silva Santos L, Wolff H, Chappuis F, Albajar-Viñas P, Vitoria M, Tran NT, Baggio S, Togni G, Vuilleumier N, Girardin F, Negro F, Gétaz L. Coinfections between Persistent Parasitic Neglected Tropical Diseases and Viral Infections among Prisoners from Sub-Saharan Africa and Latin America. J Trop Med 2018;2018:7218534. [PMID: 30532789 DOI: 10.1155/2018/7218534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
399 Zeng Z, Liu H, Xu H, Lu H, Yu Y, Xu X, Yu M, Zhang T, Tian X, Xi H, Guan L, Zhang J, O'Brien SJ; HBVstudy consortium. Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression. BMC Med Genomics 2021;14:84. [PMID: 33736632 DOI: 10.1186/s12920-021-00907-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
400 van Gemert CE, Murphy N, Mitchell TA, Hellard ME, Thornton L. Epidemiology of chronic hepatitis B virus in Ireland using routinely collected surveillance and administrative data, 2004-2014. Ir J Med Sci 2018;187:803-11. [PMID: 29224133 DOI: 10.1007/s11845-017-1720-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
401 Chakraborty S, Chakravorty R, Alam S, Kabir Y, Mahtab M, Islam MA, Yusuf MAK, Raihan R, Al Mahtab M, Akbar SMF. A Dynamic Mathematical Modeling Revelation about the Impact of Vaccination on Hepatitis B Virus-induced Infection and Death Rate in Bangladesh. Euroasian J Hepatogastroenterol 2019;9:84-90. [PMID: 32117696 DOI: 10.5005/jp-journals-10018-1303] [Reference Citation Analysis]
402 Zhang J, Wen XY, Gao RP. Hepatitis B virus-related liver cirrhosis complicated with dermatomyositis: A case report. World J Clin Cases 2019; 7(10): 1206-1212 [PMID: 31183354 DOI: 10.12998/wjcc.v7.i10.1206] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
403 Chen CY, Winer BY, Chavez D, Guerra B, Brasky KM, Eng S, Salas E, Tam D, Simmons JH, Abee CR, Delaney WE, Ploss A, Lanford RE, Voitenleitner C. Woolly Monkey-HBV Infection in Squirrel Monkeys as a Surrogate Nonhuman Primate Model of HBV Infection. Hepatol Commun 2020;4:371-86. [PMID: 32140655 DOI: 10.1002/hep4.1471] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
404 Niehrs A, Altfeld M. Regulation of NK-Cell Function by HLA Class II. Front Cell Infect Microbiol 2020;10:55. [PMID: 32133304 DOI: 10.3389/fcimb.2020.00055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
405 Broquetas T, Garcia-Retortillo M, Micó M, Canillas L, Puigvehí M, Cañete N, Coll S, Viu A, Hernandez JJ, Bessa X, Carrión JA. Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients. World J Hepatol 2020; 12(11): 1076-1088 [PMID: 33312431 DOI: 10.4254/wjh.v12.i11.1076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
406 Zhao X, Shi X, Lv M, Yuan B, Wu J. Prevalence and factors associated with hepatitis B virus infection among household members: a cross-sectional study in Beijing. Hum Vaccin Immunother 2021;17:1818-24. [PMID: 33606606 DOI: 10.1080/21645515.2020.1847951] [Reference Citation Analysis]
407 Yang JD, Gores GJ. Does cirrhosis associated with well controlled viral hepatitis confer a risk for extrahepatic cancer? Hepatology 2018;68:1217-9. [PMID: 29698552 DOI: 10.1002/hep.30063] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
408 Wang Y, Du Z, Lawrence WR, Huang Y, Deng Y, Hao Y. Predicting Hepatitis B Virus Infection Based on Health Examination Data of Community Population. Int J Environ Res Public Health 2019;16:E4842. [PMID: 31810204 DOI: 10.3390/ijerph16234842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
409 Shi H, He H, Ojha SC, Sun C, Fu J, Yan M, Deng C, Sheng Y. Association of STAT3 and STAT4 polymorphisms with susceptibility to chronic hepatitis B virus infection and risk of hepatocellular carcinoma: a meta-analysis. Biosci Rep 2019;39:BSR20190783. [PMID: 31160486 DOI: 10.1042/BSR20190783] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
410 Stasi C, Silvestri C, Voller F. Emerging Trends in Epidemiology of Hepatitis B Virus Infection. J Clin Transl Hepatol 2017;5:272-6. [PMID: 28936408 DOI: 10.14218/JCTH.2017.00010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 0.2] [Reference Citation Analysis]
411 Katamba PS, Mukunya D, Kwesiga D, Nankabirwa V. Prenatal hepatitis B screening and associated factors in a high prevalence district of Lira, northern Uganda: a community based cross sectional study. BMC Public Health 2019;19:1004. [PMID: 31349838 DOI: 10.1186/s12889-019-7344-6] [Reference Citation Analysis]
412 Koutsianas C, Thomas K, Vassilopoulos D. Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations. Ther Adv Musculoskelet Dis. 2020;12:1759720X20912646. [PMID: 32206094 DOI: 10.1177/1759720x20912646] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
413 Hecht R, Hiebert L, Spearman WC, Sonderup MW, Guthrie T, Hallett TB, Nayagam S, Razavi H, Soe-Lin S, Vilakazi-Nhlapo K, Pillay Y, Resch S. The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up. Health Policy Plan 2018;33:528-38. [PMID: 29529282 DOI: 10.1093/heapol/czy018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
414 Karacaer Z, Cakir B, Erdem H, Ugurlu K, Durmus G, Ince NK, Ozturk C, Hasbun R, Batirel A, Yilmaz EM, Bozkurt I, Sunbul M, Aynioglu A, Atilla A, Erbay A, Inci A, Kader C, Tigen ET, Karaahmetoglu G, Coskuner SA, Dik E, Tarakci H, Tosun S, Korkmaz F, Kolgelier S, Karadag FY, Erol S, Turker K, Necan C, Sahin AM, Ergen P, Iskender G, Korkmaz P, Eroglu EG, Durdu Y, Ulug M, Deniz SS, Koc F, Alpat SN, Oztoprak N, Evirgen O, Sozen H, Dogan M, Kaya S, Kaya S, Altindis M, Aslan E, Tekin R, Sezer BE, Ozdemir K, Ersoz G, Sahin A, Celik I, Aydin E, Bastug A, Harman R, Ozkaya HD, Parlak E, Yavuz I, Sacar S, Comoglu S, Yenilmez E, Sirmatel F, Balkan II, Alpay Y, Hatipoglu M, Denk A, Senol G, Bitirgen M, Geyik MF, Guner R, Kadanali A, Karakas A, Namiduru M, Udurgucu H, Boluktas RP, Karagoz E, Ormeci N. Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey. Health Qual Life Outcomes 2016;14:153. [PMID: 27809934 DOI: 10.1186/s12955-016-0557-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
415 Deng W, Lu M. The role of microRNAs in hepatocyte metabolism and hepatitis B virus replication. Virol Sin 2016;31:472-9. [PMID: 28063013 DOI: 10.1007/s12250-016-3924-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
416 Lekskulchai V. Experiences of Screening for Human Immunodeficiency Virus, Viral Hepatitis B, and Viral Hepatitis C Infections at a Hospital in Thailand: Test Utilization and Outcomes. Med Sci Monit Basic Res 2019;25:210-7. [PMID: 31597908 DOI: 10.12659/MSMBR.918374] [Reference Citation Analysis]
417 Perreira JM, Meraner P, Brass AL. Functional Genomic Strategies for Elucidating Human-Virus Interactions: Will CRISPR Knockout RNAi and Haploid Cells? Adv Virus Res 2016;94:1-51. [PMID: 26997589 DOI: 10.1016/bs.aivir.2015.11.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
418 Chevaliez S, Dauvillier C, Dubernet F, Poveda JD, Laperche S, Hézode C, Pawlotsky JM. The New Aptima HBV Quant Real-Time TMA Assay Accurately Quantifies Hepatitis B Virus DNA from Genotypes A to F. J Clin Microbiol 2017;55:1211-9. [PMID: 28202793 DOI: 10.1128/JCM.02219-16] [Cited by in Crossref: 10] [Article Influence: 2.0] [Reference Citation Analysis]
419 Dinesha TR, Boobalan J, Sivamalar S, Subashini D, Solomon SS, Murugavel KG, Balakrishnan P, Smith DM, Saravanan S. Occult HBV infection in HIV-infected adults and evaluation of pooled NAT for HBV. J Viral Hepat 2018;25:718-23. [PMID: 29316078 DOI: 10.1111/jvh.12858] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
420 Inoue J, Kondo Y, Wakui Y, Kogure T, Morosawa T, Fujisaka Y, Umetsu T, Takai S, Nakamura T, Shimosegawa T. Reactivation of resolved hepatitis B virus infection with immune escape mutations after long-term corticosteroid therapy. Clin J Gastroenterol 2016;9:93-8. [PMID: 26919858 DOI: 10.1007/s12328-016-0631-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
421 Gu S, Fu X, Ye G, Chen C, Li X, Zhong S, Tang L, Chen H, Jiang D, Hou J, Li Y. High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection. Front Immunol 2021;12:649197. [PMID: 34234772 DOI: 10.3389/fimmu.2021.649197] [Reference Citation Analysis]
422 Butler DC, Lewin DN, Batalis NI. Differential Diagnosis of Hepatic Necrosis Encountered at Autopsy. Acad Forensic Pathol 2018;8:256-95. [PMID: 31240042 DOI: 10.1177/1925362118782056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
423 Livingston CM, Ramakrishnan D, Strubin M, Fletcher SP, Beran RK. Identifying and Characterizing Interplay between Hepatitis B Virus X Protein and Smc5/6. Viruses 2017;9:E69. [PMID: 28368357 DOI: 10.3390/v9040069] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
424 Rigopoulou EI, Gatselis NK, Galanis K, Lygoura V, Gabeta S, Zachou K, Dalekos GN. The changing epidemiology of hepatitis B in Greece. Ann Gastroenterol 2021;34:431-7. [PMID: 33948070 DOI: 10.20524/aog.2021.0614] [Reference Citation Analysis]
425 Wu S, Luo W, Wu Y, Chen H, Peng J. HBsAg quantification predicts off-treatment response to interferon in chronic hepatitis B patients: a retrospective study of 250 cases. BMC Gastroenterol. 2020;20:121. [PMID: 32316928 DOI: 10.1186/s12876-020-01263-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
426 Liu Y, Wang H, Zhang J, Yang J, Bai L, Zheng B, Zheng T, Wang Y, Li J, Zhang W. SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope. Front Microbiol 2020;11:697. [PMID: 32431673 DOI: 10.3389/fmicb.2020.00697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
427 Zhang X, Chen X, Wei M, Zhang C, Xu T, Liu L, Xu Z. Potential resistant mutations within HBV reverse transcriptase sequences in nucleos(t)ide analogues-experienced patients with hepatitis B virus infection. Sci Rep 2019;9:8078. [PMID: 31147594 DOI: 10.1038/s41598-019-44604-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
428 Hambridge T, Nartey Y, Duah A, Plymoth A. Hepatitis B mother-to-child transmission in the Eastern Region of Ghana: a cross-sectional pilot study. Pan Afr Med J 2019;33:218. [PMID: 31692718 DOI: 10.11604/pamj.2019.33.218.17242] [Reference Citation Analysis]
429 Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clin Microbiol Rev. 2020;33. [PMID: 32102898 DOI: 10.1128/cmr.00046-19] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 18.5] [Reference Citation Analysis]
430 White SL, Rawlinson W, Boan P, Sheppeard V, Wong G, Waller K, Opdam H, Kaldor J, Fink M, Verran D, Webster A, Wyburn K, Grayson L, Glanville A, Cross N, Irish A, Coates T, Griffin A, Snell G, Alexander SI, Campbell S, Chadban S, Macdonald P, Manley P, Mehakovic E, Ramachandran V, Mitchell A, Ison M. Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission. Transplant Direct 2019;5:e416. [PMID: 30656214 DOI: 10.1097/TXD.0000000000000852] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
431 Van Damme E, Vanhove J, Severyn B, Verschueren L, Pauwels F. The Hepatitis B Virus Interactome: A Comprehensive Overview. Front Microbiol 2021;12:724877. [PMID: 34603251 DOI: 10.3389/fmicb.2021.724877] [Reference Citation Analysis]
432 Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, Abu-Raddad LJ, Assadi R, Bhala N, Cowie B, Forouzanfour MH, Groeger J, Hanafiah KM, Jacobsen KH, James SL, MacLachlan J, Malekzadeh R, Martin NK, Mokdad AA, Mokdad AH, Murray CJL, Plass D, Rana S, Rein DB, Richardus JH, Sanabria J, Saylan M, Shahraz S, So S, Vlassov VV, Weiderpass E, Wiersma ST, Younis M, Yu C, El Sayed Zaki M, Cooke GS. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016;388:1081-8. [PMID: 27394647 DOI: 10.1016/S0140-6736(16)30579-7] [Cited by in Crossref: 725] [Cited by in F6Publishing: 377] [Article Influence: 120.8] [Reference Citation Analysis]
433 Jafri W, Kamran M. Hepatocellular Carcinoma in Asia: A Challenging Situation. Euroasian J Hepatogastroenterol 2019;9:27-33. [PMID: 31988864 DOI: 10.5005/jp-journals-10018-1292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
434 Stockdale AJ, Kreuels B, Henrion MYR, Giorgi E, Kyomuhangi I, de Martel C, Hutin Y, Geretti AM. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J Hepatol. 2020;73:523-532. [PMID: 32335166 DOI: 10.1016/j.jhep.2020.04.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 27.5] [Reference Citation Analysis]
435 Khue PM, Thuy Linh NT, Vinh VH, Dung LV, Nguyen Van B. Hepatitis B Infection and Mother-to-Child Transmission in Haiphong, Vietnam: A Cohort Study with Implications for Interventions. Biomed Res Int 2020;2020:4747965. [PMID: 32884940 DOI: 10.1155/2020/4747965] [Reference Citation Analysis]
436 Li M, Lv T, Wu S, Wei W, Wu X, Ou X, Ma H, Chow SC, Kong Y, You H, Jia J. Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis. Hepatol Int. 2020;14:105-114. [PMID: 31898210 DOI: 10.1007/s12072-019-10005-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
437 Jekarl DW, Choi H, Lee S, Kwon JH, Lee SW, Yu H, Kim M, Kim Y, Sung PS, Yoon SK. Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients. Ann Lab Med. 2018;38:348-354. [PMID: 29611385 DOI: 10.3343/alm.2018.38.4.348] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
438 Bil JP, Schrooders PA, Prins M, Kouw PM, Klomp JH, Scholing M, Huijbregts LP, Sonder GJ, Waegemaekers TC, de Vries HJ, Meijer W, Zuure FR, Tostmann A. Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015. Euro Surveill 2018;23. [PMID: 29560855 DOI: 10.2807/1560-7917.ES.2018.23.11.17-00491] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
439 Tengan FM, Abdala E, Nascimento M, Bernardo WM, Barone AA. Prevalence of hepatitis B in people living with HIV/AIDS in Latin America and the Caribbean: a systematic review and meta-analysis. BMC Infect Dis. 2017;17:587. [PMID: 28836955 DOI: 10.1186/s12879-017-2695-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
440 Zhao J, Zhang X, Guan T, Dai Q, He W, Zhang H, Wang Y, Wang B, Peng Z, Hu X, Qi D, Yang X, Zhang Y, Ma X. The association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females. Sci Rep 2019;9:3865. [PMID: 30846733 DOI: 10.1038/s41598-019-40354-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
441 Bai X, Ran J, Zhao X, Liang Y, Yang X, Xi Y. The S100A10-AnxA2 complex is associated with the exocytosis of hepatitis B virus in intrauterine infection. Lab Invest 2021. [PMID: 34645932 DOI: 10.1038/s41374-021-00681-8] [Reference Citation Analysis]
442 Peng C, Lu M, Yang D. CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV. Virol Sin. 2015;30:317-325. [PMID: 26511989 DOI: 10.1007/s12250-015-3660-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
443 Tu T, Wei X, Yang Y, Zhang N, Li W, Tu X, Li W. Deep learning-based framework for the distinction of membranous nephropathy: a new approach through hyperspectral imagery. BMC Nephrol 2021;22:231. [PMID: 34147076 DOI: 10.1186/s12882-021-02421-y] [Reference Citation Analysis]
444 Vieira Barbosa J, Sahli R, Aubert V, Chaouch A, Moradpour D, Fraga M. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center. PLoS One 2021;16:e0250347. [PMID: 33905426 DOI: 10.1371/journal.pone.0250347] [Reference Citation Analysis]
445 van Montfoort N, van der Aa E, van den Bosch A, Brouwers H, Vanwolleghem T, Janssen HL, Javanbakht H, Buschow SI, Woltman AM. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism. J Virol. 2016;90:6187-6199. [PMID: 27099316 DOI: 10.1128/jvi.02903-15] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
446 Wang YW, Shen ZZ, Jiang Y. Comparison of ARIMA and GM(1,1) models for prediction of hepatitis B in China. PLoS One 2018;13:e0201987. [PMID: 30180159 DOI: 10.1371/journal.pone.0201987] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
447 Zhang HY, Liu LG, Ye CY, Chen CH, Hang SX, Zhu Z, Shen HY, Huang ZY, Chen WY, Xue Y. Evolution of drug-resistant mutations in HBV genomes in patients with treatment failure during the past seven years (2010-2016). Virus Genes. 2018;54:41-47. [PMID: 29119303 DOI: 10.1007/s11262-017-1518-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
448 Unchwaniwala N, Sherer NM, Loeb DD. Hepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal. J Virol 2016;90:8705-19. [PMID: 27440888 DOI: 10.1128/JVI.01229-16] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
449 Kwon JW, Tchoe HJ, Lee J, Suh JK, Lee JH, Shin S. The Impact of National Surveillance for Liver Cancer: Results from Real-World Setting in Korea. Gut Liver 2020;14:108-16. [PMID: 30974929 DOI: 10.5009/gnl18522] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
450 Vasmehjani AA, Yaghubi S, Erfani Y, Hajikhezri Z, Farahmand M, Shayestehpour M, Adeli OA, Beiranvand M. Trend in Prevalence of Hepatitis B Virus Infection Among Blood Donor Individuals: An Eleven-year of Experience in Lorestan, Iran. Int J Prev Med 2020;11:178. [PMID: 33456734 DOI: 10.4103/ijpvm.IJPVM_260_18] [Reference Citation Analysis]
451 Zhu RX, Seto WK, Lai CL, Yuen MF. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut Liver. 2016;10:332-339. [PMID: 27114433 DOI: 10.5009/gnl15257] [Cited by in Crossref: 225] [Cited by in F6Publishing: 255] [Article Influence: 45.0] [Reference Citation Analysis]
452 Kwon JH, Song MJ, Jang JW, Bae SH, Choi JY, Yoon SK, Kim HY, Kim CW, Song DS, Chang UI, Yang JM, You CR, Choi SW, Lee HL, Lee SW, Han NI, Nam SW, Kim SG, Kim YS, Kim SH, Lee BS, Lee TH, Cho EY. Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naïve Patients with Chronic Hepatitis B in Korea. Dig Dis Sci 2019;64:2039-48. [PMID: 30725293 DOI: 10.1007/s10620-019-05489-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
453 Zhang W, Chen J, Liu L, Wang L, Liu J, Su D. Prognostic value of preoperative computed tomography in HBV-related hepatocellular carcinoma patients after curative resection. Onco Targets Ther 2019;12:3791-804. [PMID: 31190879 DOI: 10.2147/OTT.S199136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
454 Zhao D, Jiang X, Xu Y, Yang H, Gao D, Li X, Gao L, Ma C, Liang X. Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication. Front Immunol 2018;9:1124. [PMID: 29899741 DOI: 10.3389/fimmu.2018.01124] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
455 Wu LL, Li XY, Deng H, Xie DY, Gu YR, Bi YH, Huang YH, Gao ZL. Transforming growth factor-β: An early predictor of a functional cure in chronic hepatitis B treated with interferon. Virus Res 2021;309:198657. [PMID: 34919970 DOI: 10.1016/j.virusres.2021.198657] [Reference Citation Analysis]
456 Mansour-Ghanaei F, Joukar F, Naghipour M, Hassanipour S, Yeganeh S, Sepehrimanesh M, Fathalipour M. Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS). BMC Res Notes 2021;14:59. [PMID: 33568187 DOI: 10.1186/s13104-021-05474-2] [Reference Citation Analysis]
457 Chak EW, Sarkar S, Bowlus C. Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis. Dig Dis Sci 2016;61:2776-83. [PMID: 27234269 DOI: 10.1007/s10620-016-4205-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
458 Xie M, Quan H, Zeng Y, Yuan S, Liu Y, Yang Y. Sero-epidemiology study of hepatitis B virus surface antibodies from 2017 to 2019 among Chinese young adults in Hunan Province: A three-year retrospective study. Medicine (Baltimore) 2021;100:e26665. [PMID: 34398029 DOI: 10.1097/MD.0000000000026665] [Reference Citation Analysis]
459 Umare A, Seyoum B, Gobena T, Haile Mariyam T. Hepatitis B Virus Infections and Associated Factors among Pregnant Women Attending Antenatal Care Clinic at Deder Hospital, Eastern Ethiopia. PLoS One 2016;11:e0166936. [PMID: 27898721 DOI: 10.1371/journal.pone.0166936] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
460 Liu T, Sun Q, Liu Y, Cen S, Zhang Q. The MOV10 helicase restricts hepatitis B virus replication by inhibiting viral reverse transcription. J Biol Chem 2019;294:19804-13. [PMID: 31722967 DOI: 10.1074/jbc.RA119.009435] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
461 Nayagam S, Sicuri E, Lemoine M, Easterbrook P, Conteh L, Hallett TB, Thursz M. Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries. BMC Infect Dis 2017;17:692. [PMID: 29143675 DOI: 10.1186/s12879-017-2778-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
462 Crawshaw AF, Pareek M, Were J, Schillinger S, Gorbacheva O, Wickramage KP, Mandal S, Delpech V, Gill N, Kirkbride H, Zenner D. Infectious disease testing of UK-bound refugees: a population-based, cross-sectional study. BMC Med 2018;16:143. [PMID: 30149810 DOI: 10.1186/s12916-018-1125-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
463 Tsukamoto Y, Ikeda S, Uwai K, Taguchi R, Chayama K, Sakaguchi T, Narita R, Yao WL, Takeuchi F, Otakaki Y, Watashi K, Wakita T, Kato H, Fujita T. Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction. PLoS One 2018;13:e0197664. [PMID: 29782545 DOI: 10.1371/journal.pone.0197664] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
464 Estevez J, Chen VL, Podlaha O, Li B, Le A, Vutien P, Chang ET, Rosenberg-Hasson Y, Jiang Z, Pflanz S, Ge D, Gaggar A, Nguyen MH. Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma. Sci Rep 2017;7:11867. [PMID: 28928388 DOI: 10.1038/s41598-017-11975-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
465 Jaquet A, Muula G, Ekouevi DK, Wandeler G. Elimination of Viral Hepatitis in Low and Middle-Income Countries: Epidemiological Research Gaps. Curr Epidemiol Rep 2021;8:89-96. [PMID: 34532216 DOI: 10.1007/s40471-021-00273-6] [Reference Citation Analysis]
466 Höner Zu Siederdissen C, Cornberg M. Management of HBV and HBV/HDV-Associated Liver Cirrhosis. Visc Med 2016;32:86-94. [PMID: 27413725 DOI: 10.1159/000445518] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
467 Suresh M, Korolowicz KE, Balarezo M, Iyer RP, Padmanabhan S, Cleary D, Gimi R, Sheri A, Yon C, Kallakury BV, Tucker RD, Afdhal N, Menne S. Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks. PLoS One. 2017;12:e0169631. [PMID: 28056062 DOI: 10.1371/journal.pone.0169631] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
468 Kamath GR, Taioli E, N Egorova N, Llovet JM, Perumalswami PV, Weiss JJ, Schwartz M, Ewala S, Bickell NA. Liver Cancer Disparities in New York City: A Neighborhood View of Risk and Harm Reduction Factors. Front Oncol 2018;8:220. [PMID: 29963497 DOI: 10.3389/fonc.2018.00220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
469 López-Gatell H, García-García L, Echániz-Avilés G, Cruz-Hervert P, Olamendi-Portugal M, Castañeda-Desales D, Sanchez-Alemán MÁ, Romero-Martínez M, DeAntonio R, Cervantes-Apolinar MY, Cortes-Alcalá R, Alpuche-Aranda C. Hepatitis B seroprevalence in 10-25-year-olds in Mexico - the 2012 national health and nutrition survey (ENSANUT) results. Hum Vaccin Immunother 2019;15:433-9. [PMID: 30380981 DOI: 10.1080/21645515.2018.1533617] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
470 Hou J, Brouwer WP, Kreefft K, Gama L, Price SL, Janssen HLA, French PJ, Vanwolleghem T, Boonstra A. Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection. PLoS One 2017;12:e0179920. [PMID: 28662087 DOI: 10.1371/journal.pone.0179920] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
471 Jha S, Devaliya D, Bergson S, Desai S. Hepatitis B knowledge among women of childbearing age in three slums in Mumbai: a cross-sectional survey. Hepatol Med Policy 2016;1:5. [PMID: 30288309 DOI: 10.1186/s41124-016-0007-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
472 Zhang Y, Li Y, Wu M, Cao P, Liu X, Ren Q, Zhai Y, Xie B, Hu Y, Hu Z, Bei J, Ping J, Liu X, Yu Y, Guo B, Lu H, Liu G, Zhang H, Cui Y, Mo Z, Shen H, Zeng YX, He F, Zhang H, Zhou G. Comprehensive assessment showed no associations of variants at the SLC10A1 locus with susceptibility to persistent HBV infection among Southern Chinese. Sci Rep 2017;7:46490. [PMID: 28429786 DOI: 10.1038/srep46490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
473 Qiu Y, Ren JJ, Wu ZK, Shen LZ, Shan H, Dai XW, Li J, Liu Y, Ren W, Yao J, Li LJ. Strategies for hepatitis B booster vaccination among children: an 8-year prospective cohort study. Hum Vaccin Immunother 2020;16:2822-30. [PMID: 32429793 DOI: 10.1080/21645515.2020.1738169] [Reference Citation Analysis]
474 Chun HS, Lee JS, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Kim SU. Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B. Dig Dis Sci 2021. [PMID: 34476661 DOI: 10.1007/s10620-021-07157-1] [Reference Citation Analysis]
475 Li J, Hu Y, Yuan Y, Zhao Y, Han Q, Liu C, Hu X, Zhou Y, Wang Y, Guo Y, Wu C, Chen X, Pei R. Repurposing of Antazoline Hydrochloride as an Inhibitor of Hepatitis B Virus DNA Secretion. Virol Sin 2021;36:501-9. [PMID: 33165771 DOI: 10.1007/s12250-020-00306-2] [Reference Citation Analysis]
476 Chuaypen N, Payungporn S, Poovorawan K, Chotiyaputta W, Piratvisuth T, Tangkijvanich P. Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B. Virus Genes 2019;55:610-8. [PMID: 31359359 DOI: 10.1007/s11262-019-01689-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
477 Suijkerbuijk AWM, van Hoek AJ, Koopsen J, de Man RA, Mangen MJ, de Melker HE, Polder JJ, de Wit GA, Veldhuijzen IK. Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country. PLoS One 2018;13:e0207037. [PMID: 30408079 DOI: 10.1371/journal.pone.0207037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
478 Lok AS, Ganova-Raeva L, Cloonan Y, Punkova L, Lin HS, Lee WM, Ghany MG; Hepatitis B Research Network (HBRN). Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. J Viral Hepat 2017;24:1032-42. [PMID: 28581155 DOI: 10.1111/jvh.12732] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
479 Tang Y, Liu X, Lu X, He Q, Li G, Zou Y. Occult Hepatitis B Virus Infection in Maintenance Hemodialysis Patients: Prevalence and Mutations in "a" Determinant. Int J Med Sci 2020;17:2299-305. [PMID: 32922195 DOI: 10.7150/ijms.49540] [Reference Citation Analysis]
480 Shan S, You H, Niu J, Shang J, Xie W, Zhang Y, Li X, Ren H, Tang H, Ding H, Wang X, Nan Y, Dou X, Han T, Zhang L, Liu X, Deng C, Cheng J, Wang X, Xie Q, Lin S, Huang Y, Xu Y, Xiong Y, Li W, Yan X, Piao H, Huang W, Lu Q, Gong W, Li S, Hu X, Zhang X, Liu S, Li Y, Yang D, Li H, Yang C, Cheng M, Zhang L, Zheng H, Luo X, Lin F, Wang L, Xu G, Xu X, Wei L, Hou J, Duan Z, Zhuang H, Yang X, Kong Y, Jia J; CR-HepB study group, Beijing, China. Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B. J Clin Transl Hepatol 2019;7:322-8. [PMID: 31915601 DOI: 10.14218/JCTH.2019.00052] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
481 Graf C, Mondorf A, Knop V, Peiffer KH, Dietz J, Friess J, Wedemeyer H, Buggisch P, Mauss S, Berg T, Rausch M, Sprinzl M, Klinker H, Hinrichsen H, Bronowicki JP, Haag S, Hüppe D, Lutz T, Poynard T, Zeuzem S, Friedrich-Rust M, Sarrazin C, Vermehren J. Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection. J Clin Med 2019;8:E2101. [PMID: 31810183 DOI: 10.3390/jcm8122101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
482 Li B, Yan C, Zhu J, Chen X, Fu Q, Zhang H, Tong Z, Liu L, Zheng Y, Zhao P, Jiang W, Fang W. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review. Front Immunol 2020;11:1037. [PMID: 32547550 DOI: 10.3389/fimmu.2020.01037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
483 Asil M, Dertli R. Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients. Medicine (Baltimore) 2016;95:e4763. [PMID: 27631226 DOI: 10.1097/MD.0000000000004763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
484 Maraolo AE, Gentile I, Buonomo AR, Pinchera B, Borgia G. Current evidence on the management of hepatitis B in pregnancy. World J Hepatol 2018; 10(9): 585-594 [PMID: 30310536 DOI: 10.4254/wjh.v10.i9.585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
485 Chen Y, Xiang X, Qi R, Wang Y, Huang Y, You M, Xian Y, Wu Y, Fu R, Kang C, Tang J, Yu H, Zhang T, Yuan Q, Luo W, Xia N. Novel monkey mAbs induced by a therapeutic vaccine targeting the hepatitis B surface antigen effectively suppress hepatitis B virus in mice. Antib Ther 2021;4:197-207. [PMID: 34646979 DOI: 10.1093/abt/tbab020] [Reference Citation Analysis]
486 Wu Y, Gao C, Cai S, Xia M, Liao G, Zhang X, Peng J. Circulating miR-122 Is a Predictor for Virological Response in CHB Patients With High Viral Load Treated With Nucleos(t)ide Analogs. Front Genet 2019;10:243. [PMID: 30967899 DOI: 10.3389/fgene.2019.00243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
487 Ozoya OO, Chavez J, Sokol L, Dalia S. Optimizing antiviral agents for hepatitis B management in malignant lymphomas. Ann Transl Med 2017;5:39. [PMID: 28251118 DOI: 10.21037/atm.2016.12.25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
488 Ren F, Yang X, Hu ZW, Wong VKW, Xu HY, Ren JH, Zhong S, Jia XJ, Jiang H, Hu JL, Cai XF, Zhang WL, Yao FL, Yu HB, Cheng ST, Zhou HZ, Huang AL, Law BYK, Chen J. Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg production. EBioMedicine 2019;49:232-46. [PMID: 31680002 DOI: 10.1016/j.ebiom.2019.10.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
489 Fu F, Li X, Liu Q, Chen C, Bai Y, Shi D, Sang J, Wang K, Wang M. Noninvasive DW-MRI metrics for staging hepatic fibrosis and grading inflammatory activity in patients with chronic hepatitis B. Abdom Radiol (NY) 2021;46:1864-75. [PMID: 33074424 DOI: 10.1007/s00261-020-02801-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
490 Dessalegn Mekonnen B. Prevalence of Hepatitis C Virus Infection among Pregnant Women in Ethiopia: A Systematic Review and Meta-Analysis. Adv Prev Med 2021;2021:6615008. [PMID: 34136287 DOI: 10.1155/2021/6615008] [Reference Citation Analysis]
491 Bandopadhyay M, Bharadwaj M. Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker. Gut Pathog. 2020;12:23. [PMID: 32346400 DOI: 10.1186/s13099-020-00353-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
492 Osiowy C, Coffin C, Andonov A. Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy. Curr Treat Options Infect Dis 2016;8:177-93. [PMID: 27547127 DOI: 10.1007/s40506-016-0080-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
493 Xie LT, Yan CH, Zhao QY, He MN, Jiang TA. Quantitative and noninvasive assessment of chronic liver diseases using two-dimensional shear wave elastography. World J Gastroenterol 2018; 24(9): 957-970 [PMID: 29531460 DOI: 10.3748/wjg.v24.i9.957] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
494 Brahmania M, Liu S, Wahed AS, Yim C, Hansen BE, Khalili M, Terrault NA, Lok AS, Ghany M, Wang J, Wong D, Janssen HLA; Hepatitis B Research Network. Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America. Ann Hepatol 2020;19:437-45. [PMID: 32139262 DOI: 10.1016/j.aohep.2020.01.005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
495 Kalinich M, Bhan I, Kwan TT, Miyamoto DT, Javaid S, LiCausi JA, Milner JD, Hong X, Goyal L, Sil S, Choz M, Ho U, Kapur R, Muzikansky A, Zhang H, Weitz DA, Sequist LV, Ryan DP, Chung RT, Zhu AX, Isselbacher KJ, Ting DT, Toner M, Maheswaran S, Haber DA. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma. Proc Natl Acad Sci USA. 2017;114:1123-1128. [PMID: 28096363 DOI: 10.1073/pnas.1617032114] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 17.2] [Reference Citation Analysis]
496 Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis. Hepat Mon 2016;16:e35577. [PMID: 27257428 DOI: 10.5812/hepatmon.35577] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]
497 Boldt ABW, Oliveira-Toré CF, Kretzschmar GC, Weinschutz Mendes H, Stinghen ST, Andrade FA, Bumiller-Bini V, Gonçalves LB, Braga ACM, Stahlke EVRS, Velavan TP, Thiel S, de Messias-Reason IJT. Hepatitis B Virus Infection Among Leprosy Patients: A Case for Polymorphisms Compromising Activation of the Lectin Pathway and Complement Receptors. Front Immunol 2020;11:574457. [PMID: 33643280 DOI: 10.3389/fimmu.2020.574457] [Reference Citation Analysis]
498 Cai M, Hao Y, Zhong J, Yao W, Cao X, Gu G, Qin G. Telbivudine Treatment during Late Pregnancy Prevents Mother-to-Child Transmission of Hepatitis B Virus: A Retrospective Study. Can J Gastroenterol Hepatol 2019;2019:9046260. [PMID: 31380321 DOI: 10.1155/2019/9046260] [Reference Citation Analysis]
499 McNaughton AL, D'Arienzo V, Ansari MA, Lumley SF, Littlejohn M, Revill P, McKeating JA, Matthews PC. Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood. Gastroenterology 2019;156:384-99. [PMID: 30268787 DOI: 10.1053/j.gastro.2018.07.058] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
500 Chimungu B, Fu M, Wu J, Wu J, Huang L, Dai Y, Tang S, Zhang J, Wan C. Prevalence of sexually transmitted infections among foreigners living in Guangzhou, China: a cross-sectional study (2010-2017). BMC Infect Dis 2020;20:345. [PMID: 32410628 DOI: 10.1186/s12879-020-04995-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
501 Hang Pham TT, Le TX, Nguyen DT, Luu CM, Truong BD, Tran PD, Toy M, So S. Knowledge, attitudes and practices of hepatitis B prevention and immunization of pregnant women and mothers in northern Vietnam. PLoS One 2019;14:e0208154. [PMID: 30969972 DOI: 10.1371/journal.pone.0208154] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
502 Zhang T, Zhang G, Deng X, Zeng J, Jin J, Zeping H, Wu M, Zheng R. APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B. Radiology 2021;301:350-9. [PMID: 34427463 DOI: 10.1148/radiol.2021204700] [Reference Citation Analysis]
503 Kato M, Hamada-Tsutsumi S, Okuse C, Sakai A, Matsumoto N, Sato M, Sato T, Arito M, Omoteyama K, Suematsu N, Okamoto K, Kato T, Itoh F, Sumazaki R, Tanaka Y, Yotsuyanagi H, Kato T, Kurokawa MS. Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes. J Gastroenterol 2017;52:1051-63. [PMID: 28197802 DOI: 10.1007/s00535-017-1316-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
504 Tatsilong HO, Noubiap JJ, Nansseu JR, Aminde LN, Bigna JJ, Ndze VN, Moyou RS. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon. BMC Public Health 2016;15:706. [PMID: 27487845 DOI: 10.1186/s12889-016-3388-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
505 Fujiwara K. Novel Genetic Rearrangements in Hepatitis B Virus: Complex Structural Variations and Structural Variation Polymorphisms. Viruses 2021;13:473. [PMID: 33809245 DOI: 10.3390/v13030473] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
506 Tu T, Block JM, Wang S, Cohen C, Douglas MW. The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure. Viruses 2020;12:E515. [PMID: 32392763 DOI: 10.3390/v12050515] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
507 Kong Z, Liang N, Yang GL, Zhang Z, Liu Y, Yang Y, Liu YX, Wang QG, Zhang F, Zhang HY, Nikolova D, Jakobsen JC, Gluud C, Liu JP. Acupuncture for chronic hepatitis B. Cochrane Database Syst Rev 2019;8:CD013107. [PMID: 31436846 DOI: 10.1002/14651858.CD013107.pub2] [Reference Citation Analysis]
508 Zhang L, Wang YY, Huang YJ, Wang QM, Nelson KE, Wang AQ, Shen HP, Liu XL, Zhang YP, Yan DH, Peng ZQ, Zhang HG, Zhang Y, Zhao J, Wang Y, Yang Y, He Y, Xu JH, Liu DJ, Guo TJ, Xin XN, Zhou H, Ma X. Status of HBsAg seroprevalence in 15 million rural couples in China: a cross-sectional study. Sci Rep 2017;7:42822. [PMID: 28220812 DOI: 10.1038/srep42822] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
509 Abulude OA, Ahmed I, Sadisu FU. Assessment of Hepatitis B Viral Infection as a Predictor of Hepatic Enzymes and Compounds Alteration among Antenatal Patients. Med Sci (Basel) 2017;5:E24. [PMID: 29099040 DOI: 10.3390/medsci5040024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
510 Noguchi R, Kaji K, Namisaki T, Moriya K, Kitade M, Takeda K, Kawaratani H, Okura Y, Aihara Y, Furukawa M, Mitoro A, Yoshiji H. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B. World J Gastroenterol 2017; 23(36): 6705-6714 [PMID: 29085215 DOI: 10.3748/wjg.v23.i36.6705] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
511 Stevenson C, Youn JH, Hayney MS, David C. Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine. Hum Vaccin Immunother 2021;:1-11. [PMID: 34505827 DOI: 10.1080/21645515.2021.1965807] [Reference Citation Analysis]
512 Zhang Q, Zhang Q, Li B, Qu Y, Li Z, Lu L, Li R, Cai X. The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B. Mediators Inflamm 2021;2021:6636947. [PMID: 33727891 DOI: 10.1155/2021/6636947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
513 Yang YW, Tsai MK, Yang CY, Lee CY, Chiang BL, Lai HS. Telbivudine for renal transplant recipients with chronic hepatitis B infection: a randomized controlled trial with early termination. Clin Exp Nephrol 2020;24:474-82. [PMID: 32219622 DOI: 10.1007/s10157-020-01850-7] [Reference Citation Analysis]
514 Mani SKK, Andrisani O. Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma. Cytokine 2019;124:154518. [PMID: 30126685 DOI: 10.1016/j.cyto.2018.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
515 Dhouib W, Kacem M, Bennasrallah C, Ben Fredj M, Abroug H, Zemni I, Chelly S, Maalel I, Samia GS, Belguith Sriha A. Hepatitis B birth vaccination, cohort study, Tunisia 2000-2017. Libyan J Med 2020;15:1809223. [PMID: 32822288 DOI: 10.1080/19932820.2020.1809223] [Reference Citation Analysis]
516 Nguyen LH, Hoang J, Nguyen NH, Vu VD, Wang C, Trinh HN, Li J, Zhang JQ, Nguyen MH. Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection. Aliment Pharmacol Ther 2016;44:390-9. [PMID: 27363288 DOI: 10.1111/apt.13709] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
517 Scheibe A, Young K, Versfeld A, Spearman CW, Sonderup MW, Prabdial-Sing N, Puren A, Hausler H. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017). BMC Infect Dis 2020;20:655. [PMID: 32894072 DOI: 10.1186/s12879-020-05359-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
518 El-Shabrawi M, Abdelgawad M, Elgaddar O, Hassanin F, Khalil A, Mahfouz A, Elbanna B. A clinical and immunological study of children with chronic hepatitis B virus infection. Prz Gastroenterol 2019;14:211-6. [PMID: 31649794 DOI: 10.5114/pg.2019.88171] [Reference Citation Analysis]
519 Laroia ST, Vellore Srinivasan S, Yadav K, Rastogi A, Kumar S, Kumar G, Kumar M. Performance of shear wave elastography: A single centre pilot study of mixed etiology liver disease patients with normal BMI. Australas J Ultrasound Med 2021;24:120-36. [PMID: 34765422 DOI: 10.1002/ajum.12244] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
520 Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doganay L. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. World J Gastroenterol 2018; 24(30): 3347-3360 [PMID: 30122875 DOI: 10.3748/wjg.v24.i30.3347] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
521 Nguyen TTL, Pham TTH, So S, Hoang THV, Nguyen TTU, Ngo TB, Nguyen MP, Thai QH, Nguyen NK, Le Ho TQA, Tran QP, Pham MK. Knowledge, Attitudes and Practices toward Hepatitis B Virus Infection among Students of Medicine in Vietnam. Int J Environ Res Public Health 2021;18:7081. [PMID: 34281017 DOI: 10.3390/ijerph18137081] [Reference Citation Analysis]
522 Hou Y, Zhang Q, Gao F, Mao D, Li J, Gong Z, Luo X, Chen G, Li Y, Yang Z, Sun K, Wang X. Artificial neural network-based models used for predicting 28- and 90-day mortality of patients with hepatitis B-associated acute-on-chronic liver failure. BMC Gastroenterol 2020;20:75. [PMID: 32188419 DOI: 10.1186/s12876-020-01191-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
523 Ofori-Asenso R, Agyeman AA. Hepatitis B in Ghana: a systematic review & amp;amp; meta-analysis of prevalence studies (1995-2015). BMC Infect Dis. 2016;16:130. [PMID: 26987556 DOI: 10.1186/s12879-016-1467-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 7.8] [Reference Citation Analysis]
524 Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA; Hepatitis B Research Network. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection. Clin Gastroenterol Hepatol 2019;17:2541-2551.e2. [PMID: 30743006 DOI: 10.1016/j.cgh.2019.02.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
525 Ye J, Wang W, Feng S, Huang Y, Liao X, Kuang M, Xie X, Liao B, Zhong B. Precise fibrosis staging with shear wave elastography in chronic hepatitis B depends on liver inflammation and steatosis. Hepatol Int 2020;14:190-201. [PMID: 32078141 DOI: 10.1007/s12072-020-10017-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
526 Tian Q, Jia J. Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia. Hepatol Int. 2016;10:854-860. [PMID: 27300749 DOI: 10.1007/s12072-016-9745-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
527 Riedel T, Hageneder S, Surman F, Pop-Georgievski O, Noehammer C, Hofner M, Brynda E, Rodriguez-Emmenegger C, Dostálek J. Plasmonic Hepatitis B Biosensor for the Analysis of Clinical Saliva. Anal Chem 2017;89:2972-7. [PMID: 28192973 DOI: 10.1021/acs.analchem.6b04432] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 5.4] [Reference Citation Analysis]
528 Liao Y, Yuan S, Chen X, Zhu P, Li J, Qin L, Liao W. Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling. Sci Rep 2017;7:7649. [PMID: 28794477 DOI: 10.1038/s41598-017-07962-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
529 Hariri S, Davari S, Malekzadeh Z, Mohammadi Z, Masoudi S, Gandomkar A, Amini-Kafiabad S, Maghsoudloo M, Merat S, Poustchi H, Malekzadeh F. Prevalence of Hepatitis B and C Infections and Associated Risk Factors in Pars Cohort Study, Southern Iran. Middle East J Dig Dis 2021;13:95-102. [PMID: 34712446 DOI: 10.34172/mejdd.2021.211] [Reference Citation Analysis]
530 Han Z, Yin Y, Zhang Y, Ehrhardt S, Thio CL, Nelson KE, Bai X, Hou H. Knowledge of and attitudes towards hepatitis B and its transmission from mother to child among pregnant women in Guangdong Province, China. PLoS One 2017;12:e0178671. [PMID: 28575040 DOI: 10.1371/journal.pone.0178671] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
531 Ma L, Zheng X, Yang Y, Wang J, Xu Y, Wang B. Epigenetic differences of chronic hepatitis B in different TCM syndromes: Protocol for a case-control, non-interventional, observational clinical study. Medicine (Baltimore) 2018;97:e12452. [PMID: 30278525 DOI: 10.1097/MD.0000000000012452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
532 Kitandwe PK, Muyanja E, Nakaweesa T, Nanvubya A, Ssetaala A, Mpendo J, Okech B, Bagaya BS, Kiwanuka N, Price MA. Hepatitis B prevalence and incidence in the fishing communities of Lake Victoria, Uganda: a retrospective cohort study. BMC Public Health 2021;21:394. [PMID: 33622281 DOI: 10.1186/s12889-021-10428-1] [Reference Citation Analysis]
533 Rivera-Andrade A, Kroker-Lobos MF, Lazo M, Freedman ND, Smith JW, Torres O, McGlynn KA, Groopman JD, Guallar E, Ramirez-Zea M. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study. Nutr Metab Cardiovasc Dis 2019;29:191-200. [PMID: 30573307 DOI: 10.1016/j.numecd.2018.10.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
534 Zhou K, Contag C, Whitaker E, Terrault N. Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses. Lancet Gastroenterol Hepatol 2019;4:227-38. [PMID: 30679109 DOI: 10.1016/S2468-1253(18)30308-X] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 10.3] [Reference Citation Analysis]
535 Choga WT, Anderson M, Zumbika E, Phinius BB, Mbangiwa T, Bhebhe LN, Baruti K, Kimathi PO, Seatla KK, Musonda RM, Bell TG, Moyo S, Blackard JT, Gaseitsiwe S. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana. Viruses 2020;12:E731. [PMID: 32640609 DOI: 10.3390/v12070731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
536 Krarup HB, Rex KF, Andersen S. Risk of hepatitis B when migrating from low to high endemic areas. Int J Circumpolar Health 2020;79:1817274. [PMID: 32883187 DOI: 10.1080/22423982.2020.1817274] [Reference Citation Analysis]
537 Fujiwara N, Qian T, Koneru B, Hoshida Y. Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases. Hepatol Res 2020;50:817-30. [PMID: 32323426 DOI: 10.1111/hepr.13506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
538 Zimmermann R, Külper-Schiek W, Steffen G, Gillesberg Lassen S, Bremer V, Dudareva S; die Hepatitis-Monitoring-Arbeitsgruppe. [How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021;64:77-90. [PMID: 33326051 DOI: 10.1007/s00103-020-03260-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
539 Pettersson JH, Piorkowski G, Mayxay M, Rattanavong S, Vongsouvath M, Davong V, Alfsnes K, Eldholm V, de Lamballerie X, Holmes EC, Newton PN, Dubot-Pérès A. Meta-transcriptomic identification of hepatitis B virus in cerebrospinal fluid in patients with central nervous system disease. Diagn Microbiol Infect Dis 2019;95:114878. [PMID: 31451314 DOI: 10.1016/j.diagmicrobio.2019.114878] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
540 Nguyen HM, Sy BT, Trung NT, Hoan NX, Wedemeyer H, Velavan TP, Bock CT. Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam. PLoS One 2017;12:e0175304. [PMID: 28403190 DOI: 10.1371/journal.pone.0175304] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
541 Li Y, Luo G. Human low-density lipoprotein receptor plays an important role in hepatitis B virus infection. PLoS Pathog 2021;17:e1009722. [PMID: 34293069 DOI: 10.1371/journal.ppat.1009722] [Reference Citation Analysis]
542 Liu A, Le A, Zhang J, Wong C, Wong C, Henry L, Nguyen MH. Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000-2015. Clin Transl Gastroenterol 2018;9:141. [PMID: 29540676 DOI: 10.1038/s41424-018-0007-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
543 Xu K, Liu LM, Farazi PA, Wang H, Rochling FA, Watanabe-Galloway S, Zhang JJ. Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B. Glob Health Action 2018;11:1433987. [PMID: 29447614 DOI: 10.1080/16549716.2018.1433987] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
544 Zhang X, Li M, Xi H, Zhang R, Chen J, Zhang Y, Xu X. Pre-existing mutations related to tenofovir in chronic hepatitis B patients with long-term nucleos(t)ide analogue drugs treatment by ultra-deep pyrosequencing. Oncotarget. 2016;7:70264-70275. [PMID: 27602500 DOI: 10.18632/oncotarget.11840] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
545 Byrne R, Carey I, Agarwal K. Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence. Therap Adv Gastroenterol 2018;11:1756284818786108. [PMID: 30034532 DOI: 10.1177/1756284818786108] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
546 Li M, Li F, Li N, Sang J, Fan X, Deng H, Zhang X, Han Q, Lv Y, Liu Z. Association of polymorphism rs1053005 in STAT3 with chronic hepatitis B virus infection in Han Chinese population. BMC Med Genet 2018;19:52. [PMID: 29609539 DOI: 10.1186/s12881-018-0569-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
547 Wang JC, Fu R, Tao XW, Mao YF, Wang F, Zhang ZC, Yu WW, Chen J, He J, Sun BC. A radiomics-based model on non-contrast CT for predicting cirrhosis: make the most of image data.Biomark Res. 2020;8:47. [PMID: 32963787 DOI: 10.1186/s40364-020-00219-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
548 Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS; Hepatitis B Research Network. Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection. Hepatology 2019;69:2338-48. [PMID: 30549279 DOI: 10.1002/hep.30417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
549 Reinharz V, Ishida Y, Tsuge M, Durso-Cain K, Chung TL, Tateno C, Perelson AS, Uprichard SL, Chayama K, Dahari H. Understanding Hepatitis B Virus Dynamics and the Antiviral Effect of Interferon Alpha Treatment in Humanized Chimeric Mice. J Virol 2021;95:e0049220. [PMID: 33910953 DOI: 10.1128/JVI.00492-20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
550 Boye S, Shimakawa Y, Vray M, Giles-Vernick T. Limited Awareness of Hepatitis B but Widespread Recognition of Its Sequelae in Rural Senegal: A Qualitative Study. Am J Trop Med Hyg 2020;102:637-43. [PMID: 31971148 DOI: 10.4269/ajtmh.19-0477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
551 Djaogol T, Coste M, Marcellin F, Jaquet A, Chabrol F, Giles-Vernick T, Diallo A, Carrieri MP, Boyer S; ANRS 12356 AmBASS Study Group. Prevention and care of hepatitis B in the rural region of Fatick in Senegal: a healthcare workers' perspective using a mixed methods approach. BMC Health Serv Res 2019;19:627. [PMID: 31484515 DOI: 10.1186/s12913-019-4416-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
552 Lingani M, Akita T, Ouoba S, Sanou AM, Sugiyama A, Tarnagda Z, Ohisa M, Tinto H, Mishiro S, Tanaka J. High prevalence of hepatitis B infections in Burkina Faso (1996-2017): a systematic review with meta-analysis of epidemiological studies. BMC Public Health 2018;18:551. [PMID: 29699534 DOI: 10.1186/s12889-018-5432-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
553 Cao X, Wang Y, Li P, Huang W, Lu X, Lu H. HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies. Front Oncol 2021;11:685706. [PMID: 34277431 DOI: 10.3389/fonc.2021.685706] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
554 Malyszko J, Zawierucha J, Marcinkowski W, Prystacki T, Dryl-Rydzynska T, Malyszko JS, Matuszkiewicz-Rowinska J. The prevalence of hepatitis C and B among patients on hemodialysis and on renal transplantation waiting list in Poland has significantly decreased during the last 10 years. Int Urol Nephrol 2018;50:1555-6. [PMID: 29868940 DOI: 10.1007/s11255-018-1897-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
555 Treem WR, Palmer M, Lonjon-Domanec I, Seekins D, Dimick-Santos L, Avigan MI, Marcinak JF, Dash A, Regev A, Maller E, Patwardhan M, Lewis JH, Rockey DC, Di Bisceglie AM, Freston JW, Andrade RJ, Chalasani N. Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis. Drug Saf 2021;44:133-65. [PMID: 33141341 DOI: 10.1007/s40264-020-01014-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
556 Phan NMH, Faddy HM, Flower RL, Dimech WJ, Spann KM, Roulis EV. Low Genetic Diversity of Hepatitis B Virus Surface Gene amongst Australian Blood Donors. Viruses 2021;13:1275. [PMID: 34208852 DOI: 10.3390/v13071275] [Reference Citation Analysis]
557 Congly SE, Brahmania M. Variable access to antiviral treatment of chronic hepatitis B in Canada: a descriptive study. CMAJ Open 2019;7:E182-9. [PMID: 30926602 DOI: 10.9778/cmajo.20180108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
558 Stinco M, Rubino C, Trapani S, Indolfi G. Treatment of hepatitis B virus infection in children and adolescents. World J Gastroenterol 2021; 27(36): 6053-6063 [PMID: 34629819 DOI: 10.3748/wjg.v27.i36.6053] [Reference Citation Analysis]
559 Wang J, Li J, Wu J, Dong M, Shen Z, Lin Y, Li F, Zhang Y, Mao R, Lu M, Zhang J. Host Gene SEL1L Involved in Endoplasmic Reticulum-Associated Degradation Pathway Could Inhibit Hepatitis B Virus at RNA, DNA, and Protein Levels. Front Microbiol 2019;10:2869. [PMID: 31921048 DOI: 10.3389/fmicb.2019.02869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
560 Jiang L, Niu W, Zheng Q, Meng G, Chen X, Zhang M, Deng G, Mao Q, Wang L. Identification of an Autoantibody Against ErbB-3-Binding Protein-1 in the Sera of Patients With Chronic Hepatitis B Virus Infection. Front Immunol 2021;12:640335. [PMID: 34113340 DOI: 10.3389/fimmu.2021.640335] [Reference Citation Analysis]
561 Tseng TC, Kao JH. Elimination of Hepatitis B: Is It a Mission Possible? BMC Med 2017;15:53. [PMID: 28292309 DOI: 10.1186/s12916-017-0820-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
562 Nayagam S, Chan P, Zhao K, Sicuri E, Wang X, Jia J, Wei L, Walsh N, Rodewald LE, Zhang G, Ailing W, Zhang L, Chang JH, Hou W, Qiu Y, Sui B, Xiao Y, Zhuang H, Thursz MR, Scano F, Low-Beer D, Schwartländer B, Wang Y, Hallett TB. Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning. Clin Infect Dis 2021;72:743-52. [PMID: 32255486 DOI: 10.1093/cid/ciaa134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
563 Nankya-Mutyoba J, Aizire J, Makumbi F, Ocama P, Kirk GD. Hepatitis B virus perceptions and health seeking behaviors among pregnant women in Uganda: implications for prevention and policy. BMC Health Serv Res 2019;19:760. [PMID: 31655575 DOI: 10.1186/s12913-019-4516-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
564 Chi XM, Wang XM, Wang ZF, Wu RH, Gao XZ, Xu HQ, Ding YH, Niu JQ. Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B. World J Gastroenterol 2021; 27(40): 6927-6938 [PMID: 34790015 DOI: 10.3748/wjg.v27.i40.6927] [Reference Citation Analysis]
565 Wu YT, Li X, Liu ZL, Xu Z, Dai W, Zhang K, Wu JS, Arshad B, Wu KN, Kong LQ. Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis. PLoS One 2017;12:e0179680. [PMID: 28640902 DOI: 10.1371/journal.pone.0179680] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
566 Ouaguia L, Dufeu-Duchesne T, Leroy V, Decaens T, Reiser JB, Sosa Cuevas E, Durantel D, Valladeau-Guilemond J, Bendriss-Vermare N, Chaperot L, Aspord C. Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs. Clin Transl Immunology 2020;9:e1208. [PMID: 33312564 DOI: 10.1002/cti2.1208] [Reference Citation Analysis]
567 Miglietta A, Quinten C, Lopalco PL, Duffell E. Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014. Euro Surveill 2018;23. [PMID: 29439751 DOI: 10.2807/1560-7917.ES.2018.23.6.17-00278] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
568 Okpechi IG, Ameh OI, Bello AK, Ronco P, Swanepoel CR, Kengne AP. Epidemiology of Histologically Proven Glomerulonephritis in Africa: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0152203. [PMID: 27011216 DOI: 10.1371/journal.pone.0152203] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
569 Ezzikouri S, Chihab H, Elhabazi A, Wakrim L, Benjelloun S. Lack of Ser267Phe variant of sodium taurocholate cotransporting polypeptide among Moroccans regardless of hepatitis B virus infection status. BMC Infect Dis 2017;17:99. [PMID: 28125961 DOI: 10.1186/s12879-017-2214-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
570 Bigna JJ, Amougou MA, Asangbeh SL, Kenne AM, Noumegni SRN, Ngo-Malabo ET, Noubiap JJ. Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis. BMJ Open 2017;7:e015298. [PMID: 28667212 DOI: 10.1136/bmjopen-2016-015298] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
571 Obeidat AE, Monti G, Sae-Ow W, Shinoda H, Lim H. Hepatitis E Virus Superinfection: an Underrecognized Trigger of Acute Hepatitis B Virus Flare. Cureus 2021;13:e13809. [PMID: 33859880 DOI: 10.7759/cureus.13809] [Reference Citation Analysis]
572 Ward H, Tang L, Poonia B, Kottilil S. Treatment of hepatitis B virus: an update. Future Microbiol. 2016;11:1581-1597. [PMID: 27855500 DOI: 10.2217/fmb-2016-0128] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
573 Huang LL, Yu XP, Li JL, Lin HM, Kang NL, Jiang JJ, Zhu YY, Liu YR, Zeng DW. Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection. World J Gastroenterol 2021; 27(7): 641-653 [PMID: 33642834 DOI: 10.3748/wjg.v27.i7.641] [Reference Citation Analysis]
574 Kane MA, Roudot-Thoraval F, Guerin N, Papaevangelou V, Van Damme P; Viral Hepatitis Prevention Board. Editorial on "What is a potentially damaging vaccination delay in children younger than 2 years?". Hum Vaccin Immunother 2016;12:2053-6. [PMID: 27261211 DOI: 10.1080/21645515.2016.1177689] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
575 Binnie A, Fernandes E, Almeida-Lousada H, de Mello RA, Castelo-Branco P. CRISPR-based strategies in infectious disease diagnosis and therapy. Infection 2021;49:377-85. [PMID: 33393066 DOI: 10.1007/s15010-020-01554-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
576 Wang M, Xi D, Ning Q. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatol Int. 2017;11:171-180. [PMID: 28097530 DOI: 10.1007/s12072-016-9779-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
577 Taheri Ezbarami Z, Hassani P, Zagheri Tafreshi M, Alavi Majd H. A qualitative study on individual experiences of chronic hepatitis B patients. Nurs Open 2017;4:310-8. [PMID: 29085657 DOI: 10.1002/nop2.100] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
578 Yao Y, Yang B, Chen Y, Huang D, Liu C, Sun H, Hu X, Zhou Y, Wang Y, Chen J, Pei R, Wen Z, Chen X. RNA-Binding motif protein 38 (RBM38) mediates HBV pgRNA packaging into the nucleocapsid. Antiviral Res 2022;:105249. [PMID: 35041910 DOI: 10.1016/j.antiviral.2022.105249] [Reference Citation Analysis]
579 Tong S, Pan J, Tang J. Study on the structure optimization and anti-hepatitis B virus activity of novel human La protein inhibitor HBSC11. J Med Virol 2019;91:1818-29. [PMID: 31241178 DOI: 10.1002/jmv.25528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
580 Pandyarajan V, Govalan R, Yang JD. Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma. Int J Mol Sci 2021;22:E479. [PMID: 33418899 DOI: 10.3390/ijms22020479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
581 Qama A, Allard N, Cowie B, Davis JS, Davies J. Hepatitis B in the Northern Territory: insights into the changing epidemiology of an ancient condition. Intern Med J 2021;51:910-22. [PMID: 32975893 DOI: 10.1111/imj.15069] [Reference Citation Analysis]
582 Xia Z, Zheng J, Zheng L, Zheng E, Zou Z, Sheng X, Wu J. Effects of dyslipidemia on E antigen seroconversion of patients with chronic hepatitis B treated by nucleoside (acid) analogs. Lipids Health Dis 2021;20:148. [PMID: 34717643 DOI: 10.1186/s12944-021-01582-x] [Reference Citation Analysis]
583 Xu WX, Li YM, Li JG, Mei YY, Chen YM, Li XJ, Lin CS, Deng H, Zhao ZX, Xie DY, Gao ZL, Peng L. The 96-week clinical outcomes after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients. Gastroenterol Rep (Oxf) 2021;9:313-22. [PMID: 34567563 DOI: 10.1093/gastro/goab013] [Reference Citation Analysis]
584 Xia WY, Gao L, Dai EH, Chen D, Xie EF, Yang L, Zhang SC, Zhang BF, Xu J, Pan SY. Liquid biopsy for non-invasive assessment of liver injury in hepatitis B patients. World J Gastroenterol 2019; 25(29): 3985-3995 [PMID: 31413532 DOI: 10.3748/wjg.v25.i29.3985] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
585 Anabire NG, Aryee PA, Abdul-Karim A, Abdulai IB, Quaye O, Awandare GA, Helegbe GK. Prevalence of malaria and hepatitis B among pregnant women in Northern Ghana: Comparing RDTs with PCR. PLoS One 2019;14:e0210365. [PMID: 30726218 DOI: 10.1371/journal.pone.0210365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
586 Kishk R, Mandour M, Elprince M, Salem A, Nemr N, Eida M, Ragheb M. Pattern and interpretation of hepatitis B virus markers among pregnant women in North East Egypt. Braz J Microbiol. 2020;51:593-600. [PMID: 31677078 DOI: 10.1007/s42770-019-00174-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
587 Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, Wei W, Lemmens VEPP, Soerjomataram I. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer 2022;161:108-18. [PMID: 34942552 DOI: 10.1016/j.ejca.2021.11.023] [Reference Citation Analysis]
588 Yang S, Chen G, Li Y, Li G, Liang Y, Zhou F, Zhou S, Yang Y, Jia W, Gao Y, Chen Y. The trend of direct medical costs and associated factors in patients with chronic hepatitis B in Guangzhou, China: an eight-year retrospective cohort study. BMC Med Inform Decis Mak 2021;21:71. [PMID: 34330262 DOI: 10.1186/s12911-021-01429-6] [Reference Citation Analysis]
589 Raju B, Andani A, Kolhapure S, Agrawal A. Need for hepatitis A prevention in patients with chronic liver disease in the changing epidemiological setting of India. Hum Vaccin Immunother 2021;17:1520-9. [PMID: 33236963 DOI: 10.1080/21645515.2020.1832408] [Reference Citation Analysis]
590 Aaron D, Nagu TJ, Rwegasha J, Komba E. Hepatitis B vaccination coverage among healthcare workers at national hospital in Tanzania: how much, who and why? BMC Infect Dis 2017;17:786. [PMID: 29262783 DOI: 10.1186/s12879-017-2893-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
591 Wang J, Zhao G, Chen J, Xia J, Wang S, Huang G, Chen F, Shi J, Yang Y, Wei Y. Association of hepatitis B infection with high-risk complications in total joint arthroplasty. BMC Musculoskelet Disord 2019;20:163. [PMID: 30971239 DOI: 10.1186/s12891-019-2535-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
592 Liu Y, Wang B, Wang L, Vikash V, Wang Q, Roggendorf M, Lu M, Yang D, Liu J. Transcriptome Analysis and Comparison of Marmota monax and Marmota himalayana. PLoS One. 2016;11:e0165875. [PMID: 27806133 DOI: 10.1371/journal.pone.0165875] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
593 Cheung KS, Seto WK, Fung J, Mak LY, Lai CL, Yuen MF. Epidemiology and natural history of Wilson’s disease in the Chinese: A territory-based study in Hong Kong between 2000 and 2016. World J Gastroenterol 2017; 23(43): 7716-7726 [PMID: 29209112 DOI: 10.3748/wjg.v23.i43.7716] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
594 Liao X, Han C, Qin W, Liu X, Yu L, Zhu G, Yu T, Lu S, Su H, Liu Z, Chen Z, Yang C, Huang K, Liu Z, Liang Y, Huang J, Dong J, Li L, Qin X, Ye X, Xiao K, Peng M, Peng T. PLCE1 polymorphisms and expression combined with serum AFP level predicts survival of HBV-related hepatocellular carcinoma patients after hepatectomy. Oncotarget 2017;8:29202-19. [PMID: 28418898 DOI: 10.18632/oncotarget.16346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
595 Liu Z, Li S, Liu Y, Guo W, Bai O. PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection. PLoS One 2017;12:e0180390. [PMID: 28662185 DOI: 10.1371/journal.pone.0180390] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
596 Friedman A, Siewe N. Chronic hepatitis B virus and liver fibrosis: A mathematical model. PLoS One 2018;13:e0195037. [PMID: 29634771 DOI: 10.1371/journal.pone.0195037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
597 Zheng JW, Cao JL, Yuan Q. Sleeping Beauty Transposon-based System forRapid Generation of HBV-replicating Stable Cell Lines. Bio Protoc 2018;8:e2908. [PMID: 34395740 DOI: 10.21769/BioProtoc.2908] [Reference Citation Analysis]
598 Poovorawan K, Soonthornworasiri N, Sa-Angchai P, Mansanguan C, Piyaphanee W. Hepatitis B vaccination for international travelers to Asia. Trop Dis Travel Med Vaccines 2016;2:14. [PMID: 28883958 DOI: 10.1186/s40794-016-0031-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
599 Froeschl G, Hoelscher M, Maganga LH, Kroidl I, Clowes P, Geis S, Saathoff E, Hoffmann D, Protzer U, Kroidl A. Hepatitis B, C and D virus prevalence in children and adults in Mbeya Region, Tanzania: results from a cohort study 2002 - 2009. Pan Afr Med J 2021;39:174. [PMID: 34584600 DOI: 10.11604/pamj.2021.39.174.26553] [Reference Citation Analysis]
600 Kilonzo SB, Gunda DW, Mpondo BCT, Bakshi FA, Jaka H. Hepatitis B Virus Infection in Tanzania: Current Status and Challenges. J Trop Med 2018;2018:4239646. [PMID: 29666656 DOI: 10.1155/2018/4239646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
601 Cao X, Zao X, Xue B, Chen H, Zhang J, Li S, Li X, Zhu S, Guo R, Li X, Ye Y. The mechanism of TiaoGanYiPi formula for treating chronic hepatitis B by network pharmacology and molecular docking verification. Sci Rep 2021;11:8402. [PMID: 33863948 DOI: 10.1038/s41598-021-87812-9] [Reference Citation Analysis]
602 Lo WC, Ku CC, Chiou ST, Chan CC, Chen CL, Lai MS, Lin HH. Adult mortality of diseases and injuries attributable to selected metabolic, lifestyle, environmental, and infectious risk factors in Taiwan: a comparative risk assessment. Popul Health Metr 2017;15:17. [PMID: 28468625 DOI: 10.1186/s12963-017-0134-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
603 Sun F, Tan W, Dan Y, Wang X, Guo Y, Deng G. Copy number gain of pro-inflammatory genes in patients with HBV-related acute-on-chronic liver failure. BMC Med Genomics 2020;13:180. [PMID: 33261607 DOI: 10.1186/s12920-020-00835-5] [Reference Citation Analysis]
604 Gounder PP, Bulkow LR, Snowball M, Negus S, Spradling PR, Simons BC, McMahon BJ. Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance. Aliment Pharmacol Ther 2016;43:1197-207. [PMID: 27061300 DOI: 10.1111/apt.13621] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
605 Pinheiro PS, Callahan KE, Ragin C, Hage RW, Hylton T, Kobetz EN. Black Heterogeneity in Cancer Mortality: US-Blacks, Haitians, and Jamaicans. Cancer Control 2016;23:347-58. [PMID: 27842324 DOI: 10.1177/107327481602300406] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
606 Hang Pham TT, Le TX, Nguyen DT, Luu CM, Truong BD, Tran PD, Toy M, Bozkurt S, So S. Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam. PLoS One 2019;14:e0223733. [PMID: 31609983 DOI: 10.1371/journal.pone.0223733] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
607 Di Bona D, Pandey JP, Aiello A, Bilancia M, Candore G, Caruso C, Colomba C, Duro G, Ligotti ME, Macchia L, Rizzo S, Accardi G. The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans. Immunology 2020;159:178-82. [PMID: 31613998 DOI: 10.1111/imm.13133] [Reference Citation Analysis]
608 Taheri Soodejani M, Haghdoost AA, Sedaghat A, Baneshi MR, Zolala F. The Trends of Viral Hepatitis B and C and HIV Infections in Donated Bloods in Iran Between 2003 and 2017. J Blood Med 2019;10:435-41. [PMID: 31908558 DOI: 10.2147/JBM.S229327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
609 Smith-Palmer J, Cerri K, Sbarigia U, Chan EKH, Pollock RF, Valentine WJ, Bonroy K. Impact of Stigma on People Living with Chronic Hepatitis B. Patient Relat Outcome Meas 2020;11:95-107. [PMID: 32214859 DOI: 10.2147/PROM.S226936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
610 Argo CK, Caldwell SH. Meeting the Eastern perspective in hepatitis B related ACLF. Annals of Hepatology 2015;14:777-9. [DOI: 10.5604/16652681.1171744] [Reference Citation Analysis]
611 Périères L, Diallo A, Marcellin F, Nishimwe ML, Ba EH, Coste M, Lo G, Halfon P, Touré Kane C, Maradan G, Carrieri P, Diouf A, Shimakawa Y, Sokhna C, Boyer S; ANRS 12356 AmBASS Survey Study Group. Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey). Hepatol Commun 2021. [PMID: 34918868 DOI: 10.1002/hep4.1879] [Reference Citation Analysis]
612 Dagnew M, Million Y, Gizachew M, Eshetie S, Yitayew G, Asrade L, Adefris M, Moges F, Tiruneh M. Hepatitis B and C Viruses' Infection and Associated Factors among Pregnant Women Attending Antenatal Care in Hospitals in the Amhara National Regional State, Ethiopia. Int J Microbiol 2020;2020:8848561. [PMID: 33133191 DOI: 10.1155/2020/8848561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
613 Fu WK, Cao J, Mi NN, Huang CF, Gao L, Zhang JD, Yue P, Bai B, Lin YY, Meng WB. Cytokines predict virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy. World J Clin Cases 2020; 8(11): 2255-2265 [PMID: 32548156 DOI: 10.12998/wjcc.v8.i11.2255] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
614 Li M, Chen L, Liu LM, Li YL, Li BA, Li B, Mao YL, Xia LF, Wang T, Liu YN, Li Z, Guo TS. Performance verification and comparison of TianLong automatic hypersensitive hepatitis B virus DNA quantification system with Roche CAP/CTM system. World J Gastroenterol 2017; 23(37): 6845-6853 [PMID: 29085227 DOI: 10.3748/wjg.v23.i37.6845] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
615 Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease. Clin Liver Dis. 2016;20:607-628. [PMID: 27742003 DOI: 10.1016/j.cld.2016.06.006] [Cited by in Crossref: 115] [Cited by in F6Publishing: 102] [Article Influence: 28.8] [Reference Citation Analysis]
616 Pereira-Gómez M, Bou JV, Andreu I, Sanjuán R. Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients. PLoS One 2016;11:e0163363. [PMID: 27649318 DOI: 10.1371/journal.pone.0163363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
617 Si J, Yu C, Guo Y, Bian Z, Qin C, Yang L, Chen Y, Yin L, Li H, Lan J, Chen J, Chen Z, Lv J, Li L;  China Kadoorie Biobank Collaborative Group. Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults. BMC Med. 2018;16:93. [PMID: 29909773 DOI: 10.1186/s12916-018-1084-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
618 Arora A, Anand AC, Kumar A, Singh SP, Aggarwal R, Dhiman RK, Aggarwal S, Alam S, Bhaumik P, Dixit VK, Goel A, Goswami B, Kumar A, Kumar M, Madan K, Murugan N, Nagral A, Puri AS, Rao PN, Saraf N, Saraswat VA, Sehgal S, Sharma P, Shenoy KT, Wadhawan M; Members of the INASL taskforce on Hepatitis B. INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids. J Clin Exp Hepatol 2018;8:403-31. [PMID: 30568345 DOI: 10.1016/j.jceh.2018.06.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
619 Liao X, Yu L, Liu X, Han C, Yu T, Qin W, Yang C, Zhu G, Su H, Peng T. Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma. Cancer Manag Res 2018;10:953-67. [PMID: 29760565 DOI: 10.2147/CMAR.S163209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
620 Meng J, Xu H, Sui D, Jiang J, Li J, Gao Y, Niu J. A retrospective serological survey of hepatitis B virus infection in Northeast China. BMC Infect Dis 2019;19:440. [PMID: 31109300 DOI: 10.1186/s12879-019-4091-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
621 Wang Z, Liu W, Zhang M, Wang M, Wu H, Lu M. Effect of Hepatitis B Virus Infection on Sperm Quality and Outcomes of Assisted Reproductive Techniques in Infertile Males. Front Med (Lausanne) 2021;8:744350. [PMID: 34796185 DOI: 10.3389/fmed.2021.744350] [Reference Citation Analysis]
622 Gao F, Wang H, Li X, Guo F, Yuan Y, Wang X, Zhang Y, Bai G. Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load. J Inflamm Res 2021;14:5619-32. [PMID: 34764667 DOI: 10.2147/JIR.S337561] [Reference Citation Analysis]
623 Tesfa T, Hawulte B, Tolera A, Abate D. Hepatitis B virus infection and associated risk factors among medical students in eastern Ethiopia. PLoS One 2021;16:e0247267. [PMID: 33606777 DOI: 10.1371/journal.pone.0247267] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
624 Pezzi C, Lee D, Kumar GS, Kawasaki B, Kennedy L, Aguirre J, Titus M, Ford R, Mamo B, Urban K, Hughes S, Payton C, Scott K, Montour J, Jentes ES. Health screenings administered during the domestic medical examination of refugees and other eligible immigrants in nine US states, 2014-2016: A cross-sectional analysis. PLoS Med 2020;17:e1003065. [PMID: 32231391 DOI: 10.1371/journal.pmed.1003065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
625 Chong ZL, Lodz NA, Mutalip MHA, Lim YC, Mahjom M, Ahmad NA. Preparing for and conducting the National Health and Morbidity Survey in Malaysia amid the COVID-19 pandemic: balancing risks and benefits to participants and society. Western Pac Surveill Response J 2021;12:71-6. [PMID: 34703638 DOI: 10.5365/wpsar.2021.12.3.842] [Reference Citation Analysis]
626 Easterbrook PJ, Roberts T, Sands A, Peeling R. Diagnosis of viral hepatitis. Curr Opin HIV AIDS. 2017;12:302-314. [PMID: 28306597 DOI: 10.1097/coh.0000000000000370] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 9.8] [Reference Citation Analysis]
627 Abaalkhail FA, Al-Hamoudi WK, Khathlan A, Alghamdi S, Alghamdi M, Alqahtani SA, Sanai FM. SASLT practice guidelines for the management of Hepatitis B virus - An update. Saudi J Gastroenterol 2021;27:115-26. [PMID: 33976009 DOI: 10.4103/sjg.sjg_539_20] [Reference Citation Analysis]
628 Adjei CA, Stutterheim SE, Naab F, Ruiter RAC. Barriers to chronic Hepatitis B treatment and care in Ghana: A qualitative study with people with Hepatitis B and healthcare providers. PLoS One. 2019;14:e0225830. [PMID: 31794577 DOI: 10.1371/journal.pone.0225830] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
629 Wong GL. Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend. Clin Mol Hepatol. 2018;24:108-113. [PMID: 29353469 DOI: 10.3350/cmh.2017.0068] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
630 Beilstein F, Blanchet M, Vaillant A, Sureau C. Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection In Vitro. J Virol 2018;92:e01416-17. [PMID: 29212929 DOI: 10.1128/JVI.01416-17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
631 Qi X, An M, Wu T, Jiang D, Peng M, Wang W, Wang J, Zhang C, Chess Study Group OBOT. Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis. Can J Gastroenterol Hepatol 2018;2018:3406789. [PMID: 29977884 DOI: 10.1155/2018/3406789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
632 Yu Y, Li S, Liang W. Bona fide receptor for hepatitis B and D viral infections: Mechanism, research models and molecular drug targets. Emerg Microbes Infect 2018;7:134. [PMID: 30050063 DOI: 10.1038/s41426-018-0137-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
633 Schönrich G, Raftery MJ. The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance. Front Cell Infect Microbiol 2019;9:207. [PMID: 31263684 DOI: 10.3389/fcimb.2019.00207] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 24.3] [Reference Citation Analysis]
634 Wahome E, Ngetsa C, Mwambi J, Gelderblom HC, Manyonyi GO, Micheni M, Hassan A, Price MA, Graham SM, Sanders EJ. Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya. Open Forum Infect Dis 2017;4:ofw253. [PMID: 28695141 DOI: 10.1093/ofid/ofw253] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
635 Almeida PH, Matielo CEL, Curvelo LA, Rocco RA, Felga G, Della Guardia B, Boteon YL. Update on the management and treatment of viral hepatitis. World J Gastroenterol 2021; 27(23): 3249-3261 [PMID: 34163109 DOI: 10.3748/wjg.v27.i23.3249] [Reference Citation Analysis]
636 Lin Y, Wu C, Wang X, Kemper T, Squire A, Gunzer M, Zhang J, Chen X, Lu M. Hepatitis B virus is degraded by autophagosome-lysosome fusion mediated by Rab7 and related components. Protein Cell 2019;10:60-6. [PMID: 29876903 DOI: 10.1007/s13238-018-0555-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
637 Le C, Sirajee R, Steenbergen R, Joyce MA, Addison WR, Tyrrell DL. In Vitro Infection with Hepatitis B Virus Using Differentiated Human Serum Culture of Huh7.5-NTCP Cells without Requiring Dimethyl Sulfoxide. Viruses 2021;13:97. [PMID: 33445753 DOI: 10.3390/v13010097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
638 Petrick JL, McGlynn KA. The changing epidemiology of primary liver cancer. Curr Epidemiol Rep 2019;6:104-11. [PMID: 31259140 DOI: 10.1007/s40471-019-00188-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
639 Lazarus JV, Mozalevskis A, Safreed-Harmon K, Eramova I. Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014). Hepatol Med Policy 2016;1:3. [PMID: 30288307 DOI: 10.1186/s41124-016-0009-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
640 Rajamoorthy Y, Taib NM, Munusamy S, Anwar S, Wagner AL, Mudatsir M, Müller R, Kuch U, Groneberg DA, Harapan H, Khin AA. Knowledge and awareness of hepatitis B among households in Malaysia: a community-based cross-sectional survey. BMC Public Health 2019;19:47. [PMID: 30630464 DOI: 10.1186/s12889-018-6375-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
641 Huang YJ, Yang SS, Yeh HZ, Chang CS, Peng YC. Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B. PLoS One 2019;14:e0221958. [PMID: 31469875 DOI: 10.1371/journal.pone.0221958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
642 Choi J, Lim YS. Secondary prevention of hepatitis B virus-related hepatocellular carcinoma with current antiviral therapies. Kaohsiung J Med Sci 2021;37:262-7. [PMID: 33502828 DOI: 10.1002/kjm2.12364] [Reference Citation Analysis]
643 Luo A, Jiang X, Ren H. Lamivudine therapy for chronic hepatitis B in children: a meta-analysis. Virol J 2019;16:88. [PMID: 31272463 DOI: 10.1186/s12985-019-1193-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
644 Yazie TD, Tebeje MG. An updated systematic review and meta-analysis of the prevalence of hepatitis B virus in Ethiopia. BMC Infect Dis 2019;19:917. [PMID: 31664923 DOI: 10.1186/s12879-019-4486-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
645 Salerno D, Chiodo L, Alfano V, Floriot O, Cottone G, Paturel A, Pallocca M, Plissonnier ML, Jeddari S, Belloni L, Zeisel M, Levrero M, Guerrieri F. Hepatitis B protein HBx binds the DLEU2 LncRNA to sustain cccDNA and host cancer-related gene transcription. Gut. 2020;69:2016-2024. [PMID: 32114505 DOI: 10.1136/gutjnl-2019-319637] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
646 Ishizaki A, Bouscaillou J, Luhmann N, Liu S, Chua R, Walsh N, Hess S, Ivanova E, Roberts T, Easterbrook P. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries. BMC Infect Dis. 2017;17:696. [PMID: 29143609 DOI: 10.1186/s12879-017-2767-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
647 Mudaliar S, Liu K. Editorial: putting more muscle into treating our chronic hepatitis B patients-the importance of assessing sarcopenia. Aliment Pharmacol Ther 2018;48:579-80. [DOI: 10.1111/apt.14894] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
648 Pan X, Chen J, Zhou L, Ou X, He F, Liu Y, Zheng S, Wang H, Cao B, Wang Z, Liu H, Liu G, Huang Z, Shen G, Liu S, Chen D. Efficacy and safety of continuous antiviral therapy from preconception to prevent perinatal transmission of hepatitis B virus. Sci Rep 2020;10:13631. [PMID: 32788743 DOI: 10.1038/s41598-020-70644-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
649 Wiktor SZ. Viral Hepatitis. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases. The World Bank; 2017. pp. 401-9. [DOI: 10.1596/978-1-4648-0524-0_ch16] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
650 Makjaroen J, Somparn P, Hodge K, Poomipak W, Hirankarn N, Pisitkun T. Comprehensive Proteomics Identification of IFN-λ3-regulated Antiviral Proteins in HBV-transfected Cells. Mol Cell Proteomics 2018;17:2197-215. [PMID: 30097535 DOI: 10.1074/mcp.RA118.000735] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
651 Chen R, Pei S, Chen Y, Tan L, Xue Y, Liu S, Huang Y, Fan X. Suboptimal Response to Tenofovir Alafenamide in Two Patients With HBeAg-Positive Hepatitis B: A Case Report. Front Med (Lausanne) 2021;8:701061. [PMID: 34307428 DOI: 10.3389/fmed.2021.701061] [Reference Citation Analysis]
652 Kaba D, Bangoura MA, Sylla MM, Sako FB, Diallo MS, Diallo I, Kolié OY, Keita AS, Diané BF, Keita F, Diakité M, Kanté MD, Savané M, Sylla D, Kaké A, Diallo K, Touré M, Cissé M. Prevalence and factors associated with hepatitis B in a cohort of HIV-infected children in the Pediatric Department at Donka National Hospital, Guinea. Pan Afr Med J 2019;34:182. [PMID: 32153722 DOI: 10.11604/pamj.2019.34.182.16275] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
653 Si J, Yu C, Guo Y, Bian Z, Meng R, Yang L, Chen Y, Jin J, Liu J, Guo Z, Chen J, Chen Z, Lv J, Li L; China Kadoorie Biobank Collaborative Group. Chronic hepatitis B virus infection and total and cause-specific mortality: a prospective cohort study of 0.5 million people. BMJ Open 2019;9:e027696. [PMID: 30967410 DOI: 10.1136/bmjopen-2018-027696] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
654 Osei E, Niyilapah J, Kofi Amenuvegbe G. Hepatitis B Knowledge, Testing, and Vaccination History among Undergraduate Public Health Students in Ghana. Biomed Res Int 2019;2019:7645106. [PMID: 31485444 DOI: 10.1155/2019/7645106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
655 Nima M, Karimi-sari H, Alavian SM. Art and viral hepatitis elimination programmes. Journal of Virus Eradication 2018;4:59-60. [DOI: 10.1016/s2055-6640(20)30244-2] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
656 Msomi N, Naidoo K, Yende-Zuma N, Padayatchi N, Govender K, Singh JA, Abdool-Karim S, Abdool-Karim Q, Mlisana K. High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa. BMC Infect Dis 2020;20:847. [PMID: 33198649 DOI: 10.1186/s12879-020-05575-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
657 Zhang X, Zhu L, Zhou Y, Shi A, Wang H, Han M, Wan X, Kilonzo SB, Luo X, Chen T, Ning Q. Interference with KCTD9 inhibits NK cell activation and ameliorates fulminant liver failure in mice. BMC Immunol 2018;19:20. [PMID: 29940856 DOI: 10.1186/s12865-018-0256-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
658 Welker MW, Zeuzem S. Pre- and Post-Transplant Antiviral Therapy (HBV, HCV). Visc Med 2016;32:105-9. [PMID: 27413727 DOI: 10.1159/000445152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
659 Parry JV, Easterbrook P, Sands AR. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? BMC Infect Dis. 2017;17:705. [PMID: 29143611 DOI: 10.1186/s12879-017-2774-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
660 Liu Z, Li S, Guo W, Wang Y, Wang M, Bai O. MYC Gene Rearrangements Are Closely Associated with Poor Survival of Diffuse Large B Cell Lymphoma with Hepatitis B Virus Infection. Biomed Res Int 2017;2017:1967648. [PMID: 29209623 DOI: 10.1155/2017/1967648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
661 Wani MA, Sodhi JS, Zargar SA, Yatoo GN, Shah A, Aziz SA, Geelani S, Haq I, Gulzar GM, Khan M, Haq I. Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children. J Clin Exp Hepatol 2020;10:150-4. [PMID: 32189930 DOI: 10.1016/j.jceh.2019.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
662 Hassan MA, Kim WR, Li R, Smith CI, Fried MW, Sterling RK, Ghany MG, Wahed AS, Ganova-Raeva LM, Roberts LR, Lok ASF; Hepatitis B Research Network. Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis B. Am J Epidemiol 2017;186:356-66. [PMID: 28525625 DOI: 10.1093/aje/kwx064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
663 Chen YC, Hsu CW, Jeng WJ, Lin CY. Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients. Dig Dis Sci 2021. [PMID: 33569664 DOI: 10.1007/s10620-020-06761-x] [Reference Citation Analysis]
664 Mason LMK, Veldhuijzen IK, Duffell E, van Ahee A, Bunge EM, Amato-Gauci AJ, Tavoschi L. Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review. J Viral Hepat 2019;26:1431-53. [PMID: 31332919 DOI: 10.1111/jvh.13182] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
665 Han N, Yan L, Wang X, Sun X, Huang F, Tang H. An updated literature review: how HBV X protein regulates the propagation of the HBV. Future Virology 2020;15:649-58. [DOI: 10.2217/fvl-2020-0251] [Reference Citation Analysis]
666 Pang J, Zhang G, Lin Y, Xie Z, Liu H, Tang L, Lu M, Yan R, Guo H, Sun J, Hou J, Zhang X. Transforming growth factor β-activated kinase 1 transcriptionally suppresses hepatitis B virus replication. Sci Rep 2017;7:39901. [PMID: 28045080 DOI: 10.1038/srep39901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
667 Yin Y, Xue M, Shi L, Qiu T, Xia D, Fu G, Peng Z. A Noninvasive Prediction Model for Hepatitis B Virus Disease in Patients with HIV: Based on the Population of Jiangsu, China. Biomed Res Int 2021;2021:6696041. [PMID: 33860053 DOI: 10.1155/2021/6696041] [Reference Citation Analysis]
668 Grzegorzewska AE, Świderska MK, Mostowska A, Jagodziński PP. Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients. Biomed Res Int 2017;2017:3713025. [PMID: 29226133 DOI: 10.1155/2017/3713025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
669 Ortega-Prieto AM, Skelton JK, Wai SN, Large E, Lussignol M, Vizcay-Barrena G, Hughes D, Fleck RA, Thursz M, Catanese MT, Dorner M. 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection. Nat Commun 2018;9:682. [PMID: 29445209 DOI: 10.1038/s41467-018-02969-8] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 23.5] [Reference Citation Analysis]
670 Yang Y, Yan Y, Chen Z, Hu J, Wang K, Tang N, Li X, Zhou Z. Histone Deacetylase Inhibitors Romidepsin and Vorinostat Promote Hepatitis B Virus Replication by Inducing Cell Cycle Arrest. J Clin Transl Hepatol 2021;9:160-8. [PMID: 34007797 DOI: 10.14218/JCTH.2020.00105] [Reference Citation Analysis]
671 Rostam-Abadi Y, Rafiemanesh H, Gholami J, Shadloo B, Amin-Esmaeili M, Rahimi-Movaghar A. Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis. Harm Reduct J 2020;17:81. [PMID: 33087141 DOI: 10.1186/s12954-020-00424-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
672 Wong RJ, Campbell B, Liu B, Baden R, Bhuket T. Sub-optimal Testing and Awareness of HCV and HBV Among High Risk Individuals at an Underserved Safety-Net Hospital. J Community Health 2018;43:65-9. [PMID: 28647860 DOI: 10.1007/s10900-017-0388-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
673 Cai H, Liu G, Zhong J, Zheng K, Xiao H, Li C, Song X, Li Y, Xu C, Wu H, He Z, Zhu Q. Immune Checkpoints in Viral Infections. Viruses 2020;12:E1051. [PMID: 32967229 DOI: 10.3390/v12091051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
674 Feustel S, Ayón-Pérez F, Sandoval-Rodriguez A, Rodríguez-Echevarría R, Contreras-Salinas H, Armendáriz-Borunda J, Sánchez-Orozco LV. Protective Effects of Moringa oleifera on HBV Genotypes C and H Transiently Transfected Huh7 Cells. J Immunol Res 2017;2017:6063850. [PMID: 29214184 DOI: 10.1155/2017/6063850] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
675 Ajmera V, Huang H, Dao D, Feld JJ, Lau DT, Patel K, Rule JA, Daly M, Lee WM, Chung RT. Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus-Related Acute Liver Failure. Cell Mol Gastroenterol Hepatol 2019;7:477-479.e4. [PMID: 30827414 DOI: 10.1016/j.jcmgh.2018.09.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
676 Orr C, Myers R, Li B, Jiang Z, Flaherty J, Gaggar A, Meissner EG. Longitudinal analysis of serum microRNAs as predictors of cirrhosis regression during treatment of hepatitis B virus infection. Liver Int 2020;40:1693-700. [PMID: 32301252 DOI: 10.1111/liv.14474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
677 Zhang Y, Xie Y, Chen Q, Chen X, Dong Z, Tan X. Prevalence and co-infection of schistosomiasis/hepatitis B among rural populations in endemic areas in Hubei, China. Trans R Soc Trop Med Hyg 2020;114:155-61. [PMID: 31722017 DOI: 10.1093/trstmh/trz086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
678 Taghiabadi M, Hosseini SY, Gorzin AA, Taghavi SA, Monavari SHR, Sarvari J. Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals. Clin Exp Hepatol 2019;5:161-8. [PMID: 31501793 DOI: 10.5114/ceh.2019.84781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
679 Cremer J, Hofstraat SHI, van Heiningen F, Veldhuijzen IK, van Benthem BHB, Benschop KSM. Genetic variation of hepatitis B surface antigen among acute and chronic hepatitis B virus infections in The Netherlands. J Med Virol 2018;90:1576-85. [PMID: 29797607 DOI: 10.1002/jmv.25232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
680 Kenney AD, Dowdle JA, Bozzacco L, McMichael TM, St Gelais C, Panfil AR, Sun Y, Schlesinger LS, Anderson MZ, Green PL, López CB, Rosenberg BR, Wu L, Yount JS. Human Genetic Determinants of Viral Diseases. Annu Rev Genet 2017;51:241-63. [PMID: 28853921 DOI: 10.1146/annurev-genet-120116-023425] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 10.8] [Reference Citation Analysis]
681 Kayesh MEH, Hashem MA, Kitab B, Tsukiyama-Kohara K. Pathogenesis and Immune Response Caused by Vector-Borne and Other Viral Infections in a Tupaia Model. Microorganisms 2019;7:E686. [PMID: 31842286 DOI: 10.3390/microorganisms7120686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
682 Zhang GL, Zhao QY, Lin CS, Hu ZX, Zhang T, Gao ZL. Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease. Biomed Res Int 2019;2019:3951574. [PMID: 30809540 DOI: 10.1155/2019/3951574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
683 Cohen D, Ghosh S, Shimakawa Y, Ramou N, Garcia PS, Dubois A, Guillot C, Kakwata-Nkor Deluce N, Tilloy V, Durand G, Voegele C, Ndow G, d'Alessandro U, Brochier-Armanet C, Alain S, Le Calvez-Kelm F, Hall J, Zoulim F, Mendy M, Thursz M, Lemoine M, Chemin I. Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma. JHEP Rep 2020;2:100144. [PMID: 32904132 DOI: 10.1016/j.jhepr.2020.100144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
684 Karamitros T, Papatheodoridis G, Paraskevis D, Hatzakis A, Mbisa JL, Georgopoulou U, Klenerman P, Magiorkinis G. Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma. Front Immunol 2018;9:777. [PMID: 29713327 DOI: 10.3389/fimmu.2018.00777] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
685 Aldersley J, Lorenz DR, Misra V, Uno H, Gabuzda D. Increased risk of anal squamous cell carcinoma in HIV-positive men with prior hepatitis B virus infection. AIDS 2019;33:145-52. [PMID: 30325778 DOI: 10.1097/QAD.0000000000002059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
686 Zhao H, Wang C, Pan Y, Guo Y, Yao N, Wang H, Jin L, Li B. Niacin, lutein and zeaxanthin and physical activity have an impact on Charlson comorbidity index using zero-inflated negative binomial regression model: National Health and Nutrition Examination Survey 2013-2014. BMC Public Health 2019;19:1589. [PMID: 31779602 DOI: 10.1186/s12889-019-7906-7] [Reference Citation Analysis]
687 Ortonne V, Wlassow M, Bouvier-Alias M, Melica G, Poveda JD, Laperche S, Pawlotsky JM, Chevaliez S. Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas® HBV Test for Use on the Cobas® 4800 System. Microorganisms 2021;9:573. [PMID: 33799562 DOI: 10.3390/microorganisms9030573] [Reference Citation Analysis]
688 Xiong M, Li J, Yang S, Zeng F, Ji Y, Liu J, Wu Q, He Q, Jiang R, Zhou F, Wen W, Chen J, Hou J. Influence of Gender and Reproductive Factors on Liver Fibrosis in Patients With Chronic Hepatitis B Infection. Clin Transl Gastroenterol 2019;10:e00085. [PMID: 31651450 DOI: 10.14309/ctg.0000000000000085] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
689 Sun Q, Lao TT, Du M, Xie M, Sun Y, Bai B, Ma J, Zhu T, Yu S, Ma R. Chronic maternal hepatitis B virus infection and pregnancy outcome- a single center study in Kunming, China. BMC Infect Dis 2021;21:253. [PMID: 33691634 DOI: 10.1186/s12879-021-05946-7] [Reference Citation Analysis]
690 Pinheiro PS, Callahan KE, Gomez SL, Marcos-Gragera R, Cobb TR, Roca-Barcelo A, Ramirez AG. High cancer mortality for US-born Latinos: evidence from California and Texas. BMC Cancer 2017;17:478. [PMID: 28693448 DOI: 10.1186/s12885-017-3469-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
691 Veronese P, Dodi I, Esposito S, Indolfi G. Prevention of vertical transmission of hepatitis B virus infection. World J Gastroenterol 2021; 27(26): 4182-4193 [PMID: 34326618 DOI: 10.3748/wjg.v27.i26.4182] [Reference Citation Analysis]
692 Dah TTE, Couderc C, Coulibaly A, Kouamé MJ, Agboyibor MK, Traoré I, Maradan G, Rojas Castro D, Mensah E, Anoma C, Dembélé Keita B, Spire B, Laurent C; CohMSM Study Group . Hepatitis B Virus Prevalence and Vaccination in Men Who Have Sex With Men in West Africa (CohMSM ANRS 12324-Expertise France). Open Forum Infect Dis 2019;6:ofz249. [PMID: 31281855 DOI: 10.1093/ofid/ofz249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
693 Oropeza CE, Tarnow G, Taha TY, Shalaby RE, Hyde MV, Maienschein-Cline M, Green SJ, McLachlan A. Relative DNA Methylation and Demethylation Efficiencies during Postnatal Liver Development Regulate Hepatitis B Virus Biosynthesis. J Virol 2021;95:e02148-20. [PMID: 33361417 DOI: 10.1128/JVI.02148-20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
694 Oliveira MP, Matos MA, Silva ÁM, Lopes CL, Teles SA, Matos MA, Spitz N, Araujo NM, Mota RM, Kerr LR, Martins RM. Prevalence, Risk Behaviors, and Virological Characteristics of Hepatitis B Virus Infection in a Group of Men Who Have Sex with Men in Brazil: Results from a Respondent-Driven Sampling Survey. PLoS One 2016;11:e0160916. [PMID: 27508385 DOI: 10.1371/journal.pone.0160916] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
695 Shen FF, Wang Y, Wang YF, Zheng RD, Xian JC, Shi JP, Qu Y, Dong YW, Xu MY, Lu LG. Prediction of hepatic necroinflammatory activity in patients with chronic hepatitis B by a simple noninvasive model. J Transl Med 2018;16:166. [PMID: 29914513 DOI: 10.1186/s12967-018-1538-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
696 Liu X, Qin S. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges. Oncologist 2019;24:S3-S10. [PMID: 30819826 DOI: 10.1634/theoncologist.2019-IO-S1-s01] [Cited by in Crossref: 24] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
697 Ly KN, Kim AA, Umuro M, Drobenuic J, Williamson JM, Montgomery JM, Fields BS, Teshale EH. Prevalence of Hepatitis B Virus Infection in Kenya, 2007. Am J Trop Med Hyg 2016;95:348-53. [PMID: 27273644 DOI: 10.4269/ajtmh.16-0059] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
698 Tang J, Xiao X, Jiang Y, Tian Y, Peng Z, Yang M, Xu Z, Gong G. miR-3 Encoded by Hepatitis B Virus Downregulates PTEN Protein Expression and Promotes Cell Proliferation. J Hepatocell Carcinoma 2020;7:257-69. [PMID: 33154957 DOI: 10.2147/JHC.S271091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
699 Jaquet A, Nouaman M, Tine J, Tanon A, Anoma C, Inwoley A, Attia A, Ekouevi DK, Seydi M, Dabis F. Hepatitis B treatment eligibility in West Africa: Uncertainties and need for prospective cohort studies. Liver Int. 2017;37:1116-1121. [PMID: 28561454 DOI: 10.1111/liv.13484] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
700 Bhattarai M, Baniya JB, Aryal N, Shrestha B, Rauniyar R, Adhikari A, Koirala P, Oli PK, Pandit RD, Stein DA, Gupta BP. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal. Biomed Res Int 2018;2018:9241679. [PMID: 29487874 DOI: 10.1155/2018/9241679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
701 Haile K, Timerga A, Mose A, Mekonnen Z. Hepatitis B vaccination status and associated factors among students of medicine and health sciences in Wolkite University, Southwest Ethiopia: A cross-sectional study. PLoS One 2021;16:e0257621. [PMID: 34547021 DOI: 10.1371/journal.pone.0257621] [Reference Citation Analysis]
702 Deng Y, Zhao H, Zhou J, Yan L, Wang G; China HepB-Related Fibrosis Assessment Research Group. Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT. BMC Infect Dis 2017;17:650. [PMID: 28962551 DOI: 10.1186/s12879-017-2728-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
703 Adjei CA, Stutterheim SE, Naab F, Ruiter RAC. "To die is better than to tell": reasons for and against disclosure of chronic hepatitis B status in Ghana. BMC Public Health 2020;20:663. [PMID: 32398150 DOI: 10.1186/s12889-020-08811-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
704 Huang X, Zheng X, Shen C. Antiviral Therapy with Entecavir following Antituberculosis Therapy Alleviates Liver Injury and Restores Innate Immunity in Tuberculosis Patients Coinfected with Hepatitis B Virus. Evid Based Complement Alternat Med 2021;2021:2884151. [PMID: